"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,US,S,US D0384890 S,053-286-572-222-725,1997-10-14,1997,US 3957695 F,1995-05-31,US 3957695 F,1995-05-31,Milk bottle,,FARMLAND DAIRIES,GOLDMAN MARC,FARMLAND DAIRIES (1995-05-25),https://lens.org/053-286-572-222-725,Design Right,yes,15,8,1,1,0,,,D 9520;;0901,0,0,,,,EXPIRED
2,US,B1,US 7810259 B1,135-805-549-234-853,2010-10-12,2010,US 29036308 A,2008-10-29,US 29036308 A,2008-10-29,Snow pusher with a removable friction-reducing edge,"Various embodiments provide an improved snow pusher with a removable friction-reducing edge. An example embodiment includes a blade having a generally rectangular shape and being of rigid material, the blade including an angled lower portion; a slider for removable attachment to the angled lower portion of the blade, the slider being fabricated from a friction-reducing material; a handle attachment mechanism for removable attachment to the blade; and a handle for removable attachment to the handle attachment mechanism.",GOLDMAN MARC,GOLDMAN MARC,,https://lens.org/135-805-549-234-853,Granted Patent,yes,11,5,1,1,0,E01H5/02;;E01H5/02,E01H5/02,37/285,0,0,,,,ACTIVE
3,US,A1,US 2019/0100341 A1,038-350-000-684-035,2019-04-04,2019,US 201715721921 A,2017-10-01,US 201715721921 A,2017-10-01,STRETCH WRAP DISPENSER,"An apparatus and method for a stretch wrap dispenser are disclosed. An example embodiment includes: a stem; a lower roll holder and stand-up base attached to the stem, beveled side up, with a stem stud, the lower roll holder and stand-up base being configured to enable the stem to stand upright; an upper roll holder attached to the stem, beveled side down, and configured to cause a stretch wrap material roll to fit snugly between the lower roll holder and stand-up base and the upper roll holder; a compression spring placed over the stem; a handle attached to the stem; and a tension control pin insertable through one of a set of holes in the stem to adjust for a desired level of tension in the compression spring.",GOLDMAN MARC,GOLDMAN MARC,,https://lens.org/038-350-000-684-035,Patent Application,yes,9,0,1,1,0,B65B67/085;;B65B67/085;;B65H75/185;;B65H75/185;;B65H2402/412;;B65H2402/412;;B65H2701/1944;;B65H2701/1944,B65B67/08;;B65H75/18,,0,0,,,,DISCONTINUED
4,US,A,US 5558897 A,198-376-551-853-71X,1996-09-24,1996,US 41814995 A,1995-04-05,US 41814995 A;;US 22304294 A,1994-04-05,Milk composition containing fiber and method for making same,"The present invention relates to a milk composition containing milk and up to about 0.0205 weight percent soluble dietary fiber prepared from guar gum which has been enzymatically hydrolyzed, and methods for making same. The milk composition may also contain non-fat milk solids and/or vitamins and minerals.",GOLDMAN; MARC S.,GOLDMAN MARC S,GOLDMAN MARC S (2007-02-15),https://lens.org/198-376-551-853-71X,Granted Patent,yes,16,29,1,3,0,A23C9/137;;A23C9/1544;;A23C9/158;;A23L2/52;;A23L33/17;;A23C9/137;;A23L2/52;;A23C9/158;;A23C9/1544;;A23L33/17,A23C9/137;;A23C9/154;;A23C9/158;;A23C11/10;;A23L1/305;;A23L2/52,426/580;;426/72;;426/74;;426/573,1,0,,,Food Applications of Sunfiber.,EXPIRED
5,US,A,US 5447741 A,085-959-030-495-985,1995-09-05,1995,US 22304294 A,1994-04-05,US 22304294 A,1994-04-05,Milk composition containing fiber and method for making same,"The present invention relates to a milk composition containing milk and soluble dietary fiber prepared from guar gum which has been enzymatically hydrolyzed, wherein the milk composition has a low viscosity (for instance, not greater than about 50 cp.), and methods for making same. The milk composition may also contain non-fat milk solids and/or vitamins and minerals.",GOLDMAN; MARC S.,GOLDMAN MARC S,GOLDMAN MARC S (2007-02-15),https://lens.org/085-959-030-495-985,Granted Patent,yes,16,23,1,3,0,A23C9/137;;A23C9/1544;;A23C9/158;;A23L2/52;;A23L33/17;;A23C9/158;;A23C9/1544;;A23L2/52;;A23C9/137;;A23L33/17,A23C9/137;;A23C9/154;;A23C9/158;;A23C11/10;;A23L1/305;;A23L2/52,426/580;;426/72;;426/74;;426/573,1,0,,,Food Applications of Sunfiber.,EXPIRED
6,US,A,US 5753295 A,052-314-085-720-363,1998-05-19,1998,US 69607196 A,1996-08-31,US 69607196 A;;US 41814995 A;;US 22304294 A,1994-04-05,Non-dairy composition containing fiber and method for making same,"The present invention relates to a non-dairy beverage composition containing non-dairy liquids such as soy milk or rice milk, and up to about 0.032 weight percent soluble dietary fiber prepared from guar gum which has been enzymatically hydrolyzed, and methods for making same. The composition may also contain non-fat solids and/or vitamins and minerals.",GOLDMAN; MARC S.,GOLDMAN MARC S,GOLDMAN MARC S (2007-02-15),https://lens.org/052-314-085-720-363,Granted Patent,yes,19,51,1,3,0,A23C9/137;;A23C9/1544;;A23C9/158;;A23C11/10;;A23C11/103;;A23L2/52;;Y10S426/804;;A23L33/17;;A23L11/65;;A23C9/137;;A23C9/1544;;A23C11/10;;A23C9/158;;A23L2/52;;A23C11/103;;A23L33/17;;Y10S426/804;;A23L11/65,A23C9/137;;A23C9/154;;A23C9/158;;A23C11/10;;A23L1/305;;A23L2/52,426/590;;426/72;;426/74;;426/573;;426/618;;426/634;;426/804,0,0,,,,EXPIRED
7,KR,A,KR 20140042870 A,003-972-260-391-358,2014-04-07,2014,KR 20147001534 A,2012-06-21,US 201113165621 A;;US 201113187397 A;;US 201113308137 A;;US 2012/0043588 W,2011-06-21,TEST UNIT CARTRIDGE FOR ALALYTE TESTING DEVICE,,YOFIMETER LLC,SHAANAN GAD;;GOLDMAN MARC,,https://lens.org/003-972-260-391-358,Patent Application,no,2,4,12,43,0,A61B5/14532;;A61B5/150022;;A61B5/150267;;A61B5/150358;;A61B5/150412;;A61B5/150572;;A61B5/15113;;A61B5/15117;;A61B5/15153;;A61B5/15174;;A61B5/157;;A61B5/14546;;A61B5/1468;;A61B2562/0295;;G01N33/48757;;A61B5/150503;;Y10T436/144444;;Y10T436/144444;;A61B5/150022;;A61B5/15113;;A61B5/15117;;A61B5/157;;A61B5/150572;;A61B5/150358;;A61B5/150267;;A61B5/150412;;A61B5/15174;;A61B5/15153;;A61B5/14532;;A61B5/14546;;A61B5/1468;;A61B2562/0295;;G01N33/48757;;A61B5/150503,A61B5/145;;A61B5/151;;A61B5/157,,0,0,,,,INACTIVE
8,EP,B1,EP 2723234 B1,092-299-302-850-227,2015-04-08,2015,EP 12741405 A,2012-06-20,US 201113165621 A;;US 201113307364 A;;US 2012/0043331 W,2011-06-21,Analyte testing device with lancet cartridge and test strip cartridge,,YOFIMETER LLC,SHAANAN GAD;;GOLDMAN MARC,,https://lens.org/092-299-302-850-227,Granted Patent,yes,4,0,12,43,0,A61B5/1411;;A61B5/150022;;A61B5/150022;;A61B5/145;;A61B5/14532;;A61B5/14532;;A61B5/1495;;A61B5/1495;;A61B5/15019;;A61B5/15019;;A61B5/150267;;A61B5/150267;;A61B5/150358;;A61B5/150358;;A61B5/150412;;A61B5/150412;;A61B5/150748;;A61B5/150748;;A61B5/150809;;A61B5/150809;;A61B5/150824;;A61B5/150824;;A61B5/150854;;A61B5/150854;;A61B5/150862;;A61B5/150862;;A61B5/15087;;A61B5/15087;;A61B5/151;;A61B5/15113;;A61B5/15113;;A61B5/15117;;A61B5/15117;;A61B5/1513;;A61B5/1513;;A61B5/15153;;A61B5/15153;;A61B5/15174;;A61B5/15174;;A61B5/15182;;A61B5/15182;;A61B5/157;;A61B5/157;;A61B5/157;;A61B2560/0228;;A61B2560/0228;;A61B2560/0456;;A61B2560/0456;;A61B2562/0295;;A61B2562/0295;;G01N33/48757;;G01N33/48757,A61B5/145;;A61B5/1495;;A61B5/15;;A61B5/151;;A61B5/157,,0,0,,,,ACTIVE
9,US,B1,US 8333716 B1,106-415-050-623-213,2012-12-18,2012,US 201113187397 A,2011-07-20,US 201113187397 A;;US 201113165621 A,2011-06-21,Methods for using an analyte testing device,"A test unit cartridge for holding a plurality of test units includes a first test unit that contains a first analyte sensor and a second test unit that contains a second analyte sensor. The first and second analyte sensors use first and second reagents to detect first and second analytes, respectively. The first analyte is different from the second analyte and the first and second test units are functionally non-fungible. The plurality of test units can also include a third test unit that contains two analyte sensors having two reagents for detecting two different analytes using one fluid sample. A method of using the test unit cartridge is also described, which comprises loading the cartridge into an analyte testing device and cocking an actuator of the device that is configured to (i) expose an analyte sensor of a test unit, (ii) ready a lancet, and (iii) advance a lancet cartridge.",SHAANAN GAD;;GOLDMAN MARC;;YOFIMETER LLC,SHAANAN GAD;;GOLDMAN MARC,GADLIGHT INC (2011-07-20);;YOFIMETER INC (2012-03-22),https://lens.org/106-415-050-623-213,Granted Patent,yes,103,0,12,43,0,A61B5/14532;;A61B5/150022;;A61B5/150267;;A61B5/150358;;A61B5/150412;;A61B5/150572;;A61B5/15113;;A61B5/15117;;A61B5/15153;;A61B5/15174;;A61B5/157;;A61B5/14546;;A61B5/1468;;A61B2562/0295;;G01N33/48757;;A61B5/150503;;Y10T436/144444;;Y10T436/144444;;A61B5/150022;;A61B5/15113;;A61B5/15117;;A61B5/157;;A61B5/150572;;A61B5/150358;;A61B5/150267;;A61B5/150412;;A61B5/15174;;A61B5/15153;;A61B5/14532;;A61B5/14546;;A61B5/1468;;A61B2562/0295;;G01N33/48757;;A61B5/150503,A61B5/00;;B65D81/00,600/584;;600/575;;600/583,8,0,,,"""Accu-Chek Mobile System"", Blood Glucose Meter, Roche LTD., Feb. 23, 2011, http://www.accu-check.co.uk/gb/products/metersystems/mobile.html.;;""Always Connected, Always Monitoring the Critical Signals You Need to Know"", CST Critical Signal Technologies, your Link to Life, Farmington Hills, MI 48335.;;Amy T., ""Lifescan's New Diabetes iPhone App"", Diabetes Mine: the all things diabetes blog, Mar. 17, 2009, http://www.diabetesmine.com/2009/03/lifescans-new-diabetes-iphone-app.html.;;""Medline Docking Station for Glucose Meter"", http://www.google.com/products/catalog?q=docking+station+for+glucose+meter&hl=en&um=1&ie=UTF-8&tbm=shop&cid=14673613440805108352&sa=X&ei=Eq-DTp2QGcnKiALyt-XwBw&ved=0CFIQ8wlwAA#.;;""OneTouch Ultra Link"" Lifescan Consumer Products, 2011, http://www.lifescan.com/products/meters/ultralink/.;;""Precision PCx Glucose Monitoring System-Medline and Abbott Diabetes Care Post Acute Care Bring You Fill Billing Capture, Compliance, and Accuracy in Blood Glucose Testing"", Med Supplies Care, 2011, http://www.medsuppliescare.com/medsupply.cfm/DOCKING-STATION-FOR-PRECISION-PCX-5650.;;""TRUEmanager-Track a healthier course to diabetes management"", Nipro Diagnostics, 2010, http://www.niprodiagnostics.com/our-products/ma-true-manager.aspx.;;""TRUEresult Docking Station and USB Cable"", Diabetes Health Supplies, 2011, http://www.diabeteshealthsupplies.com/products/TRUEresult-Docking-Station-and-USB-Cable.html.",INACTIVE
10,KR,A,KR 20140042872 A,166-378-212-798-865,2014-04-07,2014,KR 20147001537 A,2012-06-21,US 201113165621 A;;US 201113187360 A;;US 201113187397 A;;US 201113188399 A;;US 2012/0043605 W,2011-06-21,COCKING AND ADVANCING MECHANISM FOR ANALYTE TESTING DEVICE,,YOFIMETER LLC,SHAANAN GAD;;GOLDMAN MARC,,https://lens.org/166-378-212-798-865,Patent Application,no,4,0,13,43,0,A61B5/150022;;A61B5/150022;;A61B5/14532;;A61B5/14532;;A61B5/150267;;A61B5/150267;;A61B5/150358;;A61B5/150358;;A61B5/150412;;A61B5/150412;;A61B5/150503;;A61B5/150503;;A61B5/15113;;A61B5/15113;;A61B5/15117;;A61B5/15117;;A61B5/1513;;A61B5/1513;;A61B5/15153;;A61B5/15153;;A61B5/15174;;A61B5/15174;;A61B5/157;;A61B5/157;;G01N33/48757;;G01N33/48757,A61B5/15;;A61B5/145;;A61B5/151;;A61B5/157,,0,0,,,,INACTIVE
11,KR,A,KR 20140042869 A,184-923-809-891-337,2014-04-07,2014,KR 20147001533 A,2012-06-20,US 201113165621 A;;US 201113307364 A;;US 2012/0043331 W,2011-06-21,ANALYTE TESTING DEVICE WITH LANCET CARTRIDGE AND TEST STRIP CARTRIDGE,,YOFIMETER LLC,SHAANAN GAD;;GOLDMAN MARC,,https://lens.org/184-923-809-891-337,Patent Application,no,0,0,12,43,0,A61B5/1411;;A61B5/150022;;A61B5/150022;;A61B5/145;;A61B5/14532;;A61B5/14532;;A61B5/1495;;A61B5/1495;;A61B5/15019;;A61B5/15019;;A61B5/150267;;A61B5/150267;;A61B5/150358;;A61B5/150358;;A61B5/150412;;A61B5/150412;;A61B5/150748;;A61B5/150748;;A61B5/150809;;A61B5/150809;;A61B5/150824;;A61B5/150824;;A61B5/150854;;A61B5/150854;;A61B5/150862;;A61B5/150862;;A61B5/15087;;A61B5/15087;;A61B5/151;;A61B5/15113;;A61B5/15113;;A61B5/15117;;A61B5/15117;;A61B5/1513;;A61B5/1513;;A61B5/15153;;A61B5/15153;;A61B5/15174;;A61B5/15174;;A61B5/15182;;A61B5/15182;;A61B5/157;;A61B5/157;;A61B5/157;;A61B2560/0228;;A61B2560/0228;;A61B2560/0456;;A61B2560/0456;;A61B2562/0295;;A61B2562/0295;;G01N33/48757;;G01N33/48757,A61B5/145;;A61B5/15;;A61B5/151;;A61B5/157,,0,0,,,,DISCONTINUED
12,US,A1,US 2012/0330555 A1,016-296-071-603-287,2012-12-27,2012,US 201113187360 A,2011-07-20,US 201113187360 A;;US 201113165621 A,2011-06-21,Analyte Testing System with Docking Station for Data Management,"An analyte testing system having an analyte testing device and a docking station is described. The analyte testing device includes a plurality of lancets, a plurality of analyte sensors, electronics for deriving test data from the analyte sensors, a visual display that displays test data, and a data recording facility that records non-test data. Examples of non-test data include text diary information, audio diary information, food eaten, minutes exercised, medication taken, and estimated calories burned. The docking station has a power interface and data interface that provide power and data connectivity to the testing device. The docking station also has a storage facility configured to automatically store the test data and non-test data.",SHAANAN GAD;;GOLDMAN MARC;;GADLIGHT INC,SHAANAN GAD;;GOLDMAN MARC,GADLIGHT INC (2011-07-20);;YOFIMETER INC (2012-03-22),https://lens.org/016-296-071-603-287,Patent Application,yes,0,14,3,43,0,A61B5/150022;;A61B5/150022;;A61B5/145;;A61B5/145;;A61B5/14532;;A61B5/14532;;A61B5/150267;;A61B5/150267;;A61B5/150412;;A61B5/150412;;A61B5/150503;;A61B5/150503;;A61B5/150854;;A61B5/150854;;A61B5/150862;;A61B5/150862;;A61B5/15087;;A61B5/15087;;A61B5/15113;;A61B5/15113;;A61B5/15117;;A61B5/15117;;A61B5/1513;;A61B5/1513;;A61B5/15153;;A61B5/15153;;A61B5/15174;;A61B5/15174;;A61B5/15182;;A61B5/15182;;A61B5/157;;A61B5/157;;A61B2560/0456;;A61B2560/0456;;A61M2209/086;;A61M2209/086;;G01N33/48792;;G01N33/48792,G01N33/48;;G06F19/10,702/19,0,0,,,,DISCONTINUED
13,PL,T3,PL 2723237 T3,079-765-665-332-183,2015-12-31,2015,PL 12741408 T,2012-06-21,US 201113165621 A;;US 201113187360 A;;US 201113187397 A;;US 201113188399 A;;EP 12741408 A;;US 2012/0043605 W,2011-06-21,Cocking and advancing mechanism for analyte testing device,,YOFIMETER LLC,SHAANAN GAD;;GOLDMAN MARC,,https://lens.org/079-765-665-332-183,Patent Application,no,0,0,13,43,0,A61B5/150022;;A61B5/150022;;A61B5/14532;;A61B5/14532;;A61B5/150267;;A61B5/150267;;A61B5/150358;;A61B5/150358;;A61B5/150412;;A61B5/150412;;A61B5/150503;;A61B5/150503;;A61B5/15113;;A61B5/15113;;A61B5/15117;;A61B5/15117;;A61B5/1513;;A61B5/1513;;A61B5/15153;;A61B5/15153;;A61B5/15174;;A61B5/15174;;A61B5/157;;A61B5/157;;G01N33/48757;;G01N33/48757,A61B5/15;;A61B5/145;;A61B5/151;;A61B5/157,,0,0,,,,PENDING
14,US,A1,US 2013/0245392 A1,171-164-727-913-057,2013-09-19,2013,US 201313868831 A,2013-04-23,US 201313868831 A;;US 201213689618 A;;US 201113188399 A;;US 201113187360 A;;US 201113165621 A;;US 201113187397 A,2011-06-21,ANALYTE TESTING DEVICES,"Systems, devices, techniques and methods are disclosed for implementing an actuator mechanism of an analyte testing device. In one aspect, a method to test an analyte includes advancing an analyte sensor from a first position within a sensor cartridge of an analyte testing device to a second position that exposes at least a portion of the analyte sensor outside of the device, advancing a lancet projecting component from an initial position to a cocked position for a subsequent projection of a lancet, in which the advancing the analyte sensor and the advancing the lancet projecting component are initiated by a single operation, projecting the lancet to expose at least a portion of the lancet outside of the device, receiving a testing sample including an analyte at the exposed portion of the analyte sensor, processing the testing sample to determine a parameter of the analyte, and ejecting the analyte sensor from the device.",YOFIMETER LLC,SHAANAN GAD;;GOLDMAN MARC,YOFIMETER LLC (2012-12-03),https://lens.org/171-164-727-913-057,Patent Application,yes,9,4,3,43,0,A61B5/150358;;A61B5/150412;;A61B5/15117;;A61B5/15153;;A61B5/15174;;G01N33/48757;;A61B5/15087;;A61B5/15113;;A61B5/150022;;A61B5/157;;A61B5/14532;;A61B5/1513;;A61B5/150267;;A61B5/15113;;A61B5/145;;A61B5/15194;;A61B5/150022;;A61B5/157;;A61B5/150175;;A61B5/14532;;A61B5/15148;;A61B5/1513;;A61B5/0004;;A61B5/150824;;A61B5/742;;A61B5/1118;;A61B5/746;;A61B5/150267;;A61B5/150961;;A61B5/150358;;A61B5/150412;;A61B5/15117;;A61B5/15153;;A61B5/15174;;G01N33/48757;;A61B5/15087,A61B5/00;;A61B5/151;;A61B5/11;;A61B5/145;;A61B5/15,600/301;;600/309;;600/365,0,0,,,,INACTIVE
15,EP,A1,EP 2723234 A1,133-810-296-714-464,2014-04-30,2014,EP 12741405 A,2012-06-20,US 201113165621 A;;US 201113307364 A;;US 2012/0043331 W,2011-06-21,Analyte testing device with lancet cartridge and test strip cartridge,,YOFIMETER LLC,SHAANAN GAD;;GOLDMAN MARC,,https://lens.org/133-810-296-714-464,Patent Application,yes,0,0,12,43,0,A61B5/1411;;A61B5/150022;;A61B5/150022;;A61B5/145;;A61B5/14532;;A61B5/14532;;A61B5/1495;;A61B5/1495;;A61B5/15019;;A61B5/15019;;A61B5/150267;;A61B5/150267;;A61B5/150358;;A61B5/150358;;A61B5/150412;;A61B5/150412;;A61B5/150748;;A61B5/150748;;A61B5/150809;;A61B5/150809;;A61B5/150824;;A61B5/150824;;A61B5/150854;;A61B5/150854;;A61B5/150862;;A61B5/150862;;A61B5/15087;;A61B5/15087;;A61B5/151;;A61B5/15113;;A61B5/15113;;A61B5/15117;;A61B5/15117;;A61B5/1513;;A61B5/1513;;A61B5/15153;;A61B5/15153;;A61B5/15174;;A61B5/15174;;A61B5/15182;;A61B5/15182;;A61B5/157;;A61B5/157;;A61B5/157;;A61B2560/0228;;A61B2560/0228;;A61B2560/0456;;A61B2560/0456;;A61B2562/0295;;A61B2562/0295;;G01N33/48757;;G01N33/48757,A61B5/145;;A61B5/1495;;A61B5/15;;A61B5/151;;A61B5/157,,1,0,,,See references of WO 2012177748A1,ACTIVE
16,US,B1,US 8333717 B1,178-746-259-405-469,2012-12-18,2012,US 201113308137 A,2011-11-30,US 201113308137 A;;US 201113187397 A;;US 201113165621 A,2011-06-21,Test unit cartridge for analyte testing device,"A test unit cartridge for holding a plurality of test units includes a first test unit that contains a first analyte sensor and a second test unit that contains a second analyte sensor. The first and second analyte sensors use first and second reagents to detect first and second analytes, respectively. The first analyte is different from the second analyte and the first and second test units are functionally non-fungible. The plurality of test units can also include a third test unit that contains two analyte sensors having two reagents for detecting two different analytes using one fluid sample. A method of using the test unit cartridge is also described, which comprises loading the cartridge into an analyte testing device and cocking an actuator of the device that is configured to (i) expose an analyte sensor of a test unit, (ii) ready a lancet, and (iii) advance a lancet cartridge.",SHAANAN GAD;;GOLDMAN MARC;;YOFIMETER LLC,SHAANAN GAD;;GOLDMAN MARC,GADLIGHT INC (2011-07-20);;YOFIMETER INC (2012-03-22),https://lens.org/178-746-259-405-469,Granted Patent,yes,104,4,12,43,0,A61B5/14532;;A61B5/150022;;A61B5/150267;;A61B5/150358;;A61B5/150412;;A61B5/150572;;A61B5/15113;;A61B5/15117;;A61B5/15153;;A61B5/15174;;A61B5/157;;A61B5/14546;;A61B5/1468;;A61B2562/0295;;G01N33/48757;;A61B5/150503;;Y10T436/144444;;Y10T436/144444;;A61B5/150022;;A61B5/15113;;A61B5/15117;;A61B5/157;;A61B5/150572;;A61B5/150358;;A61B5/150267;;A61B5/150412;;A61B5/15174;;A61B5/15153;;A61B5/14532;;A61B5/14546;;A61B5/1468;;A61B2562/0295;;G01N33/48757;;A61B5/150503,A61B5/00;;B65D81/00,600/584;;600/575;;600/583,8,0,,,"* ""Accu-Chek Mobile System"", Blood Glucose Meter, Roche LTD., Feb. 23, 2011, http://www.accu-check.co.uk/gb/products/metersystems/mobile.html.;;* ""Always Connected, Always Monitoring the Critical Signals You Need to Know"", CST Critical Signal Technologies, your Link to Life, Farmington Hills, MI 48335.;;* Amy T., ""Lifescan's New Diabetes iPhone App"", Diabetes Mine: the all things diabetes blog, Mar. 17, 2009, http://www.diabetesmine.com/2009/03/lifescans-new-diabetes-iphone-app.html.;;* ""Medline Docking Station for Glucose Meter"", http://www.google.com/products/catalog?q=docking+station+for+glucose+meter&hl=en&um=1&ie=UTF-8&tbm=shop&cid=14673613440805108352&sa=X&ei=Eq-DTp2QGcnKiALyt-XwBw&ved=0CFIQ8w1wAA#.;;* ""OneTouch Ultra Link"" Lifescan Consumer Products, 2011, http://www.lifescan.com/products/meters/ultralink/.;;* ""Precision PCx Glucose Monitoring System-Medline and Abbott Diabetes Care Post Acute Care Bring You Fill Billing Capture, Compliance, and Accuracy in Blood Glucose Testing"", Med Supplies Care, 2011, http://www.medsuppliescare.com/medsupply.cfm/DOCKING-STATION-FOR-PRECISION-PCX-5650.;;* ""TRUEmanager-Track a healthier course to diabetes management"", Nipro Diagnostics, 2010, http://www.niprodiagnostics.com/our-products/ma-true-manager.aspx.;;* ""TRUEresult Docking Station and USB Cable"", Diabetes Health Supplies, 2011, http://www.diabeteshealthsupplies.com/products/TRUEresult-Docking-Station-and-USB-Cable.html.",INACTIVE
17,CA,A1,CA 2839885 A1,027-124-338-069-131,2012-12-27,2012,CA 2839885 A,2012-06-20,US 201113165621 A;;US 201113307364 A;;US 2012/0043331 W,2011-06-21,ANALYTE TESTING DEVICE WITH LANCET CARTRIDGE AND TEST STRIP CARTRIDGE,"An analyte testing device housing a lancet cartridge and a test strip cartridge is described. The testing device simplifies analyte testing/monitoring by providing an actuator and linkage mechanism that: (i) cocks a lancing device, (ii) exposes a test strip for use; and (iii) advances the lancet cartridge. The testing device also includes conversion electronics, which receives a signal from a test trip and converts the signal into readable data.",YOFIMETER LLC,SHAANAN GAD;;GOLDMAN MARC,,https://lens.org/027-124-338-069-131,Patent Application,no,0,0,12,43,0,A61B5/1411;;A61B5/150022;;A61B5/150022;;A61B5/145;;A61B5/14532;;A61B5/14532;;A61B5/1495;;A61B5/1495;;A61B5/15019;;A61B5/15019;;A61B5/150267;;A61B5/150267;;A61B5/150358;;A61B5/150358;;A61B5/150412;;A61B5/150412;;A61B5/150748;;A61B5/150748;;A61B5/150809;;A61B5/150809;;A61B5/150824;;A61B5/150824;;A61B5/150854;;A61B5/150854;;A61B5/150862;;A61B5/150862;;A61B5/15087;;A61B5/15087;;A61B5/151;;A61B5/15113;;A61B5/15113;;A61B5/15117;;A61B5/15117;;A61B5/1513;;A61B5/1513;;A61B5/15153;;A61B5/15153;;A61B5/15174;;A61B5/15174;;A61B5/15182;;A61B5/15182;;A61B5/157;;A61B5/157;;A61B5/157;;A61B2560/0228;;A61B2560/0228;;A61B2560/0456;;A61B2560/0456;;A61B2562/0295;;A61B2562/0295;;G01N33/48757;;G01N33/48757,A61B5/145;;A61B5/15;;A61B5/151;;A61B5/157,,0,0,,,,DISCONTINUED
18,US,B2,US 9308324 B2,060-813-048-950-799,2016-04-12,2016,US 201314371401 A,2013-09-26,US 201314371401 A;;CA 2808738 A;;US 201261706071 P;;US 2013/0062048 W,2012-09-26,Portable medicine injection device and analyte metering system,"Methods, systems, and devices are described for setting a dose of medicine and injecting the medicine. In one aspect, a method to dispense a medicine includes inserting a cartridge containing a medicine into a cartridge holder coupled to a housing of a medicine injection device, positioning a spine component of the device to make contact with the cartridge in the cartridge holder, selecting a dose of the medicine for injection, in which the selecting includes rotating an injection component of the device to a setting corresponding to the selected dose, and linearly advancing the injection component to rotate a drive gear coupled to the injection component to drive the spine component so as to push the end of the cartridge to dispense the medicine in the amount of the selected dose.",YOFIMETER LLC,SHAANAN GAD;;GOLDMAN MARC,YOFIMETER LLC (2015-05-14);;GADLIGHT INC (2014-07-17),https://lens.org/060-813-048-950-799,Granted Patent,yes,14,7,13,13,0,A61M5/31551;;A61M5/14244;;A61M5/1452;;A61M5/1454;;A61M5/1723;;A61M5/20;;A61M5/20;;A61M5/24;;A61M5/24;;A61M5/24;;A61M5/28;;A61M5/28;;A61M5/31528;;A61M5/31543;;A61M5/31543;;A61M5/31543;;A61M5/31551;;A61M5/31551;;A61M5/31558;;A61M5/31561;;A61M5/31561;;A61M5/31561;;A61M5/31575;;A61M5/31575;;A61M5/31575;;A61M5/3158;;A61M5/3158;;A61M5/3158;;A61M5/31585;;A61M5/31585;;A61M5/31585;;A61M2005/14506;;A61M2005/2407;;A61M2005/2407;;A61M2005/2407;;A61M2005/31518;;A61M2005/31518;;A61M2005/31518;;A61M2205/3584;;A61M2205/3584;;A61M2205/3592;;A61M2205/3592;;A61M2205/50;;A61M2205/50;;A61M2205/52;;A61M2205/581;;A61M2205/581;;A61M2205/581;;A61M2205/6063;;A61M2230/201;;A61M2230/201;;G16H20/17;;G16H20/17;;G06F19/3468;;G08B21/02,A61M5/20;;A61M5/142;;A61M5/145;;A61M5/24;;A61M5/28;;A61M5/315;;G06F19/00,,1,0,,,"Han, Inho, International Search Report and Written Opinion, PCT Application No. PCT/US2013/062048, dated Dec. 18, 2013, 13 pages.",INACTIVE
19,US,B1,US 8292826 B1,082-920-018-521-469,2012-10-23,2012,US 201113308315 A,2011-11-30,US 201113308315 A;;US 201113188399 A;;US 201113187360 A;;US 201113187397 A;;US 201113165621 A,2011-06-21,Cocking and advancing mechanism for analyte testing device,"An analyte testing device includes an analyte sensor, a lancet, and a mechanism with an actuator that operates to independently expose the analyte sensor and advance the lancet into position for use. The analyte sensor is preferably included in an analyte sensor cartridge that houses a plurality of sensors. Similarly, the lancet is preferably included in a lancet cartridge that houses a plurality of lancets. The actuator can be a lever configured to expose the analyte sensor and advance the lancet into position with a single motion (e.g., pulling the lever). The actuator also preferably operates to cock a hammer in preparation for lancing a body member to draw a blood sample. The mechanism can be a linkage coupled with the actuator and configured to engage the analyte sensor and lancet.",SHAANAN GAD;;GOLDMAN MARC;;YOFIMETER INC,SHAANAN GAD;;GOLDMAN MARC,GADLIGHT INC (2011-07-20);;YOFIMETER INC (2012-03-22),https://lens.org/082-920-018-521-469,Granted Patent,yes,105,3,13,43,0,A61B5/150022;;A61B5/150022;;A61B5/14532;;A61B5/14532;;A61B5/150267;;A61B5/150267;;A61B5/150358;;A61B5/150358;;A61B5/150412;;A61B5/150412;;A61B5/150503;;A61B5/150503;;A61B5/15113;;A61B5/15113;;A61B5/15117;;A61B5/15117;;A61B5/1513;;A61B5/1513;;A61B5/15153;;A61B5/15153;;A61B5/15174;;A61B5/15174;;A61B5/157;;A61B5/157;;G01N33/48757;;G01N33/48757,A61B5/00;;A61B17/14;;A61B17/32;;B65D81/00,600/583;;600/575;;600/584;;606/181;;606/183,8,0,,,"* ""Accu-Chek Mobile System"", Blood Glucose Meter, Roche LTD., Feb. 23, 2011, http://www.accu-check.co.uk/gb/products/metersystems/mobile.html.;;* ""Always Connected, Always Monitoring the Critical Signals You Need to Know"", CST Critical Signal Technologies, your Link to Life, Farmington Hills, MI 48335.;;* Amy T., ""Lifescan's New Diabetes iPhone App"", Diabetes Mine: the all things diabetes blog, Mar 17, 2009, http://www.diabetesmine.com/2009/03/lifescans-new-diabetes-iphone-app.html.;;* ""Medline Docking Station for Glucose Meter"", http://www.google.com/products/catalog?q=docking+station+for+glucose+meter&hl=en&um=1&ie=UTF-8&tbm=shop&cid=14673613440805108352&sa=X&ei=Eq-DTp2QGcnKiALyt-XwBw&ved=0CFIQ8wlwAA#.;;* ""OneTouch Ultra Link"" Lifescan Consumer Products, 2011, http://www.lifescan.com/products/meters/ultralink/.;;* ""Precision PCx Glucose Monitoring System-Medline and Abbott Diabetes Care Post Acute Care Bring You Fill Billing Capture, Compliance, and Accuracy in Blood Glucose Testing"", Med Supplies Care, 2011, http://www.medsuppliescare.com/medsupply.cfm/DOCKING-STATION-FOR-PRECISION-PCX-5650.;;* ""TRUEmanager-Track a healthier course to diabetes management"", Nipro Diagnostics, 2010, http://www.niprodiagnostics.com/our-products/ma-true-manager.aspx.;;* ""TRUEresult Docking Station and USB Cable"", Diabetes Health Supplies, 2011, http://www.diabeteshealthsupplies.com/products/TRUEresult-Docking-Station-and-USB-Cable.html.",INACTIVE
20,WO,A1,WO 2012/177908 A1,146-140-476-227-622,2012-12-27,2012,US 2012/0043588 W,2012-06-21,US 201113165621 A;;US 201113187397 A;;US 201113308137 A,2011-06-21,TEST UNIT CARTRIDGE FOR ANALYTE TESTING DEVICE,"A test unit cartridge for holding a plurality of test units includes a first test unit that contains a first analyte sensor and a second test unit that contains a second analyte sensor. The first and second analyte sensors use first and second reagents to detect first and second analytes, respectively. The first analyte is different from the second analyte and the first and second test units are functionally non-fungible. The plurality of test units can also include a third test unit that contains two analyte sensors having two reagents for detecting two different analytes using one fluid sample. A method of using the test unit cartridge is also described, which comprises loading the cartridge into an analyte testing device and cocking an actuator of the device that is configured to (i) expose an analyte sensor of a test unit, (ii) ready a lancet, and (iii) advance a lancet cartridge.",YOFIMETER LLC;;SHAANAN GAD;;GOLDMAN MARC,SHAANAN GAD;;GOLDMAN MARC,,https://lens.org/146-140-476-227-622,Patent Application,yes,16,2,12,43,0,A61B5/14532;;A61B5/150022;;A61B5/150267;;A61B5/150358;;A61B5/150412;;A61B5/150572;;A61B5/15113;;A61B5/15117;;A61B5/15153;;A61B5/15174;;A61B5/157;;A61B5/14546;;A61B5/1468;;A61B2562/0295;;G01N33/48757;;A61B5/150503;;Y10T436/144444;;Y10T436/144444;;A61B5/150022;;A61B5/15113;;A61B5/15117;;A61B5/157;;A61B5/150572;;A61B5/150358;;A61B5/150267;;A61B5/150412;;A61B5/15174;;A61B5/15153;;A61B5/14532;;A61B5/14546;;A61B5/1468;;A61B2562/0295;;G01N33/48757;;A61B5/150503,A61B5/15;;A61B5/145;;A61B5/151;;A61B5/157;;G01N33/49,,0,0,,,,PENDING
21,US,A1,US 2012/0330189 A1,006-483-244-195-500,2012-12-27,2012,US 201113307364 A,2011-11-30,US 201113307364 A;;US 201113165621 A,2011-06-21,Analyte Testing Device with Lancet Cartridge and Test Strip Cartridge,"An analyte testing device housing a lancet cartridge and a test strip cartridge is described. The testing device simplifies analyte testing/monitoring by providing an actuator and linkage mechanism that: (i) cocks a lancing device, (ii) exposes a test strip for use; and (iii) advances the lancet cartridge. The testing device also includes conversion electronics, which receives a signal from a test trip and converts the signal into readable data.",SHAANAN GAD;;GOLDMAN MARC;;GADLIGHT INC,SHAANAN GAD;;GOLDMAN MARC,GADLIGHT INC (2011-07-08);;YOFIMETER INC (2012-03-22),https://lens.org/006-483-244-195-500,Patent Application,yes,5,8,12,43,0,A61B5/1411;;A61B5/150022;;A61B5/150022;;A61B5/145;;A61B5/14532;;A61B5/14532;;A61B5/1495;;A61B5/1495;;A61B5/15019;;A61B5/15019;;A61B5/150267;;A61B5/150267;;A61B5/150358;;A61B5/150358;;A61B5/150412;;A61B5/150412;;A61B5/150748;;A61B5/150748;;A61B5/150809;;A61B5/150809;;A61B5/150824;;A61B5/150824;;A61B5/150854;;A61B5/150854;;A61B5/150862;;A61B5/150862;;A61B5/15087;;A61B5/15087;;A61B5/151;;A61B5/15113;;A61B5/15113;;A61B5/15117;;A61B5/15117;;A61B5/1513;;A61B5/1513;;A61B5/15153;;A61B5/15153;;A61B5/15174;;A61B5/15174;;A61B5/15182;;A61B5/15182;;A61B5/157;;A61B5/157;;A61B5/157;;A61B2560/0228;;A61B2560/0228;;A61B2560/0456;;A61B2560/0456;;A61B2562/0295;;A61B2562/0295;;G01N33/48757;;G01N33/48757,A61B5/151,600/583,0,0,,,,DISCONTINUED
22,EP,B1,EP 2723237 B1,024-397-771-087-765,2015-08-05,2015,EP 12741408 A,2012-06-21,US 201113165621 A;;US 201113187360 A;;US 201113187397 A;;US 201113188399 A;;US 2012/0043605 W,2011-06-21,Cocking and advancing mechanism for analyte testing device,,YOFIMETER LLC,SHAANAN GAD;;GOLDMAN MARC,,https://lens.org/024-397-771-087-765,Granted Patent,yes,8,0,13,43,0,A61B5/150022;;A61B5/150022;;A61B5/14532;;A61B5/14532;;A61B5/150267;;A61B5/150267;;A61B5/150358;;A61B5/150358;;A61B5/150412;;A61B5/150412;;A61B5/150503;;A61B5/150503;;A61B5/15113;;A61B5/15113;;A61B5/15117;;A61B5/15117;;A61B5/1513;;A61B5/1513;;A61B5/15153;;A61B5/15153;;A61B5/15174;;A61B5/15174;;A61B5/157;;A61B5/157;;G01N33/48757;;G01N33/48757,A61B5/15;;A61B5/145;;A61B5/151;;A61B5/157,,0,0,,,,ACTIVE
23,US,A1,US 2012/0330556 A1,153-293-816-651-907,2012-12-27,2012,US 201113308024 A,2011-11-30,US 201113308024 A;;US 201113187360 A;;US 201113165621 A,2011-06-21,Analyte Testing System with Docking Station for Data Management,"An analyte testing system having an analyte testing device and a docking station is described. The analyte testing device includes a plurality of lancets, a plurality of analyte sensors, electronics for deriving test data from the analyte sensors, a visual display that displays test data, and a data recording facility that records non-test data. Examples of non-test data include text diary information, audio diary information, food eaten, minutes exercised, medication taken, and estimated calories burned. The docking station has a power interface and data interface that provide power and data connectivity to the testing device. The docking station also has a storage facility configured to automatically store the test data and non-test data.",SHAANAN GAD;;GOLDMAN MARC;;GADLIGHT INC,SHAANAN GAD;;GOLDMAN MARC,GADLIGHT INC (2011-07-20);;YOFIMETER INC (2012-03-22),https://lens.org/153-293-816-651-907,Patent Application,yes,12,18,3,43,0,A61B5/150022;;A61B5/150022;;A61B5/145;;A61B5/145;;A61B5/14532;;A61B5/14532;;A61B5/150267;;A61B5/150267;;A61B5/150412;;A61B5/150412;;A61B5/150503;;A61B5/150503;;A61B5/150854;;A61B5/150854;;A61B5/150862;;A61B5/150862;;A61B5/15087;;A61B5/15087;;A61B5/15113;;A61B5/15113;;A61B5/15117;;A61B5/15117;;A61B5/1513;;A61B5/1513;;A61B5/15153;;A61B5/15153;;A61B5/15174;;A61B5/15174;;A61B5/15182;;A61B5/15182;;A61B5/157;;A61B5/157;;A61B2560/0456;;A61B2560/0456;;A61M2209/086;;A61M2209/086;;G01N33/48792;;G01N33/48792,G06F19/00;;G01N33/02;;G01N33/15;;G01N33/483,702/19,1,0,,,"RSA (Securing Data at Rest: Developing a Database Encryption Strategy A White Paper for Developers, e-Business Managers and IT, RSA Security INC, pp. 15, 2002)",DISCONTINUED
24,DK,T3,DK 2723237 T3,170-899-914-407-046,2015-10-19,2015,DK 12741408 T,2012-06-21,US 201113165621 A;;US 201113187360 A;;US 201113187397 A;;US 201113188399 A;;US 2012/0043605 W,2011-06-21,Spænde- og fremføringsmekanisme til analyttestindretning,,YOFIMETER LLC,SHAANAN GAD;;GOLDMAN MARC,,https://lens.org/170-899-914-407-046,Granted Patent,no,0,0,13,43,0,A61B5/150022;;A61B5/150022;;A61B5/14532;;A61B5/14532;;A61B5/150267;;A61B5/150267;;A61B5/150358;;A61B5/150358;;A61B5/150412;;A61B5/150412;;A61B5/150503;;A61B5/150503;;A61B5/15113;;A61B5/15113;;A61B5/15117;;A61B5/15117;;A61B5/1513;;A61B5/1513;;A61B5/15153;;A61B5/15153;;A61B5/15174;;A61B5/15174;;A61B5/157;;A61B5/157;;G01N33/48757;;G01N33/48757,A61B5/15;;A61B5/145;;A61B5/151;;A61B5/157,,0,0,,,,ACTIVE
25,WO,A1,WO 2020/023576 A1,199-924-603-109-396,2020-01-30,2020,US 2019/0043146 W,2019-07-24,US 201862703346 P,2018-07-25,SUBCUTANEOUS ACCESS HUB WITH MULTIPLE CANNULA PORTS,Subcutaneous access hub embodiments are discussed herein that include housing embodiments having a plurality of cannula ports and a fluid passageway network that allows fluid communication between a fluid source and the plurality of cannula access ports. Such a configuration may allow a user such as a patient or clinician to releasably secure the housing to an outside surface of the patient's skin. Multiple locations on the patient's skin may then be accessed for deployment of one or more delivery cannulas via a plurality of cannula ports for delivery of fluid and from the fluid source to multiple subcutaneous locations below the patient's skin and timely movement of cannula access in the patient's skin without the need for relocating the housing.,MODULAR MEDICAL INC,DIPERNA PAUL;;GOLDMAN MARC,,https://lens.org/199-924-603-109-396,Patent Application,yes,7,0,4,4,0,A61K38/28;;A61M39/0208;;A61M2005/14252;;A61M2005/1586;;A61M5/158;;A61M5/14248;;A61M2039/0036;;A61M2039/0205;;A61M2039/0223;;A61M5/158;;A61M5/14248;;A61M25/0097;;A61M25/02;;A61M39/0208;;A61M2005/14252;;A61M2039/0036;;A61M2039/0205;;A61M2039/0223;;A61M2025/0266;;A61M2005/1586;;A61K38/28,A61M5/00;;A61M5/158;;A61M25/00;;A61M39/02,,0,0,,,,PENDING
26,US,A1,US 2012/0329164 A1,062-983-827-527-580,2012-12-27,2012,US 201113308137 A,2011-11-30,US 201113308137 A;;US 201113187397 A;;US 201113165621 A,2011-06-21,Test Unit Cartridge for Analyte Testing Device,"A test unit cartridge for holding a plurality of test units includes a first test unit that contains a first analyte sensor and a second test unit that contains a second analyte sensor. The first and second analyte sensors use first and second reagents to detect first and second analytes, respectively. The first analyte is different from the second analyte and the first and second test units are functionally non-fungible. The plurality of test units can also include a third test unit that contains two analyte sensors having two reagents for detecting two different analytes using one fluid sample. A method of using the test unit cartridge is also described, which comprises loading the cartridge into an analyte testing device and cocking an actuator of the device that is configured to (i) expose an analyte sensor of a test unit, (ii) ready a lancet, and (iii) advance a lancet cartridge.",SHAANAN GAD;;GOLDMAN MARC;;GADLIGHT INC,SHAANAN GAD;;GOLDMAN MARC,GADLIGHT INC (2011-07-20);;YOFIMETER INC (2012-03-22),https://lens.org/062-983-827-527-580,Patent Application,yes,5,1,12,43,0,A61B5/14532;;A61B5/150022;;A61B5/150267;;A61B5/150358;;A61B5/150412;;A61B5/150572;;A61B5/15113;;A61B5/15117;;A61B5/15153;;A61B5/15174;;A61B5/157;;A61B5/14546;;A61B5/1468;;A61B2562/0295;;G01N33/48757;;A61B5/150503;;Y10T436/144444;;Y10T436/144444;;A61B5/150022;;A61B5/15113;;A61B5/15117;;A61B5/157;;A61B5/150572;;A61B5/150358;;A61B5/150267;;A61B5/150412;;A61B5/15174;;A61B5/15153;;A61B5/14532;;A61B5/14546;;A61B5/1468;;A61B2562/0295;;G01N33/48757;;A61B5/150503,G01N33/66,436/95;;422/69,0,0,,,,INACTIVE
27,AU,A1,AU 2013/323433 A1,174-400-642-722-586,2015-04-23,2015,AU 2013/323433 A,2013-09-26,US 201261706071 P;;CA 2808738 A;;US 2013/0062048 W,2012-09-26,Portable medicine injection device and analyte metering system,"Methods, systems, and devices are described for setting a dose of medicine and injecting the medicine. In one aspect, a method to dispense a medicine includes inserting a cartridge containing a medicine into a cartridge holder coupled to a housing of a medicine injection device, positioning a spine component of the device to make contact with the cartridge in the cartridge holder, selecting a dose of the medicine for injection, in which the selecting includes rotating an injection component of the device to a setting corresponding to the selected dose, and linearly advancing the injection component to rotate a drive gear coupled to the injection component to drive the spine component so as to push the end of the cartridge to dispense the medicine in the amount of the selected dose.",GADLIGHT INC,SHAANAN GAD;;GOLDMAN MARC,,https://lens.org/174-400-642-722-586,Patent Application,no,0,0,13,13,0,A61M5/31551;;A61M5/14244;;A61M5/1452;;A61M5/1454;;A61M5/1723;;A61M5/20;;A61M5/20;;A61M5/24;;A61M5/24;;A61M5/24;;A61M5/28;;A61M5/28;;A61M5/31528;;A61M5/31543;;A61M5/31543;;A61M5/31543;;A61M5/31551;;A61M5/31551;;A61M5/31558;;A61M5/31561;;A61M5/31561;;A61M5/31561;;A61M5/31575;;A61M5/31575;;A61M5/31575;;A61M5/3158;;A61M5/3158;;A61M5/3158;;A61M5/31585;;A61M5/31585;;A61M5/31585;;A61M2005/14506;;A61M2005/2407;;A61M2005/2407;;A61M2005/2407;;A61M2005/31518;;A61M2005/31518;;A61M2005/31518;;A61M2205/3584;;A61M2205/3584;;A61M2205/3592;;A61M2205/3592;;A61M2205/50;;A61M2205/50;;A61M2205/52;;A61M2205/581;;A61M2205/581;;A61M2205/581;;A61M2205/6063;;A61M2230/201;;A61M2230/201;;G16H20/17;;G16H20/17;;G06F19/3468;;G08B21/02,A61M5/28;;A61M5/20,,0,0,,,,DISCONTINUED
28,PL,T3,PL 2723234 T3,012-862-031-402-454,2015-10-30,2015,PL 12741405 T,2012-06-20,US 201113165621 A;;US 201113307364 A;;EP 12741405 A;;US 2012/0043331 W,2011-06-21,Analyte testing device with lancet cartridge and test strip cartridge,,YOFIMETER LLC,SHAANAN GAD;;GOLDMAN MARC,,https://lens.org/012-862-031-402-454,Patent Application,no,0,0,12,43,0,A61B5/1411;;A61B5/150022;;A61B5/150022;;A61B5/145;;A61B5/14532;;A61B5/14532;;A61B5/1495;;A61B5/1495;;A61B5/15019;;A61B5/15019;;A61B5/150267;;A61B5/150267;;A61B5/150358;;A61B5/150358;;A61B5/150412;;A61B5/150412;;A61B5/150748;;A61B5/150748;;A61B5/150809;;A61B5/150809;;A61B5/150824;;A61B5/150824;;A61B5/150854;;A61B5/150854;;A61B5/150862;;A61B5/150862;;A61B5/15087;;A61B5/15087;;A61B5/151;;A61B5/15113;;A61B5/15113;;A61B5/15117;;A61B5/15117;;A61B5/1513;;A61B5/1513;;A61B5/15153;;A61B5/15153;;A61B5/15174;;A61B5/15174;;A61B5/15182;;A61B5/15182;;A61B5/157;;A61B5/157;;A61B5/157;;A61B2560/0228;;A61B2560/0228;;A61B2560/0456;;A61B2560/0456;;A61B2562/0295;;A61B2562/0295;;G01N33/48757;;G01N33/48757,A61B5/145;;A61B5/1495;;A61B5/15;;A61B5/151;;A61B5/157,,0,0,,,,PENDING
29,US,A1,US 2012/0330119 A1,063-239-903-387-016,2012-12-27,2012,US 201113165621 A,2011-06-21,US 201113165621 A,2011-06-21,Analyte Testing Device with Lancet Cartridge and Test Strip Cartridge,"An analyte testing device housing a lancet cartridge and a test strip cartridge is described. The testing device simplifies analyte testing/monitoring by providing an actuator and linkage mechanism that: (i) cocks a lancing device, (ii) exposes a test strip for use; and (iii) advances the lancet cartridge. The testing device also includes conversion electronics, which receives a signal from a test trip and converts the signal into readable data.",SHAANAN GAD;;GOLDMAN MARC;;GADLIGHT INC,SHAANAN GAD;;GOLDMAN MARC,GADLIGHT INC (2011-07-08);;YOFIMETER INC (2012-03-22),https://lens.org/063-239-903-387-016,Patent Application,yes,0,10,12,43,0,A61B5/1411;;A61B5/150022;;A61B5/150022;;A61B5/145;;A61B5/14532;;A61B5/14532;;A61B5/1495;;A61B5/1495;;A61B5/15019;;A61B5/15019;;A61B5/150267;;A61B5/150267;;A61B5/150358;;A61B5/150358;;A61B5/150412;;A61B5/150412;;A61B5/150748;;A61B5/150748;;A61B5/150809;;A61B5/150809;;A61B5/150824;;A61B5/150824;;A61B5/150854;;A61B5/150854;;A61B5/150862;;A61B5/150862;;A61B5/15087;;A61B5/15087;;A61B5/151;;A61B5/15113;;A61B5/15113;;A61B5/15117;;A61B5/15117;;A61B5/1513;;A61B5/1513;;A61B5/15153;;A61B5/15153;;A61B5/15174;;A61B5/15174;;A61B5/15182;;A61B5/15182;;A61B5/157;;A61B5/157;;A61B5/157;;A61B2560/0228;;A61B2560/0228;;A61B2560/0456;;A61B2560/0456;;A61B2562/0295;;A61B2562/0295;;G01N33/48757;;G01N33/48757,A61B5/157,600/347;;600/345,0,0,,,,DISCONTINUED
30,EP,B1,EP 2723235 B1,082-023-784-907-280,2015-11-25,2015,EP 12743557 A,2012-06-21,US 201113165621 A;;US 201113187397 A;;US 201113308137 A;;US 2012/0043588 W,2011-06-21,TEST UNIT CARTRIDGE FOR ANALYTE TESTING DEVICE,,YOFIMETER LLC,SHAANAN GAD;;GOLDMAN MARC,,https://lens.org/082-023-784-907-280,Granted Patent,yes,10,0,12,43,0,A61B5/14532;;A61B5/150022;;A61B5/150267;;A61B5/150358;;A61B5/150412;;A61B5/150572;;A61B5/15113;;A61B5/15117;;A61B5/15153;;A61B5/15174;;A61B5/157;;A61B5/14546;;A61B5/1468;;A61B2562/0295;;G01N33/48757;;A61B5/150503;;Y10T436/144444;;Y10T436/144444;;A61B5/150022;;A61B5/15113;;A61B5/15117;;A61B5/157;;A61B5/150572;;A61B5/150358;;A61B5/150267;;A61B5/150412;;A61B5/15174;;A61B5/15153;;A61B5/14532;;A61B5/14546;;A61B5/1468;;A61B2562/0295;;G01N33/48757;;A61B5/150503,A61B5/1468;;A61B5/145;;A61B5/15;;A61B5/151;;A61B5/157;;G01N27/327;;G01N33/49,,0,0,,,,ACTIVE
31,WO,A1,WO 2014/052676 A1,086-723-673-369-291,2014-04-03,2014,US 2013/0062048 W,2013-09-26,CA 2808738 A;;US 201261706071 P,2012-09-26,PORTABLE MEDICINE INJECTION DEVICE AND ANALYTE METERING SYSTEM,"Methods, systems, and devices are described for setting a dose of medicine and injecting the medicine. In one aspect, a method to dispense a medicine includes inserting a cartridge containing a medicine into a cartridge holder coupled to a housing of a medicine injection device, positioning a spine component of the device to make contact with the cartridge in the cartridge holder, selecting a dose of the medicine for injection, in which the selecting includes rotating an injection component of the device to a setting corresponding to the selected dose, and linearly advancing the injection component to rotate a drive gear coupled to the injection component to drive the spine component so as to push the end of the cartridge to dispense the medicine in the amount of the selected dose.",GADLIGHT INC,SHAANAN GAD;;GOLDMAN MARC,,https://lens.org/086-723-673-369-291,Patent Application,yes,5,22,13,13,0,A61M5/31551;;A61M5/14244;;A61M5/1452;;A61M5/1454;;A61M5/1723;;A61M5/20;;A61M5/20;;A61M5/24;;A61M5/24;;A61M5/24;;A61M5/28;;A61M5/28;;A61M5/31528;;A61M5/31543;;A61M5/31543;;A61M5/31543;;A61M5/31551;;A61M5/31551;;A61M5/31558;;A61M5/31561;;A61M5/31561;;A61M5/31561;;A61M5/31575;;A61M5/31575;;A61M5/31575;;A61M5/3158;;A61M5/3158;;A61M5/3158;;A61M5/31585;;A61M5/31585;;A61M5/31585;;A61M2005/14506;;A61M2005/2407;;A61M2005/2407;;A61M2005/2407;;A61M2005/31518;;A61M2005/31518;;A61M2005/31518;;A61M2205/3584;;A61M2205/3584;;A61M2205/3592;;A61M2205/3592;;A61M2205/50;;A61M2205/50;;A61M2205/52;;A61M2205/581;;A61M2205/581;;A61M2205/581;;A61M2205/6063;;A61M2230/201;;A61M2230/201;;G16H20/17;;G16H20/17;;G06F19/3468;;G08B21/02,A61M5/28;;A61M5/20,,1,0,,,See also references of EP 2900300A4,PENDING
32,EP,A1,EP 2723237 A1,107-604-881-520-417,2014-04-30,2014,EP 12741408 A,2012-06-21,US 201113165621 A;;US 201113187360 A;;US 201113187397 A;;US 201113188399 A;;US 2012/0043605 W,2011-06-21,Cocking and advancing mechanism for analyte testing device,,YOFIMETER LLC,SHAANAN GAD;;GOLDMAN MARC,,https://lens.org/107-604-881-520-417,Patent Application,yes,0,0,13,43,0,A61B5/150022;;A61B5/150022;;A61B5/14532;;A61B5/14532;;A61B5/150267;;A61B5/150267;;A61B5/150358;;A61B5/150358;;A61B5/150412;;A61B5/150412;;A61B5/150503;;A61B5/150503;;A61B5/15113;;A61B5/15113;;A61B5/15117;;A61B5/15117;;A61B5/1513;;A61B5/1513;;A61B5/15153;;A61B5/15153;;A61B5/15174;;A61B5/15174;;A61B5/157;;A61B5/157;;G01N33/48757;;G01N33/48757,A61B5/15;;A61B5/145;;A61B5/151;;A61B5/157,,1,0,,,See references of WO 2012177923A1,ACTIVE
33,JP,A,JP 2016185328 A,148-370-408-447-531,2016-10-27,2016,JP 2016101629 A,2016-05-20,US 201113165621 A;;US 201113307364 A,2011-06-21,ANALYTE TESTING DEVICE WITH PUNCTURE NEEDLE CARTRIDGE AND TEST STRIP CARTRIDGE,"PROBLEM TO BE SOLVED: To provide an analyte testing device housing a puncture needle cartridge and a test strip cartridge, the testing device simplifying analyte testing/monitoring by providing an actuator and linkage mechanism.SOLUTION: The actuator and linkage mechanism of the testing device is configured to (i) make a puncturing device into a puncture ready state, (ii) expose a test strip for use, and (iii) advance the puncture needle cartridge. The testing device also includes conversion electronics. The conversion electronics receive a signal from a test strip and converts the signal into readable data.SELECTED DRAWING: Figure 8",YOFIMETER LLC,GAD SHAANAN;;MARC GOLDMAN,,https://lens.org/148-370-408-447-531,Patent Application,no,2,0,12,43,0,A61B5/1411;;A61B5/150022;;A61B5/150022;;A61B5/145;;A61B5/14532;;A61B5/14532;;A61B5/1495;;A61B5/1495;;A61B5/15019;;A61B5/15019;;A61B5/150267;;A61B5/150267;;A61B5/150358;;A61B5/150358;;A61B5/150412;;A61B5/150412;;A61B5/150748;;A61B5/150748;;A61B5/150809;;A61B5/150809;;A61B5/150824;;A61B5/150824;;A61B5/150854;;A61B5/150854;;A61B5/150862;;A61B5/150862;;A61B5/15087;;A61B5/15087;;A61B5/151;;A61B5/15113;;A61B5/15113;;A61B5/15117;;A61B5/15117;;A61B5/1513;;A61B5/1513;;A61B5/15153;;A61B5/15153;;A61B5/15174;;A61B5/15174;;A61B5/15182;;A61B5/15182;;A61B5/157;;A61B5/157;;A61B5/157;;A61B2560/0228;;A61B2560/0228;;A61B2560/0456;;A61B2560/0456;;A61B2562/0295;;A61B2562/0295;;G01N33/48757;;G01N33/48757,A61B5/157;;A61B5/1473;;A61B5/151,,0,0,,,,PENDING
34,KR,A,KR 20150065737 A,186-581-076-056-320,2015-06-15,2015,KR 20157009940 A,2013-09-26,US 201261706071 P;;CA 2808738 A;;US 2013/0062048 W,2012-09-26,PORTABLE MEDICINE INJECTION DEVICE AND ANALYTE METERING SYSTEM,"약물의 도우즈 설정 및 약물 주입을 위한 방법들, 시스템들, 및 디바이스들이 설명된다. 일 측면에서, 약물을 디스펜스하는 방법은 약물을 수용하는 카트리지를 약물 주입 디바이스의 하우징에 결합된 카트리지 홀더내로 삽입하는 단계; 카트리지 홀더내 카트리지와 접촉하도록 디바이스의 스파인 컴포넌트를 위치시키는 단계, 주입을 위한 상기 약물의 도우즈를 선택하는 단계로서, 상기 디바이스의 주입 컴포넌트를 상기 선택된 도우즈에 대응하는 설정(setting)까지 회전시키는 단계를 포함하는, 상기 선택하는 단계; 및 상기 주입 컴포넌트를 선형으로 전진시키는 단계로서 상기 주입 컴포넌트에 결합된 구동 기어(drive gear)를 회전시켜 상기 선택된 도우즈의 양으로 상기 약물을 디스펜스 하기 위해 상기 카트리지의 끝단을 밀도록 상기 스파인 컴포넌트를 구동시키는, 상기 전진시키는 단계를 포함한다.",GADLIGHT INC,SHAANAN GAD;;GOLDMAN MARC,,https://lens.org/186-581-076-056-320,Patent Application,no,0,0,13,13,0,A61M5/31551;;A61M5/14244;;A61M5/1452;;A61M5/1454;;A61M5/1723;;A61M5/20;;A61M5/20;;A61M5/24;;A61M5/24;;A61M5/24;;A61M5/28;;A61M5/28;;A61M5/31528;;A61M5/31543;;A61M5/31543;;A61M5/31543;;A61M5/31551;;A61M5/31551;;A61M5/31558;;A61M5/31561;;A61M5/31561;;A61M5/31561;;A61M5/31575;;A61M5/31575;;A61M5/31575;;A61M5/3158;;A61M5/3158;;A61M5/3158;;A61M5/31585;;A61M5/31585;;A61M5/31585;;A61M2005/14506;;A61M2005/2407;;A61M2005/2407;;A61M2005/2407;;A61M2005/31518;;A61M2005/31518;;A61M2005/31518;;A61M2205/3584;;A61M2205/3584;;A61M2205/3592;;A61M2205/3592;;A61M2205/50;;A61M2205/50;;A61M2205/52;;A61M2205/581;;A61M2205/581;;A61M2205/581;;A61M2205/6063;;A61M2230/201;;A61M2230/201;;G16H20/17;;G16H20/17;;G06F19/3468;;G08B21/02,A61M5/24;;A61M5/28;;A61M5/315;;G06F19/00,,0,0,,,,DISCONTINUED
35,US,B2,US 8961432 B2,025-969-969-332-305,2015-02-24,2015,US 201313868831 A,2013-04-23,US 201313868831 A;;US 201213689618 A;;US 201113188399 A;;US 201113187360 A;;US 201113165621 A;;US 201113187397 A,2011-06-21,Analyte testing devices,"Systems, devices, techniques and methods are disclosed for implementing an actuator mechanism of an analyte testing device. In one aspect, a method to test an analyte includes advancing an analyte sensor from a first position within a sensor cartridge of an analyte testing device to a second position that exposes at least a portion of the analyte sensor outside of the device, advancing a lancet projecting component from an initial position to a cocked position for a subsequent projection of a lancet, in which the advancing the analyte sensor and the advancing the lancet projecting component are initiated by a single operation, projecting the lancet to expose at least a portion of the lancet outside of the device, receiving a testing sample including an analyte at the exposed portion of the analyte sensor, processing the testing sample to determine a parameter of the analyte, and ejecting the analyte sensor from the device.",YOFIMETER LLC,SHAANAN GAD;;GOLDMAN MARC,YOFIMETER LLC (2012-12-03),https://lens.org/025-969-969-332-305,Granted Patent,yes,108,7,3,43,0,A61B5/150358;;A61B5/150412;;A61B5/15117;;A61B5/15153;;A61B5/15174;;G01N33/48757;;A61B5/15087;;A61B5/15113;;A61B5/150022;;A61B5/157;;A61B5/14532;;A61B5/1513;;A61B5/150267;;A61B5/15113;;A61B5/145;;A61B5/15194;;A61B5/150022;;A61B5/157;;A61B5/150175;;A61B5/14532;;A61B5/15148;;A61B5/1513;;A61B5/0004;;A61B5/150824;;A61B5/742;;A61B5/1118;;A61B5/746;;A61B5/150267;;A61B5/150961;;A61B5/150358;;A61B5/150412;;A61B5/15117;;A61B5/15153;;A61B5/15174;;G01N33/48757;;A61B5/15087,A61B5/00;;A61B5/151;;A61B5/11;;A61B5/145;;A61B5/15;;A61B5/157,600/583;;606/181,9,1,065-283-824-642-868,23098076;;10.1186/1687-9856-2012-28;;pmc3541087,"Accu-Chek Mobile System, Blood Glucose Meter, Roche Ltd., Feb. 23, 2011, http://www.accu-check.co.uk/gb/products/metersystems/mobile.html.;;Always Connected, Always Monitoring the Critical Signals You Need to Know, CST Critical Signal Technologies, your Link to Life, Farmington Hills, MI 48335.;;Amy T., ""Lifescan's New Diabetes iPhone App"", Diabetes Mine: the all things diabetes blog, Mar 17, 2009, http://www.diabetesmine.com/2009/03/lifescans-new-diabetes-iphone-app.html.;;Medline Docking Station for Glucose Meter, http://www.google.com/products/catalog?q=docking+station+for+glucose+meter&hl=en&um=1&ie=UTF-8&tbm=shop&cid=14673613440805108352&sa=X&ei=Eq-DTp2QGcnKiALyt-XwBw&ved=0CFIQ8wlwAA#.;;OneTouch Ultra Link Lifescan Consumer Products, 2011, http://www.lifescan.com/products/meters/ultralink/.;;Precision PCx Glucose Monitoring System-Medline and Abbott Diabetes Care Post Acute Care Bring You Fill Billing Capture, Compliance, and Accuracy in Blood Glucose Testing, Med Supplies Care, 2011, http://www.medsuppliescare.com/medsupply.cfm/Docking-Station-For-Precision-PCX-5650.;;TRUEmanager-Track a healthier course to diabetes management, Nipro Diagnostics, 2010, http://www.niprodiagnostics.com/our-products/ma-true-manager.aspx.;;TRUEresult Docking Station and USB Cable, Diabetes Health Supplies, 2011, http://www.diabeteshealthsupplies.com/products/TRUEresult-Docking-Station-and-USB-Cable.html.;;Ramchandani et al., ""New Technologies for Diabetes: A review of the present and the future,"" International Journal of Pediatric Endocrinology, 2012:28, 2012.",INACTIVE
36,US,A1,US 2016/0220754 A1,137-316-151-697-992,2016-08-04,2016,US 201615094886 A,2016-04-08,US 201615094886 A;;CA 2808738 A;;US 201414371401 A;;US 2013/0062048 W;;US 201261706071 P,2012-09-26,PORTABLE MEDICINE INJECTION DEVICE AND ANALYTE METERING SYSTEM,"Methods, systems, and devices are described for setting a dose of medicine and injecting the medicine. In one aspect, a method to dispense a medicine includes inserting a cartridge containing a medicine into a cartridge holder coupled to a housing of a medicine injection device, positioning a spine component of the device to make contact with the cartridge in the cartridge holder, selecting a dose of the medicine for injection, in which the selecting includes rotating an injection component of the device to a setting corresponding to the selected dose, and linearly advancing the injection component to rotate a drive gear coupled to the injection component to drive the spine component so as to push the end of the cartridge to dispense the medicine in the amount of the selected dose.",YOFIMETER LLC,SHAANAN GAD;;GOLDMAN MARC,,https://lens.org/137-316-151-697-992,Patent Application,yes,9,18,13,13,0,A61M5/31551;;A61M5/14244;;A61M5/1452;;A61M5/1454;;A61M5/1723;;A61M5/20;;A61M5/20;;A61M5/24;;A61M5/24;;A61M5/24;;A61M5/28;;A61M5/28;;A61M5/31528;;A61M5/31543;;A61M5/31543;;A61M5/31543;;A61M5/31551;;A61M5/31551;;A61M5/31558;;A61M5/31561;;A61M5/31561;;A61M5/31561;;A61M5/31575;;A61M5/31575;;A61M5/31575;;A61M5/3158;;A61M5/3158;;A61M5/3158;;A61M5/31585;;A61M5/31585;;A61M5/31585;;A61M2005/14506;;A61M2005/2407;;A61M2005/2407;;A61M2005/2407;;A61M2005/31518;;A61M2005/31518;;A61M2005/31518;;A61M2205/3584;;A61M2205/3584;;A61M2205/3592;;A61M2205/3592;;A61M2205/50;;A61M2205/50;;A61M2205/52;;A61M2205/581;;A61M2205/581;;A61M2205/581;;A61M2205/6063;;A61M2230/201;;A61M2230/201;;G16H20/17;;G16H20/17;;G06F19/3468;;G08B21/02,A61M5/145;;A61M5/172;;G08B21/02,,0,0,,,,DISCONTINUED
37,EP,A1,EP 2723235 A1,182-538-820-484-413,2014-04-30,2014,EP 12743557 A,2012-06-21,US 201113165621 A;;US 201113187397 A;;US 201113308137 A;;US 2012/0043588 W,2011-06-21,TEST UNIT CARTRIDGE FOR ANALYTE TESTING DEVICE,,YOFIMETER LLC,SHAANAN GAD;;GOLDMAN MARC,,https://lens.org/182-538-820-484-413,Patent Application,yes,0,0,12,43,0,A61B5/14532;;A61B5/150022;;A61B5/150267;;A61B5/150358;;A61B5/150412;;A61B5/150572;;A61B5/15113;;A61B5/15117;;A61B5/15153;;A61B5/15174;;A61B5/157;;A61B5/14546;;A61B5/1468;;A61B2562/0295;;G01N33/48757;;A61B5/150503;;Y10T436/144444;;Y10T436/144444;;A61B5/150022;;A61B5/15113;;A61B5/15117;;A61B5/157;;A61B5/150572;;A61B5/150358;;A61B5/150267;;A61B5/150412;;A61B5/15174;;A61B5/15153;;A61B5/14532;;A61B5/14546;;A61B5/1468;;A61B2562/0295;;G01N33/48757;;A61B5/150503,A61B5/1468;;A61B5/145;;A61B5/15;;A61B5/151;;A61B5/157;;G01N27/327;;G01N33/49,,0,0,,,,ACTIVE
38,ES,T3,ES 2550833 T3,116-911-274-986-684,2015-11-12,2015,ES 12741408 T,2012-06-21,US 201113165621 A;;US 201113187360 A;;US 201113187397 A;;US 201113188399 A;;US 2012/0043605 W,2011-06-21,Mecanismo de montaje y avance para dispositivo de prueba de analitos,"Dispositivo de prueba de analitos (100), que comprende: un alojamiento (105) que aloja un sensor de analitos (126) y una lanceta (117); y un mecanismo de varillaje (180) que tiene una primera varilla (183) acoplada con el sensor de analitos (126) y una segunda varilla (182) acoplada con la lanceta (117), en el que las varillas primera (183) y segunda (182) están acopladas entre sí en el mecanismo de varillaje (180); y un accionador (140) que funciona a través del mecanismo de varillaje (180) para (a) expulsar el sensor de analitos (126) en una primera posición (133) del alojamiento, y (b) hacer avanzar la lanceta para su proyección desde una segunda posición (113) del alojamiento en un solo movimiento del accionador.",YOFIMETER LLC,SHAANAN GAD;;GOLDMAN MARC,,https://lens.org/116-911-274-986-684,Granted Patent,no,0,0,13,43,0,A61B5/150022;;A61B5/150022;;A61B5/14532;;A61B5/14532;;A61B5/150267;;A61B5/150267;;A61B5/150358;;A61B5/150358;;A61B5/150412;;A61B5/150412;;A61B5/150503;;A61B5/150503;;A61B5/15113;;A61B5/15113;;A61B5/15117;;A61B5/15117;;A61B5/1513;;A61B5/1513;;A61B5/15153;;A61B5/15153;;A61B5/15174;;A61B5/15174;;A61B5/157;;A61B5/157;;G01N33/48757;;G01N33/48757,A61B5/15;;A61B5/145;;A61B5/151;;A61B5/157,,0,0,,,,ACTIVE
39,CA,A1,CA 2808738 A1,167-714-947-890-909,2013-05-15,2013,CA 2808738 A,2013-03-06,US 201261706071 P,2012-09-26,PORTABLE MEDICINE INJECTION DEVICE AND ANALYTE METERING SYSTEM,"Methods, systems, and devices are described for setting a dose of medicine and injecting the medicine. In one aspect, a method to dispense a medicine includes inserting a cartridge containing a medicine into a cartridge holder coupled to a housing of a medicine injection device, positioning a spine component of the device to make contact with the cartridge in the cartridge holder, selecting a dose of the medicine for injection, in which the selecting includes rotating an injection component of the device to a setting corresponding to the selected dose, and linearly advancing the injection component to rotate a drive gear coupled to the injection component to drive the spine component so as to push the end of the cartridge to dispense the medicine in the amount of the selected dose.",GADLIGHT INC,SHAANAN GAD;;GOLDMAN MARC,,https://lens.org/167-714-947-890-909,Patent Application,no,0,0,13,13,0,A61M5/31551;;A61M5/14244;;A61M5/1452;;A61M5/1454;;A61M5/1723;;A61M5/20;;A61M5/20;;A61M5/24;;A61M5/24;;A61M5/24;;A61M5/28;;A61M5/28;;A61M5/31528;;A61M5/31543;;A61M5/31543;;A61M5/31543;;A61M5/31551;;A61M5/31551;;A61M5/31558;;A61M5/31561;;A61M5/31561;;A61M5/31561;;A61M5/31575;;A61M5/31575;;A61M5/31575;;A61M5/3158;;A61M5/3158;;A61M5/3158;;A61M5/31585;;A61M5/31585;;A61M5/31585;;A61M2005/14506;;A61M2005/2407;;A61M2005/2407;;A61M2005/2407;;A61M2005/31518;;A61M2005/31518;;A61M2005/31518;;A61M2205/3584;;A61M2205/3584;;A61M2205/3592;;A61M2205/3592;;A61M2205/50;;A61M2205/50;;A61M2205/52;;A61M2205/581;;A61M2205/581;;A61M2205/581;;A61M2205/6063;;A61M2230/201;;A61M2230/201;;G16H20/17;;G16H20/17;;G06F19/3468;;G08B21/02,A61M5/178;;A61M5/20;;A61M5/28,,0,0,,,,INACTIVE
40,EP,A1,EP 2900300 A1,174-085-667-324-19X,2015-08-05,2015,EP 13841539 A,2013-09-26,US 201261706071 P;;CA 2808738 A;;US 2013/0062048 W,2012-09-26,PORTABLE MEDICINE INJECTION DEVICE AND ANALYTE METERING SYSTEM,,GADLIGHT INC,SHAANAN GAD;;GOLDMAN MARC,,https://lens.org/174-085-667-324-19X,Patent Application,yes,0,0,13,13,0,A61M5/31551;;A61M5/14244;;A61M5/1452;;A61M5/1454;;A61M5/1723;;A61M5/20;;A61M5/20;;A61M5/24;;A61M5/24;;A61M5/24;;A61M5/28;;A61M5/28;;A61M5/31528;;A61M5/31543;;A61M5/31543;;A61M5/31543;;A61M5/31551;;A61M5/31551;;A61M5/31558;;A61M5/31561;;A61M5/31561;;A61M5/31561;;A61M5/31575;;A61M5/31575;;A61M5/31575;;A61M5/3158;;A61M5/3158;;A61M5/3158;;A61M5/31585;;A61M5/31585;;A61M5/31585;;A61M2005/14506;;A61M2005/2407;;A61M2005/2407;;A61M2005/2407;;A61M2005/31518;;A61M2005/31518;;A61M2005/31518;;A61M2205/3584;;A61M2205/3584;;A61M2205/3592;;A61M2205/3592;;A61M2205/50;;A61M2205/50;;A61M2205/52;;A61M2205/581;;A61M2205/581;;A61M2205/581;;A61M2205/6063;;A61M2230/201;;A61M2230/201;;G16H20/17;;G16H20/17;;G06F19/3468;;G08B21/02,A61M5/28;;A61M5/142;;A61M5/145;;A61M5/20;;A61M5/24;;A61M5/315;;G06F19/00,,0,0,,,,DISCONTINUED
41,CA,C,CA 2808738 C,003-504-251-798-896,2014-03-18,2014,CA 2808738 A,2013-03-06,US 201261706071 P,2012-09-26,PORTABLE MEDICINE INJECTION DEVICE AND METERING SYSTEM,"Methods, systems, and devices are described for setting a dose of medicine and injecting the medicine. In one aspect, a method to dispense a medicine includes inserting a cartridge containing a medicine into a cartridge holder coupled to a housing of a medicine injection device, positioning a spine component of the device to make contact with the cartridge in the cartridge holder, selecting a dose of the medicine for injection, in which the selecting includes rotating an injection component of the device to a setting corresponding to the selected dose, and linearly advancing the injection component to rotate a drive gear coupled to the injection component to drive the spine component so as to push the end of the cartridge to dispense the medicine in the amount of the selected dose.",GADLIGHT INC,SHAANAN GAD;;GOLDMAN MARC,,https://lens.org/003-504-251-798-896,Granted Patent,no,0,0,13,13,0,A61M5/31551;;A61M5/14244;;A61M5/1452;;A61M5/1454;;A61M5/1723;;A61M5/20;;A61M5/20;;A61M5/24;;A61M5/24;;A61M5/24;;A61M5/28;;A61M5/28;;A61M5/31528;;A61M5/31543;;A61M5/31543;;A61M5/31543;;A61M5/31551;;A61M5/31551;;A61M5/31558;;A61M5/31561;;A61M5/31561;;A61M5/31561;;A61M5/31575;;A61M5/31575;;A61M5/31575;;A61M5/3158;;A61M5/3158;;A61M5/3158;;A61M5/31585;;A61M5/31585;;A61M5/31585;;A61M2005/14506;;A61M2005/2407;;A61M2005/2407;;A61M2005/2407;;A61M2005/31518;;A61M2005/31518;;A61M2005/31518;;A61M2205/3584;;A61M2205/3584;;A61M2205/3592;;A61M2205/3592;;A61M2205/50;;A61M2205/50;;A61M2205/52;;A61M2205/581;;A61M2205/581;;A61M2205/581;;A61M2205/6063;;A61M2230/201;;A61M2230/201;;G16H20/17;;G16H20/17;;G06F19/3468;;G08B21/02,A61M5/178;;A61M5/20;;A61M5/28,,0,0,,,,INACTIVE
42,WO,A1,WO 2012/177923 A1,075-167-647-506-359,2012-12-27,2012,US 2012/0043605 W,2012-06-21,US 201113165621 A;;US 201113187360 A;;US 201113187397 A;;US 201113188399 A,2011-06-21,COCKING AND ADVANCING MECHANISM FOR ANALYTE TESTING DEVICE,"An analyte testing device includes an analyte sensor, a lancet, and a mechanism with an actuator that operates to independently expose the analyte sensor and advance the lancet into position for use. The analyte sensor is preferably included in an analyte sensor cartridge that houses a plurality of sensors. Similarly, the lancet is preferably included in a lancet cartridge that houses a plurality of lancets. The actuator can be a lever configured to expose the analyte sensor and advance the lancet into position with a single motion (e.g., pulling the lever). The actuator also preferably operates to cock a hammer in preparation for lancing a body member to draw a blood sample. The mechanism can be a linkage coupled with the actuator and configured to engage the analyte sensor and lancet.",YOFIMETER LLC;;SHAANAN GAD;;GOLDMAN MARC,SHAANAN GAD;;GOLDMAN MARC,,https://lens.org/075-167-647-506-359,Patent Application,yes,16,0,13,43,0,A61B5/150022;;A61B5/150022;;A61B5/14532;;A61B5/14532;;A61B5/150267;;A61B5/150267;;A61B5/150358;;A61B5/150358;;A61B5/150412;;A61B5/150412;;A61B5/150503;;A61B5/150503;;A61B5/15113;;A61B5/15113;;A61B5/15117;;A61B5/15117;;A61B5/1513;;A61B5/1513;;A61B5/15153;;A61B5/15153;;A61B5/15174;;A61B5/15174;;A61B5/157;;A61B5/157;;G01N33/48757;;G01N33/48757,A61B5/15;;A61B5/145;;A61B5/151;;A61B5/157,,0,0,,,,PENDING
43,US,A1,US 2012/0329083 A1,087-242-831-929-960,2012-12-27,2012,US 201113187397 A,2011-07-20,US 201113187397 A;;US 201113165621 A,2011-06-21,TEST UNIT CARTRIDGE FOR ANALYTE TESTING DEVICE,"A test unit cartridge for holding a plurality of test units includes a first test unit that contains a first analyte sensor and a second test unit that contains a second analyte sensor. The first and second analyte sensors use first and second reagents to detect first and second analytes, respectively. The first analyte is different from the second analyte and the first and second test units are functionally non-fungible. The plurality of test units can also include a third test unit that contains two analyte sensors having two reagents for detecting two different analytes using one fluid sample. A method of using the test unit cartridge is also described, which comprises loading the cartridge into an analyte testing device and cocking an actuator of the device that is configured to (i) expose an analyte sensor of a test unit, (ii) ready a lancet, and (iii) advance a lancet cartridge.",SHAANAN GAD;;GOLDMAN MARC;;GADLIGHT INC,SHAANAN GAD;;GOLDMAN MARC,GADLIGHT INC (2011-07-20);;YOFIMETER INC (2012-03-22),https://lens.org/087-242-831-929-960,Patent Application,yes,0,2,12,43,0,A61B5/14532;;A61B5/150022;;A61B5/150267;;A61B5/150358;;A61B5/150412;;A61B5/150572;;A61B5/15113;;A61B5/15117;;A61B5/15153;;A61B5/15174;;A61B5/157;;A61B5/14546;;A61B5/1468;;A61B2562/0295;;G01N33/48757;;A61B5/150503;;Y10T436/144444;;Y10T436/144444;;A61B5/150022;;A61B5/15113;;A61B5/15117;;A61B5/157;;A61B5/150572;;A61B5/150358;;A61B5/150267;;A61B5/150412;;A61B5/15174;;A61B5/15153;;A61B5/14532;;A61B5/14546;;A61B5/1468;;A61B2562/0295;;G01N33/48757;;A61B5/150503,G01N33/48;;C12Q1/54,435/14;;435/287.2,0,0,,,,INACTIVE
44,EP,A4,EP 2900300 A4,112-683-148-721-346,2016-06-01,2016,EP 13841539 A,2013-09-26,US 201261706071 P;;CA 2808738 A;;US 2013/0062048 W,2012-09-26,PORTABLE MEDICINE INJECTION DEVICE AND ANALYTE METERING SYSTEM,,GADLIGHT INC,SHAANAN GAD;;GOLDMAN MARC,,https://lens.org/112-683-148-721-346,Search Report,no,4,0,13,13,0,G06F19/3468;;A61M5/20;;A61M5/28;;A61M5/31551;;A61M5/31561;;A61M5/31575;;A61M5/3158;;A61M2205/581;;A61M2205/50;;A61M2205/3584;;A61M2205/3592;;A61M2005/2407;;A61M2005/31518;;A61M5/24;;A61M5/31585;;A61M5/31543;;A61M2230/201;;A61M5/24;;A61M5/31543;;A61M5/31551;;A61M5/31561;;A61M5/31575;;A61M5/3158;;A61M5/31585;;A61M2005/2407;;A61M2005/31518;;A61M2205/581;;G16H20/17;;A61M5/14244;;A61M2005/14506;;A61M5/1454;;A61M5/31528;;A61M5/31558;;A61M5/24;;A61M5/31543;;A61M5/31551;;A61M5/31561;;A61M5/31575;;A61M5/3158;;A61M5/31585;;A61M2005/2407;;A61M2005/31518;;A61M2205/581;;G16H20/17;;A61M5/20;;A61M5/28;;A61M2205/3584;;A61M2205/3592;;A61M2205/50;;A61M2230/201;;A61M5/1452;;A61M5/1723;;A61M2205/52;;A61M2205/6063;;G08B21/02,A61M5/28;;A61M5/142;;A61M5/145;;A61M5/20;;A61M5/24;;A61M5/315;;G06F19/00,,1,0,,,See also references of WO 2014052676A1,DISCONTINUED
45,CA,A1,CA 2885825 A1,165-353-508-473-261,2014-04-03,2014,CA 2885825 A,2013-09-26,US 201261706071 P;;CA 2808738 A;;US 2013/0062048 W;;CA 2885825 A,2012-09-26,PORTABLE MEDICINE INJECTION DEVICE AND ANALYTE METERING SYSTEM,"Methods, systems, and devices are described for setting a dose of medicine and injecting the medicine. In one aspect, a method to dispense a medicine includes inserting a cartridge containing a medicine into a cartridge holder coupled to a housing of a medicine injection device, positioning a spine component of the device to make contact with the cartridge in the cartridge holder, selecting a dose of the medicine for injection, in which the selecting includes rotating an injection component of the device to a setting corresponding to the selected dose, and linearly advancing the injection component to rotate a drive gear coupled to the injection component to drive the spine component so as to push the end of the cartridge to dispense the medicine in the amount of the selected dose.",GADLIGHT INC,SHAANAN GAD;;GOLDMAN MARC,,https://lens.org/165-353-508-473-261,Patent Application,no,0,0,13,13,0,A61M5/31551;;A61M5/14244;;A61M5/1452;;A61M5/1454;;A61M5/1723;;A61M5/20;;A61M5/20;;A61M5/24;;A61M5/24;;A61M5/24;;A61M5/28;;A61M5/28;;A61M5/31528;;A61M5/31543;;A61M5/31543;;A61M5/31543;;A61M5/31551;;A61M5/31551;;A61M5/31558;;A61M5/31561;;A61M5/31561;;A61M5/31561;;A61M5/31575;;A61M5/31575;;A61M5/31575;;A61M5/3158;;A61M5/3158;;A61M5/3158;;A61M5/31585;;A61M5/31585;;A61M5/31585;;A61M2005/14506;;A61M2005/2407;;A61M2005/2407;;A61M2005/2407;;A61M2005/31518;;A61M2005/31518;;A61M2005/31518;;A61M2205/3584;;A61M2205/3584;;A61M2205/3592;;A61M2205/3592;;A61M2205/50;;A61M2205/50;;A61M2205/52;;A61M2205/581;;A61M2205/581;;A61M2205/581;;A61M2205/6063;;A61M2230/201;;A61M2230/201;;G16H20/17;;G16H20/17;;G06F19/3468;;G08B21/02,A61M5/28;;A61M5/20,,0,0,,,,PENDING
46,WO,A1,WO 2012/177748 A1,053-401-881-775-244,2012-12-27,2012,US 2012/0043331 W,2012-06-20,US 201113165621 A;;US 201113307364 A,2011-06-21,ANALYTE TESTING DEVICE WITH LANCET CARTRIDGE AND TEST STRIP CARTRIDGE,"An analyte testing device housing a lancet cartridge and a test strip cartridge is described. The testing device simplifies analyte testing/monitoring by providing an actuator and linkage mechanism that: (i) cocks a lancing device, (ii) exposes a test strip for use; and (iii) advances the lancet cartridge. The testing device also includes conversion electronics, which receives a signal from a test trip and converts the signal into readable data.",YOFIMETER LLC;;SHAANAN GAD;;GOLDMAN MARC,SHAANAN GAD;;GOLDMAN MARC,,https://lens.org/053-401-881-775-244,Patent Application,yes,12,0,12,43,0,A61B5/1411;;A61B5/150022;;A61B5/150022;;A61B5/145;;A61B5/14532;;A61B5/14532;;A61B5/1495;;A61B5/1495;;A61B5/15019;;A61B5/15019;;A61B5/150267;;A61B5/150267;;A61B5/150358;;A61B5/150358;;A61B5/150412;;A61B5/150412;;A61B5/150748;;A61B5/150748;;A61B5/150809;;A61B5/150809;;A61B5/150824;;A61B5/150824;;A61B5/150854;;A61B5/150854;;A61B5/150862;;A61B5/150862;;A61B5/15087;;A61B5/15087;;A61B5/151;;A61B5/15113;;A61B5/15113;;A61B5/15117;;A61B5/15117;;A61B5/1513;;A61B5/1513;;A61B5/15153;;A61B5/15153;;A61B5/15174;;A61B5/15174;;A61B5/15182;;A61B5/15182;;A61B5/157;;A61B5/157;;A61B5/157;;A61B2560/0228;;A61B2560/0228;;A61B2560/0456;;A61B2560/0456;;A61B2562/0295;;A61B2562/0295;;G01N33/48757;;G01N33/48757,A61B5/145;;A61B5/15;;A61B5/151;;A61B5/157,,0,0,,,,PENDING
47,US,A1,US 2013/0085349 A1,074-405-543-518-202,2013-04-04,2013,US 201213689618 A,2012-11-29,US 201213689618 A;;US 201113188399 A;;US 201113187360 A;;US 201113165621 A;;US 201113187397 A,2011-06-21,ANALYTE TESTING DEVICES,"Systems, devices, techniques and methods are disclosed for implementing an actuator mechanism of an analyte testing device. In one aspect, a method to test an analyte includes advancing an analyte sensor from a first position within a sensor cartridge of an analyte testing device to a second position that exposes at least a portion of the analyte sensor outside of the device, advancing a lancet projecting component from an initial position to a cocked position for a subsequent projection of a lancet, in which the advancing the analyte sensor and the advancing the lancet projecting component are initiated by a single operation, projecting the lancet to expose at least a portion of the lancet outside of the device, receiving a testing sample including an analyte at the exposed portion of the analyte sensor, processing the testing sample to determine a parameter of the analyte, and ejecting the analyte sensor from the device.",YOFIMETER LLC;;YOFIMETER LLC,SHAANAN GAD;;GOLDMAN MARC,YOFIMETER LLC (2012-12-03),https://lens.org/074-405-543-518-202,Patent Application,yes,3,20,3,43,0,A61B5/150358;;A61B5/150412;;A61B5/15117;;A61B5/15153;;A61B5/15174;;G01N33/48757;;A61B5/15087;;A61B5/15113;;A61B5/150022;;A61B5/157;;A61B5/14532;;A61B5/1513;;A61B5/150267;;A61B5/15113;;A61B5/145;;A61B5/15194;;A61B5/150022;;A61B5/157;;A61B5/150175;;A61B5/14532;;A61B5/15148;;A61B5/1513;;A61B5/0004;;A61B5/150824;;A61B5/742;;A61B5/1118;;A61B5/746;;A61B5/150267;;A61B5/150961;;A61B5/150358;;A61B5/150412;;A61B5/15117;;A61B5/15153;;A61B5/15174;;G01N33/48757;;A61B5/15087,A61B5/00;;A61B5/151;;A61B5/11;;A61B5/145;;A61B5/15;;A61B5/157,600/301;;600/309;;600/365,0,0,,,,DISCONTINUED
48,US,A1,US 2015/0190577 A1,014-573-053-518-484,2015-07-09,2015,US 201314371401 A,2013-09-26,US 201314371401 A;;CA 2808738 A;;US 201261706071 P;;US 2013/0062048 W,2012-09-26,PORTABLE MEDICINE INJECTION DEVICE AND ANALYTE METERING SYSTEM,"Methods, systems, and devices are described for setting a dose of medicine and injecting the medicine. In one aspect, a method to dispense a medicine includes inserting a cartridge containing a medicine into a cartridge holder coupled to a housing of a medicine injection device, positioning a spine component of the device to make contact with the cartridge in the cartridge holder, selecting a dose of the medicine for injection, in which the selecting includes rotating an injection component of the device to a setting corresponding to the selected dose, and linearly advancing the injection component to rotate a drive gear coupled to the injection component to drive the spine component so as to push the end of the cartridge to dispense the medicine in the amount of the selected dose.",GADLIGHT INC,SHAANAN GAD;;GOLDMAN MARC,YOFIMETER LLC (2015-05-14);;GADLIGHT INC (2014-07-17),https://lens.org/014-573-053-518-484,Patent Application,yes,11,33,13,13,0,A61M5/31551;;A61M5/14244;;A61M5/1452;;A61M5/1454;;A61M5/1723;;A61M5/20;;A61M5/20;;A61M5/24;;A61M5/24;;A61M5/24;;A61M5/28;;A61M5/28;;A61M5/31528;;A61M5/31543;;A61M5/31543;;A61M5/31543;;A61M5/31551;;A61M5/31551;;A61M5/31558;;A61M5/31561;;A61M5/31561;;A61M5/31561;;A61M5/31575;;A61M5/31575;;A61M5/31575;;A61M5/3158;;A61M5/3158;;A61M5/3158;;A61M5/31585;;A61M5/31585;;A61M5/31585;;A61M2005/14506;;A61M2005/2407;;A61M2005/2407;;A61M2005/2407;;A61M2005/31518;;A61M2005/31518;;A61M2005/31518;;A61M2205/3584;;A61M2205/3584;;A61M2205/3592;;A61M2205/3592;;A61M2205/50;;A61M2205/50;;A61M2205/52;;A61M2205/581;;A61M2205/581;;A61M2205/581;;A61M2205/6063;;A61M2230/201;;A61M2230/201;;G16H20/17;;G16H20/17;;G06F19/3468;;G08B21/02,A61M5/20;;A61M5/28;;A61M5/315;;G06F19/00,,0,0,,,,INACTIVE
49,CA,A1,CA 2839903 A1,008-248-396-424-598,2012-12-27,2012,CA 2839903 A,2012-06-21,US 201113165621 A;;US 201113187360 A;;US 201113187397 A;;US 201113188399 A;;US 2012/0043605 W,2011-06-21,COCKING AND ADVANCING MECHANISM FOR ANALYTE TESTING DEVICE,"An analyte testing device includes an analyte sensor, a lancet, and a mechanism with an actuator that operates to independently expose the analyte sensor and advance the lancet into position for use. The analyte sensor is preferably included in an analyte sensor cartridge that houses a plurality of sensors. Similarly, the lancet is preferably included in a lancet cartridge that houses a plurality of lancets. The actuator can be a lever configured to expose the analyte sensor and advance the lancet into position with a single motion (e.g., pulling the lever). The actuator also preferably operates to cock a hammer in preparation for lancing a body member to draw a blood sample. The mechanism can be a linkage coupled with the actuator and configured to engage the analyte sensor and lancet.",YOFIMETER LLC,SHAANAN GAD;;GOLDMAN MARC,,https://lens.org/008-248-396-424-598,Patent Application,no,0,0,13,43,0,A61B5/150022;;A61B5/150022;;A61B5/14532;;A61B5/14532;;A61B5/150267;;A61B5/150267;;A61B5/150358;;A61B5/150358;;A61B5/150412;;A61B5/150412;;A61B5/150503;;A61B5/150503;;A61B5/15113;;A61B5/15113;;A61B5/15117;;A61B5/15117;;A61B5/1513;;A61B5/1513;;A61B5/15153;;A61B5/15153;;A61B5/15174;;A61B5/15174;;A61B5/157;;A61B5/157;;G01N33/48757;;G01N33/48757,A61B5/15;;A61B5/145;;A61B5/151;;A61B5/157,,0,0,,,,DISCONTINUED
50,ES,T3,ES 2541534 T3,045-730-692-146-091,2015-07-21,2015,ES 12741405 T,2012-06-20,US 201113165621 A;;US 201113307364 A;;US 2012/0043331 W,2011-06-21,Dispositivo de prueba de analitos con cartucho de lancetas y cartucho de tiras reactivas,"Un dispositivo (100) de prueba de analitos, que comprende: un alojamiento que retiene de forma desmontable (a) un primer cartucho (115) que tiene una pluralidad de lancetas (117), y (b) un segundo cartucho (125) que tiene una pluralidad de tiras (127) reactivas extraíbles; la electrónica (137) de conversión que recibe una señal desde aquellas individuales de la pluralidad de tiras (127) reactivas y convierte la señal en datos legibles; y un accionador (140) configurado para (i) montar un dispositivo de punción, (ii) exponer aquellas individuales de la pluralidad de tiras (127) reactivas para su uso; y (iii) hacer avanzar el cartucho (115) de lancetas.",YOFIMETER LLC,SHAANAN GAD;;GOLDMAN MARC,,https://lens.org/045-730-692-146-091,Granted Patent,no,0,0,12,43,0,A61B5/1411;;A61B5/150022;;A61B5/150022;;A61B5/145;;A61B5/14532;;A61B5/14532;;A61B5/1495;;A61B5/1495;;A61B5/15019;;A61B5/15019;;A61B5/150267;;A61B5/150267;;A61B5/150358;;A61B5/150358;;A61B5/150412;;A61B5/150412;;A61B5/150748;;A61B5/150748;;A61B5/150809;;A61B5/150809;;A61B5/150824;;A61B5/150824;;A61B5/150854;;A61B5/150854;;A61B5/150862;;A61B5/150862;;A61B5/15087;;A61B5/15087;;A61B5/151;;A61B5/15113;;A61B5/15113;;A61B5/15117;;A61B5/15117;;A61B5/1513;;A61B5/1513;;A61B5/15153;;A61B5/15153;;A61B5/15174;;A61B5/15174;;A61B5/15182;;A61B5/15182;;A61B5/157;;A61B5/157;;A61B5/157;;A61B2560/0228;;A61B2560/0228;;A61B2560/0456;;A61B2560/0456;;A61B2562/0295;;A61B2562/0295;;G01N33/48757;;G01N33/48757,A61B5/145;;A61B5/1495;;A61B5/15;;A61B5/151;;A61B5/157,,0,0,,,,ACTIVE
51,WO,A1,WO 2012/177898 A1,124-614-084-469-714,2012-12-27,2012,US 2012/0043571 W,2012-06-21,US 201113165621 A;;US 201113187360 A;;US 201113308024 A,2011-06-21,ANALYTE TESTING SYSTEM WITH DOCKING STATION FOR DATA MANAGEMENT,"An analyte testing system having an analyte testing device and a docking station is described. The analyte testing device includes a plurality of lancets, a plurality of analyte sensors, electronics for deriving test data from the analyte sensors, a visual display that displays test data, and a data recording facility that records non-test data. Examples of non-test data include text diary information, audio diary information, food eaten, minutes exercised, medication taken, and estimated calories burned. The docking station has a power interface and data interface that provide power and data connectivity to the testing device. The docking station also has a storage facility configured to automatically store the test data and non-test data.",YOFIMETER INC;;SHAANAN GAD;;GOLDMAN MARC,SHAANAN GAD;;GOLDMAN MARC,,https://lens.org/124-614-084-469-714,Patent Application,yes,21,0,3,43,0,A61B5/150022;;A61B5/150022;;A61B5/145;;A61B5/145;;A61B5/14532;;A61B5/14532;;A61B5/150267;;A61B5/150267;;A61B5/150412;;A61B5/150412;;A61B5/150503;;A61B5/150503;;A61B5/150854;;A61B5/150854;;A61B5/150862;;A61B5/150862;;A61B5/15087;;A61B5/15087;;A61B5/15113;;A61B5/15113;;A61B5/15117;;A61B5/15117;;A61B5/1513;;A61B5/1513;;A61B5/15153;;A61B5/15153;;A61B5/15174;;A61B5/15174;;A61B5/15182;;A61B5/15182;;A61B5/157;;A61B5/157;;A61B2560/0456;;A61B2560/0456;;A61M2209/086;;A61M2209/086;;G01N33/48792;;G01N33/48792,A61B5/145;;A61B5/15;;A61B5/151;;A61B5/157,,0,0,,,,PENDING
52,US,A1,US 2012/0330188 A1,120-896-733-912-230,2012-12-27,2012,US 201113188399 A,2011-07-21,US 201113188399 A;;US 201113187360 A;;US 201113187397 A;;US 201113165621 A,2011-06-21,Cocking and Advancing Mechanism for Analyte Testing Device,"An analyte testing device includes an analyte sensor, a lancet, and a mechanism with an actuator that operates to independently expose the analyte sensor and advance the lancet into position for use. The analyte sensor is preferably included in an analyte sensor cartridge that houses a plurality of sensors. Similarly, the lancet is preferably included in a lancet cartridge that houses a plurality of lancets. The actuator can be a lever configured to expose the analyte sensor and advance the lancet into position with a single motion (e.g., pulling the lever). The actuator also preferably operates to cock a hammer in preparation for lancing a body member to draw a blood sample. The mechanism can be a linkage coupled with the actuator and configured to engage the analyte sensor and lancet.",SHAANAN GAD;;GOLDMAN MARC;;GADLIGHT INC,SHAANAN GAD;;GOLDMAN MARC,GADLIGHT INC (2011-07-20);;YOFIMETER INC (2012-03-22),https://lens.org/120-896-733-912-230,Patent Application,yes,0,2,13,43,0,A61B5/150022;;A61B5/150022;;A61B5/14532;;A61B5/14532;;A61B5/150267;;A61B5/150267;;A61B5/150358;;A61B5/150358;;A61B5/150412;;A61B5/150412;;A61B5/150503;;A61B5/150503;;A61B5/15113;;A61B5/15113;;A61B5/15117;;A61B5/15117;;A61B5/1513;;A61B5/1513;;A61B5/15153;;A61B5/15153;;A61B5/15174;;A61B5/15174;;A61B5/157;;A61B5/157;;G01N33/48757;;G01N33/48757,A61B5/151,600/583,0,0,,,,DISCONTINUED
53,CN,A,CN 104755117 A,177-566-236-719-698,2015-07-01,2015,CN 201380055537 A,2013-09-26,US 2013/0062048 W;;CA 2808738 A;;US 201261706071 P,2012-09-26,Portable medicine injection device and analyte metering system,"Methods, systems, and devices are described for setting a dose of medicine and injecting the medicine. In one aspect, a method to dispense a medicine includes inserting a cartridge containing a medicine into a cartridge holder coupled to a housing of a medicine injection device, positioning a spine component of the device to make contact with the cartridge in the cartridge holder, selecting a dose of the medicine for injection, in which the selecting includes rotating an injection component of the device to a setting corresponding to the selected dose, and linearly advancing the injection component to rotate a drive gear coupled to the injection component to drive the spine component so as to push the end of the cartridge to dispense the medicine in the amount of the selected dose.",GADLIGHT INC,SHAANAN GAD;;GOLDMAN MARC,,https://lens.org/177-566-236-719-698,Patent Application,no,0,8,13,13,0,A61M5/31551;;A61M5/14244;;A61M5/1452;;A61M5/1454;;A61M5/1723;;A61M5/20;;A61M5/20;;A61M5/24;;A61M5/24;;A61M5/24;;A61M5/28;;A61M5/28;;A61M5/31528;;A61M5/31543;;A61M5/31543;;A61M5/31543;;A61M5/31551;;A61M5/31551;;A61M5/31558;;A61M5/31561;;A61M5/31561;;A61M5/31561;;A61M5/31575;;A61M5/31575;;A61M5/31575;;A61M5/3158;;A61M5/3158;;A61M5/3158;;A61M5/31585;;A61M5/31585;;A61M5/31585;;A61M2005/14506;;A61M2005/2407;;A61M2005/2407;;A61M2005/2407;;A61M2005/31518;;A61M2005/31518;;A61M2005/31518;;A61M2205/3584;;A61M2205/3584;;A61M2205/3592;;A61M2205/3592;;A61M2205/50;;A61M2205/50;;A61M2205/52;;A61M2205/581;;A61M2205/581;;A61M2205/581;;A61M2205/6063;;A61M2230/201;;A61M2230/201;;G16H20/17;;G16H20/17;;G06F19/3468;;G08B21/02,A61M5/28;;A61M5/20,,0,0,,,,DISCONTINUED
54,CA,A1,CA 2839900 A1,013-866-425-525-486,2012-12-27,2012,CA 2839900 A,2012-06-21,US 201113165621 A;;US 201113187397 A;;US 201113308137 A;;US 2012/0043588 W,2011-06-21,TEST UNIT CARTRIDGE FOR ANALYTE TESTING DEVICE,"A test unit cartridge for holding a plurality of test units includes a first test unit that contains a first analyte sensor and a second test unit that contains a second analyte sensor. The first and second analyte sensors use first and second reagents to detect first and second analytes, respectively. The first analyte is different from the second analyte and the first and second test units are functionally non-fungible. The plurality of test units can also include a third test unit that contains two analyte sensors having two reagents for detecting two different analytes using one fluid sample. A method of using the test unit cartridge is also described, which comprises loading the cartridge into an analyte testing device and cocking an actuator of the device that is configured to (i) expose an analyte sensor of a test unit, (ii) ready a lancet, and (iii) advance a lancet cartridge.",YOFIMETER LLC,SHAANAN GAD;;GOLDMAN MARC,,https://lens.org/013-866-425-525-486,Patent Application,no,0,0,12,43,0,A61B5/14532;;A61B5/150022;;A61B5/150267;;A61B5/150358;;A61B5/150412;;A61B5/150572;;A61B5/15113;;A61B5/15117;;A61B5/15153;;A61B5/15174;;A61B5/157;;A61B5/14546;;A61B5/1468;;A61B2562/0295;;G01N33/48757;;A61B5/150503;;Y10T436/144444;;Y10T436/144444;;A61B5/150022;;A61B5/15113;;A61B5/15117;;A61B5/157;;A61B5/150572;;A61B5/150358;;A61B5/150267;;A61B5/150412;;A61B5/15174;;A61B5/15153;;A61B5/14532;;A61B5/14546;;A61B5/1468;;A61B2562/0295;;G01N33/48757;;A61B5/150503,A61B5/145;;A61B5/15;;A61B5/151;;A61B5/157;;G01N33/49,,0,0,,,,DISCONTINUED
55,US,A1,US 2020/0030529 A1,175-021-813-584-920,2020-01-30,2020,US 201916520521 A,2019-07-24,US 201916520521 A;;US 201862703346 P,2018-07-25,SUBCUTANEOUS ACCESS HUB WITH MULTIPLE CANNULA PORTS,Subcutaneous access hub embodiments are discussed herein that include housing embodiments having a plurality of cannula ports and a fluid passageway network that allows fluid communication between a fluid source and the plurality of cannula access ports. Such a configuration may allow a user such as a patient or clinician to releasably secure the housing to an outside surface of the patient's skin. Multiple locations on the patient's skin may then be accessed for deployment of one or more delivery cannulas via a plurality of cannula ports for delivery of fluid and from the fluid source to multiple subcutaneous locations below the patient's skin and timely movement of cannula access in the patient's skin without the need for relocating the housing.,MODULAR MEDICAL INC,DIPERNA PAUL M;;GOLDMAN MARC,QUASURAS INC (2019-11-08),https://lens.org/175-021-813-584-920,Patent Application,yes,0,8,4,4,0,A61K38/28;;A61M39/0208;;A61M2005/14252;;A61M2005/1586;;A61M5/158;;A61M5/14248;;A61M2039/0036;;A61M2039/0205;;A61M2039/0223;;A61M5/158;;A61M5/14248;;A61M25/0097;;A61M25/02;;A61M39/0208;;A61M2005/14252;;A61M2039/0036;;A61M2039/0205;;A61M2039/0223;;A61M2025/0266;;A61M2005/1586;;A61K38/28,A61M5/158;;A61K38/28;;A61M5/142;;A61M25/00;;A61M25/02;;A61M39/02,,0,0,,,,ACTIVE
56,US,A1,US 2022/0347382 A1,195-259-911-391-167,2022-11-03,2022,US 202217868600 A,2022-07-19,US 202217868600 A;;US 201916520521 A;;US 201862703346 P,2018-07-25,SUBCUTANEOUS ACCESS HUB WITH MULTIPLE CANNULA PORTS,Subcutaneous access hub embodiments are discussed herein that include housing embodiments having a plurality of cannula ports and a fluid passageway network that allows fluid communication between a fluid source and the plurality of cannula access ports. Such a configuration may allow a user such as a patient or clinician to releasably secure the housing to an outside surface of the patient's skin. Multiple locations on the patient's skin may then be accessed for deployment of one or more delivery cannulas via a plurality of cannula ports for delivery of fluid and from the fluid source to multiple subcutaneous locations below the patient's skin and timely movement of cannula access in the patient's skin without the need for relocating the housing.,QUASURAS INC,DIPERNA PAUL M;;GOLDMAN MARC,QUASURAS INC (2019-11-08),https://lens.org/195-259-911-391-167,Patent Application,yes,0,0,4,4,0,A61K38/28;;A61M39/0208;;A61M2005/14252;;A61M2005/1586;;A61M5/158;;A61M5/14248;;A61M2039/0036;;A61M2039/0205;;A61M2039/0223;;A61M5/158;;A61M5/14248;;A61M25/0097;;A61M25/02;;A61M39/0208;;A61M2005/14252;;A61M2039/0036;;A61M2039/0205;;A61M2039/0223;;A61M2025/0266;;A61M2005/1586;;A61K38/28,A61M5/158;;A61K38/28;;A61M5/142;;A61M25/00;;A61M25/02;;A61M39/02,,0,0,,,,PENDING
57,US,B2,US 11419978 B2,113-728-757-843-448,2022-08-23,2022,US 201916520521 A,2019-07-24,US 201916520521 A;;US 201862703346 P,2018-07-25,Subcutaneous access hub with multiple cannula ports,Subcutaneous access hub embodiments are discussed herein that include housing embodiments having a plurality of cannula ports and a fluid passageway network that allows fluid communication between a fluid source and the plurality of cannula access ports. Such a configuration may allow a user such as a patient or clinician to releasably secure the housing to an outside surface of the patient's skin. Multiple locations on the patient's skin may then be accessed for deployment of one or more delivery cannulas via a plurality of cannula ports for delivery of fluid and from the fluid source to multiple subcutaneous locations below the patient's skin and timely movement of cannula access in the patient's skin without the need for relocating the housing.,QUASURAS INC,DIPERNA PAUL M;;GOLDMAN MARC,QUASURAS INC (2019-11-08),https://lens.org/113-728-757-843-448,Granted Patent,yes,50,1,4,4,0,A61K38/28;;A61M39/0208;;A61M2005/14252;;A61M2005/1586;;A61M5/158;;A61M5/14248;;A61M2039/0036;;A61M2039/0205;;A61M2039/0223;;A61M5/158;;A61M5/14248;;A61M25/0097;;A61M25/02;;A61M39/0208;;A61M2005/14252;;A61M2039/0036;;A61M2039/0205;;A61M2039/0223;;A61M2025/0266;;A61M2005/1586;;A61K38/28,A61M5/158;;A61K38/28;;A61M5/142;;A61M25/00;;A61M25/02;;A61M39/00;;A61M39/02,,9,0,,,"“Grip, 2011, Houghton Mifflin Harcourt Publishing Company, American Heritage® Dictionary of the English Language, Fifth Edition” (Year: 2011).;;“Septum, 2011, Houghton Mifflin Harcourt Publishing Company, American Heritage® Dictionary of the English Language, Fifth Edition” (Year: 2011).;;International Search Report and Written Opinion dated Oct. 4, 2019 in International Application No. PCT/US2019/43146 filed: Jul. 24, 2019.;;Final Office Action dated Jun. 26, 2020 in U.S. Appl. No. 15/122,132, filed Aug. 26, 2016 and published as: 2016/0361489 on Dec. 15, 2016.;;Office Action dated Jan. 2, 2020 in U.S. Appl. No. 15/122,132, filed Aug. 26, 2016 and published as: 2016/0361489 on Dec. 15, 2016.;;International Search Report and Written Opinion dated Oct. 18, 2018 in International Application No. PCT/US2018/40944, filed: Jul. 5, 2018 and published as: WO/2019/010324 on Jan. 10, 2019.;;International Search Report and Written Opinion dated Jul. 31, 2015 in International Application No. PCT/US2015/18525 filed: Mar. 3, 2015 and published as: WO/2015/134526 on: Sep. 11, 2015.;;Office Action dated Nov. 16, 2020 in U.S. Appl. No. 16/028,256, filed Jul. 5, 2018 and published as: 2019/0009023 on Jan. 1, 2019.;;International Preliminary Report on Patentability dated Jan. 26, 2021 in International Application No. PCT/US2019/43146 filed: Jul. 24, 2019.",ACTIVE
58,WO,A1,WO 2015/138799 A1,159-097-963-138-660,2015-09-17,2015,US 2015/0020283 W,2015-03-12,US 201461952070 P,2014-03-12,ANALYTE TESTING DEVICES WITH LANCET ADVANCEMENT TRACKING AND COLOR TOUCHSCREEN USER INTERFACE,"Analyte testing and monitoring methods, systems, and devices are disclosed. In one aspect, an analyte testing device indudes an analyte sensor module configured to hold a sensor cassette structured to store analyte sensors, the analyte sensor module induding an opening from which an analyte sensor advances to a testing position to expose at least a portion of the analyte sensor to outside of the analyte testing device; and a lancing module configured to hold a lancet cassette structured to store lancets and project the lancets to outside of the analyte testing device during a blood sample acquisition event to pierce a user's skin.",YOFIMETER LLC,SHAANAN GAD;;GOLDMAN MARC;;SHAANAN JESSICA,,https://lens.org/159-097-963-138-660,Patent Application,yes,6,0,7,7,0,A61B5/157;;A61B5/157;;A61B5/14532;;A61B5/14532;;A61B5/14546;;A61B5/150022;;A61B5/150022;;A61B5/150175;;A61B5/150175;;A61B5/150267;;A61B5/150412;;A61B5/150801;;A61B5/15087;;A61B5/150961;;A61B5/15153;;A61B5/15153;;A61B5/15176;;A61B5/15176;;A61B5/15182;;A61B5/15182;;A61B5/7435;;A61B2562/0295;;A61B2562/0295,A61B5/151,,1,0,,,See also references of EP 3116400A4,PENDING
59,CA,A1,CA 2942067 A1,057-892-835-130-116,2015-09-17,2015,CA 2942067 A,2015-03-12,US 201461952070 P;;US 2015/0020283 W,2014-03-12,ANALYTE TESTING DEVICES WITH LANCET ADVANCEMENT TRACKING AND COLOR TOUCHSCREEN USER INTERFACE,"Analyte testing and monitoring methods, systems, and devices are disclosed. In one aspect, an analyte testing device indudes an analyte sensor module configured to hold a sensor cassette structured to store analyte sensors, the analyte sensor module induding an opening from which an analyte sensor advances to a testing position to expose at least a portion of the analyte sensor to outside of the analyte testing device; and a lancing module configured to hold a lancet cassette structured to store lancets and project the lancets to outside of the analyte testing device during a blood sample acquisition event to pierce a user's skin.",YOFIMETER LLC,SHAANAN GAD;;GOLDMAN MARC;;SHAANAN JESSICA,,https://lens.org/057-892-835-130-116,Patent Application,no,0,0,7,7,0,A61B5/150022;;A61B5/150175;;A61B5/15153;;A61B5/15176;;A61B5/15182;;A61B5/14532;;A61B2562/0295;;A61B5/157;;A61B5/150267;;A61B5/150175;;A61B5/15153;;A61B5/15182;;A61B5/14532;;A61B5/15176;;A61B5/150022;;A61B2562/0295;;A61B5/157;;A61B5/14546;;A61B5/150412;;A61B5/150801;;A61B5/15087;;A61B5/150961;;A61B5/7435,A61B5/151,,0,0,,,,DISCONTINUED
60,US,A1,US 2016/0374603 A1,073-704-930-330-641,2016-12-29,2016,US 201515125118 A,2015-03-12,US 201515125118 A;;US 201461952070 P;;US 2015/0020283 W,2014-03-12,ANALYTE TESTING DEVICES WITH LANCET ADVANCEMENT TRACKING AND COLOR TOUCH SCREEN USER INTERFACE,"Analyte testing and monitoring methods, systems, and devices are disclosed. In one aspect, an analyte testing device includes an analyte sensor module configured to hold a sensor cassette structured to store analyte sensors, the analyte sensor module including an opening from which an analyte sensor advances to a testing position to expose at least a portion of the analyte sensor to outside of the analyte testing device; and a lancing module configured to hold a lancet cassette structured to store lancets and project the lancets to outside of the analyte testing device during a blood sample acquisition event to pierce a user's skin.",YOFIMETER LLC,SHAANAN GAD;;GOLDMAN MARC;;SHAANAN JESSICA,,https://lens.org/073-704-930-330-641,Patent Application,yes,10,8,7,7,0,A61B5/157;;A61B5/157;;A61B5/14532;;A61B5/14532;;A61B5/14546;;A61B5/150022;;A61B5/150022;;A61B5/150175;;A61B5/150175;;A61B5/150267;;A61B5/150412;;A61B5/150801;;A61B5/15087;;A61B5/150961;;A61B5/15153;;A61B5/15153;;A61B5/15176;;A61B5/15176;;A61B5/15182;;A61B5/15182;;A61B5/7435;;A61B2562/0295;;A61B2562/0295,A61B5/157;;A61B5/00;;A61B5/145;;A61B5/15;;A61B5/151,,0,0,,,,DISCONTINUED
61,EP,A1,EP 3116400 A1,182-604-361-925-146,2017-01-18,2017,EP 15761131 A,2015-03-12,US 201461952070 P;;US 2015/0020283 W,2014-03-12,ANALYTE TESTING DEVICES WITH LANCET ADVANCEMENT TRACKING AND COLOR TOUCHSCREEN USER INTERFACE,,YOFIMETER LLC,SHAANAN GAD;;GOLDMAN MARC;;SHAANAN JESSICA,,https://lens.org/182-604-361-925-146,Patent Application,yes,0,0,7,7,0,A61B5/157;;A61B5/157;;A61B5/14532;;A61B5/14532;;A61B5/14546;;A61B5/150022;;A61B5/150022;;A61B5/150175;;A61B5/150175;;A61B5/150267;;A61B5/150412;;A61B5/150801;;A61B5/15087;;A61B5/150961;;A61B5/15153;;A61B5/15153;;A61B5/15176;;A61B5/15176;;A61B5/15182;;A61B5/15182;;A61B5/7435;;A61B2562/0295;;A61B2562/0295,A61B5/151,,0,0,,,,DISCONTINUED
62,EP,A4,EP 3116400 A4,151-264-145-998-188,2017-10-25,2017,EP 15761131 A,2015-03-12,US 201461952070 P;;US 2015/0020283 W,2014-03-12,ANALYTE TESTING DEVICES WITH LANCET ADVANCEMENT TRACKING AND COLOR TOUCHSCREEN USER INTERFACE,,YOFIMETER LLC,SHAANAN GAD;;GOLDMAN MARC;;SHAANAN JESSICA,,https://lens.org/151-264-145-998-188,Search Report,no,0,0,7,7,0,A61B5/157;;A61B5/157;;A61B5/14532;;A61B5/14532;;A61B5/14546;;A61B5/150022;;A61B5/150022;;A61B5/150175;;A61B5/150175;;A61B5/150267;;A61B5/150412;;A61B5/150801;;A61B5/15087;;A61B5/150961;;A61B5/15153;;A61B5/15153;;A61B5/15176;;A61B5/15176;;A61B5/15182;;A61B5/15182;;A61B5/7435;;A61B2562/0295;;A61B2562/0295,A61B5/157;;A61B5/145;;A61B5/15;;A61B5/151,,2,0,,,No further relevant documents disclosed;;See also references of WO 2015138799A1,DISCONTINUED
63,WO,A1,WO 2021/113538 A1,182-859-032-395-679,2021-06-10,2021,US 2020/0063152 W,2020-12-03,US 201962945033 P;;US 201962944999 P,2019-12-06,TRAINING CARTRIDGE FOR MEDICAL PUMP SYSTEMS,"Rotary microfluidic medical pump and pumping method embodiments are discussed herein that may be used for controlled delivery of small and precise volumes of therapeutic or non-therapeutic fluids in a variety of environmental conditions. Certain medical pump and pumping method embodiments discussed herein may also be useful for the controlled delivery of certain therapeutic fluids that may be susceptible to degradation when exposed to high levels of pressure, flow velocity, shear stress or the like. Training cartridge device and method embodiments discussed herein may be useful for familiarizing patients with the medical pump systems they are using.",QUASURAS INC,DIPERNA KELSIE;;GOLDMAN MARC;;DIPERNA PAUL,,https://lens.org/182-859-032-395-679,Patent Application,yes,5,2,8,8,0,A61M2005/14288;;A61M5/14248;;A61M2205/273;;A61M2205/3327;;A61M2205/3331;;A61M2205/3553;;A61M2205/6072;;A61M2205/8206;;A61M2205/50;;A61M2205/52;;A61M2005/14268;;A61M5/14586;;A61M5/16809;;A61M2205/581;;A61M2205/584;;A61M2205/3368;;A61M2005/16868;;A61M2205/18;;A61M2205/6018;;A61M2205/6027;;A61M2205/6036;;A61M2205/6045;;A61M2205/6054;;A61M5/142;;A61M2005/14288;;A61M2205/273;;A61M2205/3327;;A61M2205/3553;;A61M2205/6072;;A61M5/145;;A61M2205/3331;;A61M2205/8206;;A61M5/14248;;A61M2205/50;;A61M2205/52;;G09B23/285;;A61M5/1413,G09B23/28;;A61M5/142;;G16H20/17,,1,0,,,See also references of EP 4070303A4,PENDING
64,US,B1,US 7511654 B1,164-900-373-839-695,2009-03-31,2009,US 33011106 A,2006-01-12,US 33011106 A,2006-01-12,Systems and methods for mine detection,"Systems, methods, and devices for detecting land mines and unexploded ordnance are disclosed. A first embodiment may be construed as a method that includes: inserting an antenna into the ground; transmitting an electromagnetic signal into the ground via the antenna; receiving a response via the antenna; and processing the response to generate an image which can be examined to determine whether a mine exists within proximity of the antenna.",US ARMY,GOLDMAN GEOFFREY H;;RESSLER MARC A,UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (2006-03-13),https://lens.org/164-900-373-839-695,Granted Patent,yes,23,55,1,1,0,G01S13/885;;G01S13/90;;G01V3/15;;G01S13/885;;G01S13/90;;G01V3/15,G01S13/89;;G01S13/88,342/22;;342/27;;342/90;;342/179,15,7,086-531-432-687-401;;024-763-489-780-918;;053-307-757-945-591;;148-593-903-022-387;;095-993-755-677-489;;000-911-370-190-049;;096-628-033-931-458,10.1109/36.387571;;10.1109/tap.2003.820975;;10.1109/74.755021;;10.1117/12.396189;;10.1109/5254.995459;;10.1109/igarss.2000.857226;;10.1109/ccece.2001.933666,"""A space marching inversion algorithm for pulsed borehole radar in the time-domain"", Yongmin Zhang: Ce Liy Geoscience and Remote Sensing, IEEE Transactions on vol. 33, Issue 3, May 1995 pp. 541-550.;;""Super-resolution imaging for point reflectors near transmitting and receiving array"", Miwa, T.; Arai, I. Antennas and Propagation, IEEE Transactions on vol. 52, Issue 1, Jan. 2004 pp. 220-229.;;Ultra-wideband Synthetic Aperture Radar for Mine-field Detection, by Carin, et al, IEEE Ant. Prop. Mag. vol. 41, pp. 18-33, Feb. 1999.;;""Time Domain Sensing of Targets Buried Under a General Rough Alt-Ground Interface,"" SPIE, v. 4038, pp. 942-953 Apr. 2000.;;Dual Hidden Markov Model Characterization of Wavelet Coefficients From Multi-Aspect scattering Data, by Dasgupta, et al., SPIE, v. 4038, pp. 954-965, Apr. 2000.;;Detection of Symmetrical Objects Using the Blstatic Multipolarimetric Reverse-time Migration Imaging Technique, by Beh, et al., SPIE, v. 4038, pp. 1019-1027, Apr. 2000.;;Combined High-dimensional Analysis of Variance (HANOVA) and Sequential Probability Ratio Test (SPRT) to Detect Buried Mines, Xu, et al. , Proceedings of SPIE vol. 4038 (2000) pp. 1037-1046.;;Landmine Detection Research Pushes Forward, Despite Challanges, by Schreiner, et al., Intelligent Systems, IEEE vol. 17, Issue 2, Mar.-Apr. 2002, p. 4-7.;;Development Status of the Army's New Handheld Mine Detection Systems, (HSTAMIDS), by Amazeen, et al., Second International Conference on the (IEEE Conf. Publ. No. 458) Oct. 1998, pp. 193-197.;;Impact of Interfacial Dipole Radiation on UXO target Detection Using 3-D Kirchoff Imaging, by Moran, et al., Geoscience and Remote Sensing Symposium, 2000, Proceedings, IGARSS 2000, IEEE 2000 International, vol. 4, 24-28, Jul. 2000, pp. 1421-1423.;;Adaptive Fuzzy Force Control of an Anti-Personal (AP) Mine Detector Robot, by Shahri, et al., IEEE Canadian Conference on Electrical and Computer Engineering, May 2001, pp. 99-104.;;Electromagnetic Analysis of an Antenna Buried in a Composite Environment, by Pasvolsk, et al., Antennas and Propagation Society, 1999, IEEE International Symposium 1999, vol. 2, 11-16, Jul. 1999, pp. 854-857, vol. 2.;;Complex Rays with an Application to Gaussian Beams, by Keller, et al., J. Opt. Soc. of American Jan. 1971, V. 61, pp. 40-43.;;Complex-source-point Solutions of the Field Equations and Their Relation to the Propagation and Scattering of Gaussian Beams, by Felsen, Symp. Matermat. Ins. Naz. De Alta Matematica, V. 18, pp. 39-56, London: Academic, 1976.;;Home page of Avtech Electrosystems Ltd.; http://www.avtechpulse.com dated Jan. 8, 2006.",INACTIVE
65,CN,A,CN 106413553 A,183-415-049-119-952,2017-02-15,2017,CN 201580026523 A,2015-03-12,US 201461952070 P;;US 2015/0020283 W,2014-03-12,Analyte testing devices with lancet advancement tracking and color touchscreen user interface,"Analyte testing and monitoring methods, systems, and devices are disclosed. In one aspect, an analyte testing device indudes an analyte sensor module configured to hold a sensor cassette structured to store analyte sensors, the analyte sensor module induding an opening from which an analyte sensor advances to a testing position to expose at least a portion of the analyte sensor to outside of the analyte testing device; and a lancing module configured to hold a lancet cassette structured to store lancets and project the lancets to outside of the analyte testing device during a blood sample acquisition event to pierce a user's skin.",YOFIMETER LLC,SHAANAN GAD;;GOLDMAN MARC;;SHAANAN JESSICA,,https://lens.org/183-415-049-119-952,Patent Application,no,4,0,7,7,0,A61B5/157;;A61B5/157;;A61B5/14532;;A61B5/14532;;A61B5/14546;;A61B5/150022;;A61B5/150022;;A61B5/150175;;A61B5/150175;;A61B5/150267;;A61B5/150412;;A61B5/150801;;A61B5/15087;;A61B5/150961;;A61B5/15153;;A61B5/15153;;A61B5/15176;;A61B5/15176;;A61B5/15182;;A61B5/15182;;A61B5/7435;;A61B2562/0295;;A61B2562/0295,A61B5/151,,0,0,,,,DISCONTINUED
66,US,A1,US 2023/0044763 A1,121-336-788-246-141,2023-02-09,2023,US 202217968599 A,2022-10-18,US 202217968599 A;;US 201816028256 A;;US 201762529086 P,2017-07-06,MEDICAL PUMP WITH FLOW CONTROL,Methods and devices for accurately pumping small quantities of liquid to a patient with a broad range of flow and low cost.,QUASURAS INC,DIPERNA PAUL M;;ROSE FREEMAN;;GOLDMAN MARC,QUASURAS INC (2019-11-08),https://lens.org/121-336-788-246-141,Patent Application,yes,0,0,7,7,0,A61M5/16809;;A61M5/16881;;A61M2205/3331;;A61M5/14248;;A61M5/14224;;A61M5/1723;;A61M5/14248;;A61M5/14224;;A61M5/16804;;A61M5/31513;;A61M2005/14252;;A61M5/16881;;A61M5/16809;;A61M2205/3331;;A61M5/14586;;A61M5/14526;;A61M5/14593;;A61M5/145;;A61M5/1452;;A61M2005/14264;;A61M2005/14533;;A61M2039/2446;;A61M2039/246;;A61M2039/244;;A61M2039/2433;;A61M39/24;;A61M5/16877,A61M5/172;;A61M5/142;;A61M5/145;;A61M5/168;;A61M5/315;;A61M39/24,,0,0,,,,PENDING
67,CA,A1,CA 3067841 A1,056-912-277-388-604,2019-01-10,2019,CA 3067841 A,2018-07-05,US 201762529086 P;;US 2018/0040944 W,2017-07-06,MEDICAL PUMP WITH FLOW CONTROL,Methods and devices for accurately pumping small quantities of liquid to a patient with a broad range of flow and low cost.,QUASURAS INC,DIPERNA PAUL M;;ROSE FREEMAN;;GOLDMAN MARC,,https://lens.org/056-912-277-388-604,Patent Application,no,0,0,7,7,0,A61M5/16809;;A61M5/16881;;A61M2205/3331;;A61M5/14248;;A61M5/14224;;A61M5/1723;;A61M5/14248;;A61M5/14224;;A61M5/16804;;A61M5/31513;;A61M2005/14252;;A61M5/16881;;A61M5/16809;;A61M2205/3331;;A61M5/14586;;A61M5/14526;;A61M5/14593;;A61M5/145;;A61M5/1452;;A61M2005/14264;;A61M2005/14533;;A61M2039/2446;;A61M2039/246;;A61M2039/244;;A61M2039/2433;;A61M39/24;;A61M5/16877,A61M5/142;;F04B43/00;;F04B43/02;;F04B43/14,,0,0,,,,PENDING
68,EP,A4,EP 4070303 A4,054-961-397-054-658,2024-02-21,2024,EP 20896021 A,2020-12-03,US 201962945033 P;;US 201962944999 P;;US 2020/0063152 W,2019-12-06,TRAINING CARTRIDGE FOR MEDICAL PUMP SYSTEMS,,QUASURAS INC,DIPERNA KELSIE;;GOLDMAN MARC;;DIPERNA PAUL M,,https://lens.org/054-961-397-054-658,Search Report,no,4,0,8,8,0,A61M2005/14288;;A61M5/14248;;A61M2205/273;;A61M2205/3327;;A61M2205/3331;;A61M2205/3553;;A61M2205/6072;;A61M2205/8206;;A61M2205/50;;A61M2205/52;;A61M2005/14268;;A61M5/14586;;A61M5/16809;;A61M2205/581;;A61M2205/584;;A61M2205/3368;;A61M2005/16868;;A61M2205/18;;A61M2205/6018;;A61M2205/6027;;A61M2205/6036;;A61M2205/6045;;A61M2205/6054;;A61M5/142;;A61M2005/14288;;A61M2205/273;;A61M2205/3327;;A61M2205/3553;;A61M2205/6072;;A61M5/145;;A61M2205/3331;;A61M2205/8206;;A61M5/14248;;A61M2205/50;;A61M2205/52;;G09B23/285;;A61M5/1413,A61M5/142;;A61M5/168;;A61M5/172,,1,0,,,See also references of WO 2021113538A1,PENDING
69,US,B2,US 11504472 B2,141-008-179-916-421,2022-11-22,2022,US 201816028256 A,2018-07-05,US 201816028256 A;;US 201762529086 P,2017-07-06,Medical pump with flow control,Methods and devices for accurately pumping small quantities of liquid to a patient with a broad range of flow and low cost.,QUASURAS INC,DIPERNA PAUL M;;ROSE FREEMAN;;GOLDMAN MARC,,https://lens.org/141-008-179-916-421,Granted Patent,yes,62,0,7,7,0,A61M5/16809;;A61M5/16881;;A61M2205/3331;;A61M5/14248;;A61M5/14224;;A61M5/1723;;A61M5/14248;;A61M5/14224;;A61M5/16804;;A61M5/31513;;A61M2005/14252;;A61M5/16881;;A61M5/16809;;A61M2205/3331;;A61M5/14586;;A61M5/14526;;A61M5/14593;;A61M5/145;;A61M5/1452;;A61M2005/14264;;A61M2005/14533;;A61M2039/2446;;A61M2039/246;;A61M2039/244;;A61M2039/2433;;A61M39/24;;A61M5/16877,A61M5/172;;A61M5/142;;A61M5/145;;A61M5/168;;A61M5/315;;A61M39/24,,12,0,,,"International Search Report and Written Opinion dated Oct. 4, 2019 in International Application No. PCT/US2019/43146 filed: Jul. 24, 2019.;;Office Action dated Jan. 2, 2020 in U.S. Appl. No. 15/122,132, filed Aug. 26, 2016 and published as: 2016/0361489 on Dec. 15, 2016.;;International Search Report and Written Opinion dated Jul. 31, 2015 in International Application No. PCT/US2015/18525 filed: Mar. 3, 2015 and published as: WO/2015/134526 on: Sep. 11, 2015.;;International Search Report and Written Opinion dated Oct. 18, 2018 in International Application No. PCT/US0218/40944.;;Final Office Action dated Jun. 26, 2020 in U.S. Appl. No. 15/122,132, filed Aug. 26, 2016 and published as: 2016/0361489 on Dec. 15, 2016.;;Supplementary European Search Report dated Mar. 12, 2021 in European Patent Application No. EP 18828123.2 filed: Jul. 5, 2018.;;Invitation to Pay Additional Fees dated: Feb. 23, 2021 in International Application No. PCT/US2020/63152 filed: Dec. 3, 2020.;;International Preliminary Report on Patentability dated Jan. 26, 2021 in International Application No. PCT/US2019/43146 filed: Jul. 24, 2019.;;Corrected Notice of Allowance dated Jun. 28, 2021 in U.S. Appl. No. 15/122,132, filed Aug. 26, 2016 and published as: 2016/0361489 on: Dec. 15, 2016.;;Notice of Allowance dated Jun. 1, 2021 in U.S. Appl. No. 15/122,132, filed Aug. 26, 2016 and published as: 2016/0361489 on: Dec. 15, 2016.;;International Search Report and Written Opinion dated Feb. 26, 2021 in International Patent Application No. PCT/US2020/63151 filed: Dec. 3, 2020.;;International Preliminary Report on Patentability dated May 17, 2022 in International Patent Application No. PCT/US2020/63151 filed: Dec. 3, 2020.",ACTIVE
70,US,B2,US 6762294 B2,146-713-760-439-425,2004-07-13,2004,US 93058901 A,2001-08-15,US 93058901 A;;US 0004189 W;;US 12081299 P,1999-02-19,Polynucleotides encoding polymorphic human GABAA receptor alpha-6 subunit,"
    Compositions and methods based on a polymorphism in the gene encoding the 6 subunit of the human GABA _{ A } neurotransmitter receptor are disclosed. This polymorphism results in the substitution of a serine residue for a proline residue ordinarily present at amino acid position 385 of the 6 polypeptide sequence. Significantly, the polymorphism was associated with decreased sensitivity to ethanol and benzodiazepine drugs. 
",US HEALTH,GOLDMAN DAVID;;IWATA NAKAO;;SCHUCKIT MARC A,GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES (2002-12-11),https://lens.org/146-713-760-439-425,Granted Patent,yes,2,0,2,11,14,C07K14/70571;;C07K14/70571,C07K14/705,536/23.5;;435/6,18,16,057-234-111-317-87X;;040-537-330-786-394;;016-318-439-871-648;;053-113-519-691-084;;000-470-206-645-354;;120-894-864-784-698;;060-552-071-696-052;;128-530-640-017-194;;084-196-452-810-050;;028-351-149-591-744;;077-750-740-364-43X;;039-679-414-845-847;;057-051-145-273-412;;035-546-031-867-77X;;032-313-209-584-827;;125-734-099-576-267,10.1096/fasebj.5.14.1661244;;1661244;;2782481;;10.1176/ajp.146.10.1333;;7259422;;10.1001/archpsyc.1981.01780330019001;;1335221;;10.1111/j.1530-0277.1992.tb00699.x;;8048734;;10.1111/j.1530-0277.1994.tb00021.x;;2700603;;8632757;;10.1176/ajp.156.9.1447;;10484961;;10.1038/sj.mp.4000706;;10889535;;7678923;;10.1038/361356a0;;10.1038/346648a0;;2166916;;10.1176/ajp.149.11.1534;;1415821;;10.1016/s0006-3223(98)00248-0;;10088053;;10.1111/j.1530-0277.1988.tb00228.x;;3056066;;1758188;;10.15288/jsa.1991.52.601;;10.1016/s0165-6147(97)90675-1,"Burt, D. R. and Kamatchi, G. L. (1991) GABAA receptor subtypes: from pharmacology to molecular biology. FASEB J. 5:2916-2923.;;Ciraulo, D. A., et al. (1989) Parental Alcoholism as a Risk Factor in Benzodiazepine Abuse: A Pilot Study. Am. J. Psychiatry 146:1333-1335.;;Cloninger, C. R., et al. (1981) Inheritance of Alcohol Abuse. Arch. Gen. Psychiatry 38:861-868.;;Cowley, D. S., et al. (1992) Response to Diazepam in Sons of Alcoholics. Alcohol. Clin. Exp. Res. 16(6):1057-1063.;;Cowley, D. S., et al. (1994) Eye Movement Effects of Diazepam in Sons of Alcoholic Fathers and Male Control Subjects. Alcohol. Clin. Exp. Res 18(2):324-332.;;Deitrich, R. A., et al. (1989) Mechanism of Action of Ethanol: Initial Central Nervous System Actions. Pharmacol. Rev. 41(4):489-537.;;Hadingham, K. L., et al. (1996) Cloning of cDNAs Encoding the Human gamma-Aminobutyric acid Type A Receptor alpha6 Subunit and Characterization of the Pharmacology of alpha6-Containing receptors. Mol. Pharmacol. 49:253-259.;;Iwata, N., et al. (1999) Relationship Between a GABAA alpha6 Pro385Ser Substitution and Benzodiazepine Sensitivity. Am. J. Psychiatry 156(9):1447-1449.;;Iwata, N., et al. (1999) GABAA alpha6 polymorphisms and relationship to benzodiazepine sensitivity. (Abstract) Biol. Psychiatry Suppl. 45:82S;;Iwata, N., et al. (2000) Identification of a naturally occuring Pro385-Ser385 substitution in the GABAA receptor alpha6 subunit gene in alcoholics and healthy volunteers. Mol. Psychiatry 5:316-319.;;Korpi, E. R., et al. (1993) Benzodiazepine-induced motor impairment linked to point mutation in cerebellar GABAA receptor. Nature 361:356-359.;;Luddens, H., et al. (1990) Cerebellar GABAA receptor selective for a behavioural alcohol antagonist. Nature 346:648-651.;;Pollock, V. E. (1992) Meta-Analysis of Subjective Sensitivity to Alcohol in Sons of Alcoholics. Am. J. Psychiatry 149:1534-1538.;;Radel, M., et al. (1998) Detection of Sequence Variants in GABAA Receptor Subunit Genes by DHPLC Analysis. (Abstract) (Alcohol Clin. Exp. Res. 22(3):98A.;;Schuckit, M. A., et al. (1999) Selective Genotyping for the Role of 5-HT2A, 5-HT2C, and GABAalpha6 Receptors and the Serotonin Transporter in the Level of Response to Alcohol: A Pilot Study, Biol. Psychiatry 45:647-651.;;Schuckit, M. A. (1988) Reactions to Alcohol in Sons of Alcoholics and Controls. Alcohol Clin. Exp. Res. 12(4): 465-470.;;Schuckit, M. A., et al. (1991) Subjective Feelings and Changes in Body Sway Following Diazepam in Sons of Alcoholics and Control Subjects. J. Stud. Alcohol 52(6):601-608.;;Sigel, E. and Buhr, A. (1997) The benzodiazepine binding site of GABAA receptors. TiPS 18:425-429.",EXPIRED
71,EP,A1,EP 4070303 A1,176-600-846-800-784,2022-10-12,2022,EP 20896021 A,2020-12-03,US 201962945033 P;;US 201962944999 P;;US 2020/0063152 W,2019-12-06,TRAINING CARTRIDGE FOR MEDICAL PUMP SYSTEMS,,QUASURAS INC,DIPERNA KELSIE;;GOLDMAN MARC;;DIPERNA PAUL M,,https://lens.org/176-600-846-800-784,Patent Application,yes,0,0,8,8,0,A61M2005/14288;;A61M5/14248;;A61M2205/273;;A61M2205/3327;;A61M2205/3331;;A61M2205/3553;;A61M2205/6072;;A61M2205/8206;;A61M2205/50;;A61M2205/52;;A61M2005/14268;;A61M5/14586;;A61M5/16809;;A61M2205/581;;A61M2205/584;;A61M2205/3368;;A61M2005/16868;;A61M2205/18;;A61M2205/6018;;A61M2205/6027;;A61M2205/6036;;A61M2205/6045;;A61M2205/6054;;A61M5/142;;A61M2005/14288;;A61M2205/273;;A61M2205/3327;;A61M2205/3553;;A61M2205/6072;;A61M5/145;;A61M2205/3331;;A61M2205/8206;;A61M5/14248;;A61M2205/50;;A61M2205/52;;G09B23/285;;A61M5/1413,G09B23/28;;A61M5/142;;G16H20/17,,0,0,,,,PENDING
72,US,A1,US 2021/0170094 A1,066-078-277-154-008,2021-06-10,2021,US 202017111402 A,2020-12-03,US 202017111402 A;;US 201962945033 P;;US 201962944999 P,2019-12-06,TRAINING CARTRIDGE FOR MEDICAL PUMP SYSTEMS,"Rotary microfluidic medical pump and pumping method embodiments are discussed herein that may be used for controlled delivery of small and precise volumes of therapeutic or non-therapeutic fluids in a variety of environmental conditions. Certain medical pump and pumping method embodiments discussed herein may also be useful for the controlled delivery of certain therapeutic fluids that may be susceptible to degradation when exposed to high levels of pressure, flow velocity, shear stress or the like. Training cartridge device and method embodiments discussed herein may be useful for familiarizing patients with the medical pump systems they are using.",QUASURAS INC,DIPERNA KELSIE;;GOLDMAN MARC;;DIPERNA PAUL M,QUASURAS INC (2021-11-22),https://lens.org/066-078-277-154-008,Patent Application,yes,6,4,8,8,0,A61M2005/14288;;A61M5/14248;;A61M2205/273;;A61M2205/3327;;A61M2205/3331;;A61M2205/3553;;A61M2205/6072;;A61M2205/8206;;A61M2205/50;;A61M2205/52;;A61M2005/14268;;A61M5/14586;;A61M5/16809;;A61M2205/581;;A61M2205/584;;A61M2205/3368;;A61M2005/16868;;A61M2205/18;;A61M2205/6018;;A61M2205/6027;;A61M2205/6036;;A61M2205/6045;;A61M2205/6054;;A61M5/142;;A61M2005/14288;;A61M2205/273;;A61M2205/3327;;A61M2205/3553;;A61M2205/6072;;A61M5/145;;A61M2205/3331;;A61M2205/8206;;A61M5/14248;;A61M2205/50;;A61M2205/52;;G09B23/285;;A61M5/1413,A61M5/142,,0,0,,,,PENDING
73,WO,A1,WO 2023/055819 A1,015-099-252-705-822,2023-04-06,2023,US 2022/0045065 W,2022-09-28,US 202163249802 P,2021-09-29,INFUSION PUMP WITH MULTIPLE RESERVOIRS,Rotary microfluidic medical pump and pumping method embodiments are discussed herein that may be used for controlled delivery of small and precise volumes of therapeutic or non-therapeutic fluids in a variety of environmental conditions. Certain medical pump and pumping method embodiments discussed herein may also include pump systems having a plurality of reservoirs and which are configured for pumping a plurality of fluids such as medicaments via a common pump mechanism and outlet tubing.,QUASURAS INC,NEESE DAVID;;GOLDMAN MARC;;DIPERNA PAUL M,,https://lens.org/015-099-252-705-822,Patent Application,yes,7,0,2,2,0,A61M5/14248;;A61M5/1452;;A61M2005/14533;;A61M2205/3331;;A61M5/172;;A61M5/16827;;A61M2205/3523;;A61M5/14248;;A61M5/1452;;A61M2205/3327;;A61M2205/8206;;A61M2205/3331;;A61M2005/14533;;A61M2205/128,A61M5/142;;A61M5/172;;G16H20/17,,0,0,,,,PENDING
74,US,A1,US 2019/0009023 A1,059-894-291-596-47X,2019-01-10,2019,US 201816028256 A,2018-07-05,US 201816028256 A;;US 201762529086 P,2017-07-06,MEDICAL PUMP WITH FLOW CONTROL,Methods and devices for accurately pumping small quantities of liquid to a patient with a broad range of flow and low cost.,MODULAR MEDICAL INC,DIPERNA PAUL M;;ROSE FREEMAN;;GOLDMAN MARC,QUASURAS INC (2019-11-08),https://lens.org/059-894-291-596-47X,Patent Application,yes,0,9,7,7,0,A61M5/16809;;A61M5/16881;;A61M2205/3331;;A61M5/14248;;A61M5/14224;;A61M5/1723;;A61M5/14248;;A61M5/14224;;A61M5/16804;;A61M5/31513;;A61M2005/14252;;A61M5/16881;;A61M5/16809;;A61M2205/3331;;A61M5/14586;;A61M5/14526;;A61M5/14593;;A61M5/145;;A61M5/1452;;A61M2005/14264;;A61M2005/14533;;A61M2039/2446;;A61M2039/246;;A61M2039/244;;A61M2039/2433;;A61M39/24;;A61M5/16877,A61M5/172;;A61M5/142,,0,0,,,,ACTIVE
75,US,A1,US 2003/0138776 A1,027-953-766-421-654,2003-07-24,2003,US 93058901 A,2001-08-15,US 93058901 A;;US 0004189 W;;US 12081299 P,1999-02-19,Polymorphic human GABAA receptor alpha-6 subunit,"
    Compositions and methods based on a polymorphism in the gene encoding the 6 subunit of the human GABA _{A } neurotransmitter receptor are disclosed. This polymorphism results in the substitution of a serine residue for a proline residue ordinarily present at amino acid position 385 of the 6 polypeptide sequence. Significantly, the polymorphism was associated with decreased sensitivity to ethanol and benzodiazepine drugs. 
",GOLDMAN DAVID;;IWATA NAKAO;;SCHUCKIT MARC A.,GOLDMAN DAVID;;IWATA NAKAO;;SCHUCKIT MARC A,GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES (2002-12-11),https://lens.org/027-953-766-421-654,Patent Application,yes,0,5,2,11,13,C07K14/70571;;C07K14/70571,C07K14/705,435/6;;435/69.1;;435/320.1;;435/325;;X53035;;536/23.5,0,0,,,,EXPIRED
76,US,A1,US 2023/0108800 A1,039-287-404-222-600,2023-04-06,2023,US 202217955174 A,2022-09-28,US 202217955174 A;;US 202163249802 P,2021-09-29,INFUSION PUMP WITH MULTIPLE RESERVOIRS,Rotary microfluidic medical pump and pumping method embodiments are discussed herein that may be used for controlled delivery of small and precise volumes of therapeutic or non-therapeutic fluids in a variety of environmental conditions. Certain medical pump and pumping method embodiments discussed herein may also include pump systems having a plurality of reservoirs and which are configured for pumping a plurality of fluids such as medicaments via a common pump mechanism and outlet tubing.,QUASURAS INC,NEESE DAVID;;GOLDMAN MARC;;DIPERNA PAUL M,QUASURAS INC (2022-11-04),https://lens.org/039-287-404-222-600,Patent Application,yes,0,0,2,2,0,A61M5/14248;;A61M5/1452;;A61M2005/14533;;A61M2205/3331;;A61M5/172;;A61M5/16827;;A61M2205/3523;;A61M5/14248;;A61M5/1452;;A61M2205/3327;;A61M2205/8206;;A61M2205/3331;;A61M2005/14533;;A61M2205/128,A61M5/142;;A61M5/145,,0,0,,,,PENDING
77,EP,A1,EP 3648815 A1,060-818-234-256-437,2020-05-13,2020,EP 18828123 A,2018-07-05,US 201762529086 P;;US 2018/0040944 W,2017-07-06,MEDICAL PUMP WITH FLOW CONTROL,,QUASURAS INC,DIPERNA PAUL M;;ROSE FREEMAN;;GOLDMAN MARC,,https://lens.org/060-818-234-256-437,Patent Application,yes,0,0,7,7,0,A61M5/16809;;A61M5/16881;;A61M2205/3331;;A61M5/14248;;A61M5/14224;;A61M5/1723;;A61M5/14248;;A61M5/14224;;A61M5/16804;;A61M5/31513;;A61M2005/14252;;A61M5/16881;;A61M5/16809;;A61M2205/3331;;A61M5/14586;;A61M5/14526;;A61M5/14593;;A61M5/145;;A61M5/1452;;A61M2005/14264;;A61M2005/14533;;A61M2039/2446;;A61M2039/246;;A61M2039/244;;A61M2039/2433;;A61M39/24;;A61M5/16877,A61M5/142;;F04B43/00;;F04B43/02;;F04B43/14,,0,0,,,,PENDING
78,EP,A4,EP 3648815 A4,019-848-642-501-869,2021-04-14,2021,EP 18828123 A,2018-07-05,US 201762529086 P;;US 2018/0040944 W,2017-07-06,MEDICAL PUMP WITH FLOW CONTROL,,QUASURAS INC,DIPERNA PAUL M;;ROSE FREEMAN;;GOLDMAN MARC,,https://lens.org/019-848-642-501-869,Search Report,no,3,0,7,7,0,A61M5/16809;;A61M5/16881;;A61M2205/3331;;A61M5/14248;;A61M5/14224;;A61M5/1723;;A61M5/14248;;A61M5/14224;;A61M5/16804;;A61M5/31513;;A61M2005/14252;;A61M5/16881;;A61M5/16809;;A61M2205/3331;;A61M5/14586;;A61M5/14526;;A61M5/14593;;A61M5/145;;A61M5/1452;;A61M2005/14264;;A61M2005/14533;;A61M2039/2446;;A61M2039/246;;A61M2039/244;;A61M2039/2433;;A61M39/24;;A61M5/16877,A61M5/142;;A61M5/168;;F04B43/00;;F04B43/02;;F04B43/14,,1,0,,,See also references of WO 2019010324A1,PENDING
79,WO,A1,WO 2019/010324 A1,187-846-628-178-359,2019-01-10,2019,US 2018/0040944 W,2018-07-05,US 201762529086 P,2017-07-06,MEDICAL PUMP WITH FLOW CONTROL,Methods and devices for accurately pumping small quantities of liquid to a patient with a broad range of flow and low cost.,MODULAR MEDICAL INC,DIPERNA PAUL M;;ROSE FREEMAN;;GOLDMAN MARC,,https://lens.org/187-846-628-178-359,Patent Application,yes,7,5,7,7,0,A61M5/16809;;A61M5/16881;;A61M2205/3331;;A61M5/14248;;A61M5/14224;;A61M5/1723;;A61M5/14248;;A61M5/14224;;A61M5/16804;;A61M5/31513;;A61M2005/14252;;A61M5/16881;;A61M5/16809;;A61M2205/3331;;A61M5/14586;;A61M5/14526;;A61M5/14593;;A61M5/145;;A61M5/1452;;A61M2005/14264;;A61M2005/14533;;A61M2039/2446;;A61M2039/246;;A61M2039/244;;A61M2039/2433;;A61M39/24;;A61M5/16877,A61M5/142;;F04B43/00;;F04B43/02;;F04B43/14,,1,0,,,See also references of EP 3648815A4,PENDING
80,WO,A1,WO 2022/046370 A1,078-450-258-094-162,2022-03-03,2022,US 2021/0044301 W,2021-08-03,US 202017001330 A,2020-08-24,PORTABLE INFUSION PUMP WITH PINCH/SQUEEZE PUMPING ACTION,"A device for infusing a medicament into a patient includes a disposable component having a collapsible reservoir for holding the medicament, a cannula, and an elastomeric tube connected in fluid communication between the reservoir and the cannula. A manipulator is mounted on a chassis for engagement with the elastomeric tube. The manipulator includes a piston and respective pinchers upstream and downstream from the piston for a close/open open/close changeover operation. In concert therewith, the piston cyclically advances and withdraws relative to a platen to thereby alternatingly dilate/constrict the tube section. When the upstream pincher is open, the piston withdraws to create a low fluid pressure, P Lo , in the tube section to draw medicament into the tube. Alternately, when the downstream pincher is open, the piston is advanced to create a high fluid pressure, P Hi , on the tube to infuse medicament into the patient.",MODULAR MEDICAL INC,NEESE DAVID;;DIPERNA PAUL M;;GOLDMAN MARC D,,https://lens.org/078-450-258-094-162,Patent Application,yes,6,0,3,3,0,A61M5/14244;;A61M5/14216;;A61M2205/10;;A61M2205/106;;A61M5/14216;;A61M2205/8275;;A61M5/14244;;A61M5/1452,A61M5/142,,0,0,,,,PENDING
81,WO,A1,WO 2023/158511 A1,145-308-136-733-369,2023-08-24,2023,US 2022/0080468 W,2022-11-25,US 202217673415 A,2022-02-16,PORTABLE INFUSION PUMP WITH REMOTE ACTIVATOR,"A system for activating a portable infusion pump includes a remote interaction device operated by the user for direct communication with the pump. Upon receipt of an initiate signal from the user, a computer on-board the infusion pump evaluates status metrics from the infusion pump, along with clinical information, to validate the initiate signal. With this validation, the computer identifies an appropriate response for operating the infusion pump. An indicator on the infusion pump then informs the user of the appropriate response for the user to follow for activating the infusion pump.",MODULAR MEDICAL INC,DIPERNA PAUL M;;GOLDMAN MARC D;;DIPERNA KELSIE,,https://lens.org/145-308-136-733-369,Patent Application,yes,3,0,2,2,0,A61M5/172;;G16H40/63;;A61M5/142;;A61M5/14244;;A61M2005/14208;;A61M5/172;;G16H40/67;;G16H20/17;;A61M2205/3553;;A61M2205/505;;A61M2205/3389;;A61M2205/80;;A61M2205/582;;A61M2205/587;;A61M2205/3317;;A61M2205/3327;;A61M2205/609;;A61M2205/581,G16H20/17;;A61M5/142;;A61M5/172;;G16H40/67,,0,0,,,,PENDING
82,WO,A1,WO 2021/113537 A1,196-532-885-002-121,2021-06-10,2021,US 2020/0063151 W,2020-12-03,US 201962945033 P;;US 201962944999 P,2019-12-06,ROTARY MICROFLUIDIC MEDICAL PUMP,"Rotary microfluidic medical pump and pumping method embodiments are discussed herein that may be used for controlled delivery of small and precise volumes of therapeutic or non-therapeutic fluids in a variety of environmental conditions. Certain medical pump and pumping method embodiments discussed herein may also be useful for the controlled delivery of certain therapeutic fluids that may be susceptible to degradation when exposed to high levels of pressure, flow velocity, shear stress or the like.",QUASURAS INC,DIPERNA PAUL;;GOLDMAN MARC;;NEESE DAVID;;HEARTY PATRICK,,https://lens.org/196-532-885-002-121,Patent Application,yes,8,2,8,8,0,A61M2005/14288;;A61M5/14248;;A61M2205/273;;A61M2205/3327;;A61M2205/3331;;A61M2205/3553;;A61M2205/6072;;A61M2205/8206;;A61M2205/50;;A61M2205/52;;A61M2005/14268;;A61M5/14586;;A61M5/16809;;A61M2205/581;;A61M2205/584;;A61M2205/3368;;A61M2005/16868;;A61M2205/18;;A61M2205/6018;;A61M2205/6027;;A61M2205/6036;;A61M2205/6045;;A61M2205/6054;;A61M5/142;;A61M2005/14288;;A61M2205/273;;A61M2205/3327;;A61M2205/3553;;A61M2205/6072;;A61M5/145;;A61M2205/3331;;A61M2205/8206;;A61M5/14248;;A61M2205/50;;A61M2205/52;;G09B23/285;;A61M5/1413,A61M5/142;;A61M5/172,,1,0,,,See also references of EP 4069333A4,PENDING
83,CN,A,CN 107614036 A,133-394-029-969-446,2018-01-19,2018,CN 201680027691 A,2016-03-10,US 201562133114 P;;US 2016/0021800 W,2015-03-13,PORTABLE MEDICINE INJECTION DEVICE,"A medicine dispensing device can include a recess configured to receive a medicine cartridge having a plunger assembly and a medicine chamber, and a gear assembly configured to cause displacement of the plunger assembly to dispense medicine or draw medicine into the chamber. The gear assembly can be activated by both a motorized and manual activation mechanism.",YOFIMETER LLC,SHAANAN GAD;;GOLDMAN MARC;;BUSBY BRUCE;;MANULIS ALEKS,,https://lens.org/133-394-029-969-446,Patent Application,no,5,4,3,3,0,A61M5/16831;;A61M5/16831;;A61M5/24;;A61M5/14244;;A61M5/14244;;A61M5/14566;;A61M5/14566;;A61M5/16831;;A61M5/1684;;A61M5/1684;;A61M5/20;;A61M5/24;;A61M5/31526;;A61M5/31528;;A61M5/31576;;A61M2005/3114;;A61M2005/3126;;A61M2005/31588;;A61M2205/14;;A61M2205/27;;A61M2205/3515;;A61M2205/3523;;A61M2205/50;;A61M2205/502;;A61M2205/52;;A61M2205/8206;;G16H20/10;;G16H20/10;;G16H20/13;;G16H20/13;;G16H20/17;;G16H20/17;;G16H20/17,A61M5/315;;A61M5/20,,0,0,,,,DISCONTINUED
84,KR,A,KR 20170139012 A,045-356-990-980-378,2017-12-18,2017,KR 20177029293 A,2016-03-10,US 201562133114 P;;US 2016/0021800 W,2015-03-13,휴대용 약물 주입 디바이스,"약물 투여 디바이스는, 약물 챔버 및 플런저 어셈블리를 갖는 약물 카트리지를 수용하도록 구성된 리세스, 및 플런저 어셈블리의 변위가 약물을 투여하거나 또는 약물을 챔버 내로 끌어당기는 것을 야기하도록 구성된 기어 어셈블리를 포함할 수 있다. 기어 어셈블리는 동력형 및 수동 작동 메커니즘 둘 모두에 의해 작동될 수 있다.",YOFIMETER LLC,SHAANAN GAD;;GOLDMAN MARC;;BUSBY BRUCE;;MANULIS ALEKS,,https://lens.org/045-356-990-980-378,Patent Application,no,0,0,3,3,0,A61M5/16831;;A61M5/16831;;A61M5/24;;A61M5/14244;;A61M5/14244;;A61M5/14566;;A61M5/14566;;A61M5/16831;;A61M5/1684;;A61M5/1684;;A61M5/20;;A61M5/24;;A61M5/31526;;A61M5/31528;;A61M5/31576;;A61M2005/3114;;A61M2005/3126;;A61M2005/31588;;A61M2205/14;;A61M2205/27;;A61M2205/3515;;A61M2205/3523;;A61M2205/50;;A61M2205/502;;A61M2205/52;;A61M2205/8206;;G16H20/10;;G16H20/10;;G16H20/13;;G16H20/13;;G16H20/17;;G16H20/17;;G16H20/17,A61M5/24;;A61M5/20;;A61M5/315;;G06F19/00,,0,0,,,,PENDING
85,US,A1,US 2023/0256166 A1,082-226-734-463-538,2023-08-17,2023,US 202217673415 A,2022-02-16,US 202217673415 A,2022-02-16,PORTABLE INFUSION PUMP WITH REMOTE ACTIVATOR,"A system for activating a portable infusion pump includes a remote interaction device operated by the user for direct communication with the pump. Upon receipt of an initiate signal from the user, a computer on-board the infusion pump evaluates status metrics from the infusion pump, along with clinical information, to validate the initiate signal. With this validation, the computer identifies an appropriate response for operating the infusion pump. An indicator on the infusion pump then informs the user of the appropriate response for the user to follow for activating the infusion pump.",MODULAR MEDICAL INC,DIPERNA PAUL M;;GOLDMAN MARC D;;DIPERNA KELSIE,MODULAR MEDICAL INC (2022-05-11),https://lens.org/082-226-734-463-538,Patent Application,yes,0,0,2,2,0,A61M5/172;;G16H40/63;;A61M5/142;;A61M5/14244;;A61M2005/14208;;A61M5/172;;G16H40/67;;G16H20/17;;A61M2205/3553;;A61M2205/505;;A61M2205/3389;;A61M2205/80;;A61M2205/582;;A61M2205/587;;A61M2205/3317;;A61M2205/3327;;A61M2205/609;;A61M2205/581,A61M5/172;;G16H20/17;;G16H40/67,,0,0,,,,PENDING
86,EP,A1,EP 4199995 A1,090-006-431-583-36X,2023-06-28,2023,EP 21862342 A,2021-08-03,US 202017001330 A;;US 2021/0044301 W,2020-08-24,PORTABLE INFUSION PUMP WITH PINCH/SQUEEZE PUMPING ACTION,,MODULAR MEDICAL INC,NEESE DAVID;;DIPERNA PAUL M;;GOLDMAN MARC D,,https://lens.org/090-006-431-583-36X,Patent Application,yes,0,0,3,3,0,A61M5/14244;;A61M5/14216;;A61M2205/10;;A61M2205/106;;A61M5/14216;;A61M2205/8275;;A61M5/14244;;A61M5/1452,A61M5/142,,0,0,,,,PENDING
87,US,A1,US 2016/0263324 A1,170-248-502-114-539,2016-09-15,2016,US 201615068244 A,2016-03-11,US 201615068244 A;;US 201562133144 P,2015-03-13,PORTABLE MEDICINE INJECTION DEVICE,"A medicine dispensing device can include a recess configured to receive a medicine cartridge having a plunger assembly and a medicine chamber, and a gear assembly configured to cause displacement of the plunger assembly to dispense medicine or draw medicine into the chamber. The gear assembly can be activated by both a motorized and manual activation mechanism.",YOFIMETER LLC,SHAANAN GAD;;GOLDMAN MARC;;BUSBY BRUCE;;MANULIS ALEKS,YOFIMETER LLC (2016-03-29),https://lens.org/170-248-502-114-539,Patent Application,yes,0,18,1,1,0,A61M5/1684;;A61M5/24;;A61M2205/3515;;A61M2205/3523;;A61M2205/50;;A61M2205/502;;A61M2205/52;;A61M2205/8206;;A61M5/14566;;A61M5/16831;;A61M5/14244;;A61M2005/3114;;A61M2005/3126;;A61M2205/14;;A61M2205/27;;G16H40/63;;G16H20/17;;A61M2005/2026;;A61M2005/2093;;A61M2005/3114;;A61M2005/3126;;A61M2205/14;;A61M2205/27;;A61M5/16831;;A61M2205/52;;A61M2205/3515;;A61M2205/50;;A61M2205/3523;;A61M2205/502;;A61M5/14566;;A61M5/1684;;A61M5/24;;A61M5/14244;;A61M2205/8206;;G16H20/17;;G16H40/63,A61M5/20;;A61M5/315,,0,0,,,,DISCONTINUED
88,US,A1,US 2022/0054742 A1,065-168-218-742-873,2022-02-24,2022,US 202017001330 A,2020-08-24,US 202017001330 A,2020-08-24,PORTABLE INFUSION PUMP WITH PINCH/SQUEEZE PUMPING ACTION,"A device for infusing a medicament into a patient includes a disposable component having a collapsible reservoir for holding the medicament, a cannula, and an elastomeric tube connected in fluid communication between the reservoir and the cannula. A manipulator is mounted on a chassis for engagement with the elastomeric tube. The manipulator includes a piston and respective pinchers upstream and downstream from the piston for a close/open open/close changeover operation. In concert therewith, the piston cyclically advances and withdraws relative to a platen to thereby alternatingly dilate/constrict the tube section. When the upstream pincher is open, the piston withdraws to create a low fluid pressure, p Lo , in the tube section to draw medicament into the tube. Alternately, when the downstream pincher is open, the piston is advanced to create a high fluid pressure, p Hi , on the tube to infuse medicament into the patient.",MODULAR MEDICAL INC,NEESE DAVID;;DIPERNA PAUL M;;GOLDMAN MARC D,MODULAR MEDICAL INC (2021-03-04),https://lens.org/065-168-218-742-873,Patent Application,yes,3,0,3,3,0,A61M5/14244;;A61M5/14216;;A61M2205/10;;A61M2205/106;;A61M5/14216;;A61M2205/8275;;A61M5/14244;;A61M5/1452,A61M5/142;;A61M5/145,,2,0,,,"“Cohesive.” Merriam-Webster.com Dictionary, Merriam-Webster, https://www.merriam-webster.com/dictionary/cohesive. (Year: 2023);;“Cohesion.” Merriam-Webster.com Dictionary, Merriam-Webster, https://www.merriam-webster.com/dictionary/cohesion. (Year: 2023)",PENDING
89,US,A1,US 2023/0260616 A1,041-549-341-553-187,2023-08-17,2023,US 202217673124 A,2022-02-16,US 202217673124 A,2022-02-16,USER DEVICE COMMUNICATION DEVICE,"A system for controlling the operations of a computerized device requires a sequence of two-way communications between a user and a computer. These communications both validate and control the operation of the device. A first communication from the user to the computer provides instructions that typically include changes for an operation of the device. In response, the computer requests user validation and identification. A second communication from the computer to the user then provides an operational status report of the system and a request for operational confirmation from the user, together with revalidation of user identification. An operation of the communication system is accomplished by selectively using audio, visual, and tactile signals from the user, interactively with vibrations, light variations, visual presentations and sound sequences from the device.",MODULAR MEDICAL INC,DIPERNA PAUL M;;GOLDMAN MARC D;;DIPERNA KELSIE,MODULAR MEDICAL INC (2022-05-11),https://lens.org/041-549-341-553-187,Patent Application,yes,0,0,2,2,0,G08B3/10;;G08B5/36;;G08B6/00;;G16H10/60;;G16H40/60;;G16H20/17;;G08B6/00;;G08B5/36;;G08B3/10,G16H20/17;;G08B3/10;;G08B5/36;;G08B6/00,,0,0,,,,PENDING
90,WO,A1,WO 2016/149038 A1,059-678-416-556-775,2016-09-22,2016,US 2016/0021800 W,2016-03-10,US 201562133114 P,2015-03-13,PORTABLE MEDICINE INJECTION DEVICE,"A medicine dispensing device can include a recess configured to receive a medicine cartridge having a plunger assembly and a medicine chamber, and a gear assembly configured to cause displacement of the plunger assembly to dispense medicine or draw medicine into the chamber. The gear assembly can be activated by both a motorized and manual activation mechanism.",YOFIMETER LLC,SHAANAN GAD;;GOLDMAN MARC;;BUSBY BRUCE;;MANULIS ALEKS,,https://lens.org/059-678-416-556-775,Patent Application,yes,10,4,3,3,0,A61M5/16831;;A61M5/16831;;A61M5/24;;A61M5/14244;;A61M5/14244;;A61M5/14566;;A61M5/14566;;A61M5/16831;;A61M5/1684;;A61M5/1684;;A61M5/20;;A61M5/24;;A61M5/31526;;A61M5/31528;;A61M5/31576;;A61M2005/3114;;A61M2005/3126;;A61M2005/31588;;A61M2205/14;;A61M2205/27;;A61M2205/3515;;A61M2205/3523;;A61M2205/50;;A61M2205/502;;A61M2205/52;;A61M2205/8206;;G16H20/10;;G16H20/10;;G16H20/13;;G16H20/13;;G16H20/17;;G16H20/17;;G16H20/17,A61M5/315;;A61M5/20,,0,0,,,,PENDING
91,WO,A1,WO 2023/158510 A1,150-109-081-179-231,2023-08-24,2023,US 2022/0080467 W,2022-11-25,US 202217673124 A,2022-02-16,USER DEVICE COMMUNICATION SYSTEM,"A system for controlling the operations of a computerized device requires a sequence of two-way communications between a user and a computer. These communications both validate and control the operation of the device. A first communication from the user to the computer provides instructions that typically include changes for an operation of the device. In response, the computer requests user validation and identification. A second communication from the computer to the user then provides an operational status report of the system and a request for operational confirmation from the user, together with revalidation of user identification. An operation of the communication system is accomplished by selectively using audio, visual, and tactile signals from the user, interactively with vibrations, light variations, visual presentations and sound sequences from the device.",MODULAR MEDICAL INC,DIPERNA PAUL M;;GOLDMAN MARC D;;DIPERNA KELSIE,,https://lens.org/150-109-081-179-231,Patent Application,yes,3,0,2,2,0,G08B3/10;;G08B5/36;;G08B6/00;;G16H10/60;;G16H40/60;;G16H20/17;;G08B6/00;;G08B5/36;;G08B3/10,H04W12/00;;A61M5/00,,0,0,,,,PENDING
92,EP,A4,EP 4069333 A4,102-384-206-314-595,2023-12-20,2023,EP 20896925 A,2020-12-03,US 201962945033 P;;US 201962944999 P;;US 2020/0063151 W,2019-12-06,ROTARY MICROFLUIDIC MEDICAL PUMP,,QUASURAS INC,DIPERNA PAUL M;;GOLDMAN MARC;;NEESE DAVID;;HEARTY PATRICK,,https://lens.org/102-384-206-314-595,Search Report,no,8,0,8,8,0,A61M2005/14288;;A61M5/14248;;A61M2205/273;;A61M2205/3327;;A61M2205/3331;;A61M2205/3553;;A61M2205/6072;;A61M2205/8206;;A61M2205/50;;A61M2205/52;;A61M2005/14268;;A61M5/14586;;A61M5/16809;;A61M2205/581;;A61M2205/584;;A61M2205/3368;;A61M2005/16868;;A61M2205/18;;A61M2205/6018;;A61M2205/6027;;A61M2205/6036;;A61M2205/6045;;A61M2205/6054;;A61M5/142;;A61M2005/14288;;A61M2205/273;;A61M2205/3327;;A61M2205/3553;;A61M2205/6072;;A61M5/145;;A61M2205/3331;;A61M2205/8206;;A61M5/14248;;A61M2205/50;;A61M2205/52;;G09B23/285;;A61M5/1413,A61M5/142;;A61M5/168;;A61M5/172,,1,0,,,See also references of WO 2021113537A1,PENDING
93,JP,A,JP 2017062229 A,064-175-833-533-984,2017-03-30,2017,JP 2016163426 A,2016-08-24,US 201514836021 A,2015-08-26,MULTI-TRACK ABSOLUTE ENCODER,"PROBLEM TO BE SOLVED: To provide an encoder for optically filtering trouble of a scale and an influence of contamination and outputting an accurate signal.SOLUTION: An encoder includes a scale that includes a plurality of tracks including an increment track and an absolute track separated in a direction orthogonal to an advance direction, and generates second rays including respective components having optical patterns formed by each of the increment track and the absolute track by interaction with first incident rays. In a set of photodetectors including at least first and second detector arrays having different performances for detecting optical patterns formed by each of the increment track and the absolute track, the first and second detector arrays are configured so as to extend to a plurality of tracks of the scale each, and the other of the detector arrays corresponding to a second ray more strongly reacts with a detector corresponding to the second ray for a characteristic component than another characteristic component.SELECTED DRAWING: Figure 2",NOVANTA CORP,ANDREW M GOLDMAN;;MARC A BERNARD;;WILLIAM G THORBURN,,https://lens.org/064-175-833-533-984,Patent Application,no,10,0,6,6,0,G01D5/34715;;G01D5/34792;;G01D5/34715;;G01D5/34792;;G01D5/34776,G01D5/347,,0,0,,,,ACTIVE
94,US,B2,US 9933284 B2,047-544-350-077-536,2018-04-03,2018,US 201514836021 A,2015-08-26,US 201514836021 A,2015-08-26,Multi-track absolute encoder,"An optical position encoder includes a scale having multiple tracks separated in a direction perpendicular to travel, the tracks including an incremental track and an absolute track, the scale interacting with an incident first light beam to generate a second light beam having components carrying respective optical patterns produced by the incremental track and absolute track respectively. The encoder further includes a set of optical detectors including at least first and second detector arrays of differing properties to detect the respective optical patterns produced by the incremental track and absolute track respectively, each of the first and second detector arrays spanning multiple tracks of the scale and configured to respond to a respective detector-specific component of the second light beam more strongly than to another component of the second beam specific to another of the detector arrays.",NOVANTA CORP,GOLDMAN ANDREW M;;BERNARD MARC A;;THORBURN WILLIAM G,NOVANTA CORPORATION (2015-08-25),https://lens.org/047-544-350-077-536,Granted Patent,yes,4,3,6,6,0,G01D5/34715;;G01D5/34792;;G01D5/34715;;G01D5/34792;;G01D5/34776,G01D5/34;;G01D5/347,,0,0,,,,ACTIVE
95,EP,A1,EP 3136058 A1,150-172-122-009-768,2017-03-01,2017,EP 16184923 A,2016-08-19,US 201514836021 A,2015-08-26,MULTI-TRACK ABSOLUTE ENCODER,"An optical position encoder includes a scale having multiple tracks separated in a direction perpendicular to travel, the tracks including an incremental track and an absolute track, the scale interacting with an incident first light beam to generate a second light beam having components carrying respective optical patterns produced by the incremental track and absolute track respectively. The encoder further includes a set of optical detectors including at least first and second detector arrays of differing properties to detect the respective optical patterns produced by the incremental track and absolute track respectively, each of the first and second detector arrays spanning multiple tracks of the scale and configured to respond to a respective detector-specific component of the second light beam more strongly than to another component of the second beam specific to another of the detector arrays.
",NOVANTA CORP,GOLDMAN ANDREW M;;BERNARD MARC A;;THORBURN WILLIAM G,,https://lens.org/150-172-122-009-768,Patent Application,yes,5,0,6,6,0,G01D5/34715;;G01D5/34792;;G01D5/34715;;G01D5/34792;;G01D5/34776,G01D5/347,,0,0,,,,ACTIVE
96,US,A1,US 2021/0170095 A1,130-296-308-991-605,2021-06-10,2021,US 202017111396 A,2020-12-03,US 202017111396 A;;US 201962945033 P;;US 201962944999 P,2019-12-06,ROTARY MICROFLUIDIC MEDICAL PUMP,"Rotary microfluidic medical pump and pumping method embodiments are discussed herein that may be used for controlled delivery of small and precise volumes of therapeutic or non-therapeutic fluids in a variety of environmental conditions. Certain medical pump and pumping method embodiments discussed herein may also be useful for the controlled delivery of certain therapeutic fluids that may be susceptible to degradation when exposed to high levels of pressure, flow velocity, shear stress or the like.",QUASURAS INC,DIPERNA PAUL M;;GOLDMAN MARC;;NEESE DAVID;;HEARTY PATRICK,QUASURAS INC (2021-02-04),https://lens.org/130-296-308-991-605,Patent Application,yes,5,4,8,8,0,A61M2005/14288;;A61M5/14248;;A61M2205/273;;A61M2205/3327;;A61M2205/3331;;A61M2205/3553;;A61M2205/6072;;A61M2205/8206;;A61M2205/50;;A61M2205/52;;A61M2005/14268;;A61M5/14586;;A61M5/16809;;A61M2205/581;;A61M2205/584;;A61M2205/3368;;A61M2005/16868;;A61M2205/18;;A61M2205/6018;;A61M2205/6027;;A61M2205/6036;;A61M2205/6045;;A61M2205/6054;;A61M5/142;;A61M2005/14288;;A61M2205/273;;A61M2205/3327;;A61M2205/3553;;A61M2205/6072;;A61M5/145;;A61M2205/3331;;A61M2205/8206;;A61M5/14248;;A61M2205/50;;A61M2205/52;;G09B23/285;;A61M5/1413,A61M5/145,,0,0,,,,PENDING
97,EP,A1,EP 4069333 A1,187-914-865-319-241,2022-10-12,2022,EP 20896925 A,2020-12-03,US 201962945033 P;;US 201962944999 P;;US 2020/0063151 W,2019-12-06,ROTARY MICROFLUIDIC MEDICAL PUMP,,QUASURAS INC,DIPERNA PAUL M;;GOLDMAN MARC;;NEESE DAVID;;HEARTY PATRICK,,https://lens.org/187-914-865-319-241,Patent Application,yes,0,0,8,8,0,A61M2005/14288;;A61M5/14248;;A61M2205/273;;A61M2205/3327;;A61M2205/3331;;A61M2205/3553;;A61M2205/6072;;A61M2205/8206;;A61M2205/50;;A61M2205/52;;A61M2005/14268;;A61M5/14586;;A61M5/16809;;A61M2205/581;;A61M2205/584;;A61M2205/3368;;A61M2005/16868;;A61M2205/18;;A61M2205/6018;;A61M2205/6027;;A61M2205/6036;;A61M2205/6045;;A61M2205/6054;;A61M5/142;;A61M2005/14288;;A61M2205/273;;A61M2205/3327;;A61M2205/3553;;A61M2205/6072;;A61M5/145;;A61M2205/3331;;A61M2205/8206;;A61M5/14248;;A61M2205/50;;A61M2205/52;;G09B23/285;;A61M5/1413,A61M5/142;;A61M5/172,,0,0,,,,PENDING
98,EP,B1,EP 3136058 B1,113-656-410-778-448,2019-01-30,2019,EP 16184923 A,2016-08-19,US 201514836021 A,2015-08-26,MULTI-TRACK ABSOLUTE ENCODER,,NOVANTA CORP,GOLDMAN ANDREW M;;BERNARD MARC A;;THORBURN WILLIAM G,,https://lens.org/113-656-410-778-448,Granted Patent,yes,3,0,6,6,0,G01D5/34715;;G01D5/34792;;G01D5/34715;;G01D5/34792;;G01D5/34776,G01D5/347,,0,0,,,,ACTIVE
99,US,A1,US 2017/0059367 A1,009-235-289-237-862,2017-03-02,2017,US 201514836021 A,2015-08-26,US 201514836021 A,2015-08-26,Multi-Track Absolute Encoder,"An optical position encoder includes a scale having multiple tracks separated in a direction perpendicular to travel, the tracks including an incremental track and an absolute track, the scale interacting with an incident first light beam to generate a second light beam having components carrying respective optical patterns produced by the incremental track and absolute track respectively. The encoder further includes a set of optical detectors including at least first and second detector arrays of differing properties to detect the respective optical patterns produced by the incremental track and absolute track respectively, each of the first and second detector arrays spanning multiple tracks of the scale and configured to respond to a respective detector-specific component of the second light beam more strongly than to another component of the second beam specific to another of the detector arrays.",GSI GROUP CORP,GOLDMAN ANDREW M;;BERNARD MARC A;;THORBURN WILLIAM G,NOVANTA CORPORATION (2015-08-25),https://lens.org/009-235-289-237-862,Patent Application,yes,1,3,6,6,0,G01D5/34715;;G01D5/34792;;G01D5/34715;;G01D5/34792;;G01D5/34776,G01D5/347,,0,0,,,,ACTIVE
100,CN,A,CN 106169099 A,038-696-303-781-543,2016-11-30,2016,CN 201610528089 A,2013-08-01,US 201261678570 P;;CN 201380051654 A,2012-08-01,User interface for analyte monitoring systems,"Methods, devices and systems are disclosed for implementing a user interface for analyte monitoring systems. In one aspect, the analyte monitoring systems of the present technology include an interactive graphical and audio user interface that enables a user to identify individual patterns and changes in the level of analytical substances found in a bodily fluid (e.g., blood, saliva, or urine) of a patient, as well as guide the patient as to what actions to take based on the analyte level, e.g., such as the timing and dosage of a medication, meal planning, physical activities, or other interventions.",YOFIMETER LLC,SHAANAN JESSICA;;GOLDMAN MARC;;BARTIG KEVIN;;KIM INHOE;;SHAANAN GAD,,https://lens.org/038-696-303-781-543,Patent Application,no,4,0,12,12,0,G06Q10/00;;G06Q50/22;;G16H40/67;;G16H40/67;;G06Q10/00;;G06Q10/00;;G06Q50/10;;G06Q50/22;;G16H10/40;;G16H10/40,G06Q10/00;;G06Q50/22,,0,0,,,,DISCONTINUED
101,CA,C,CA 2848541 C,109-909-236-140-577,2015-10-27,2015,CA 2848541 A,2013-08-01,US 201261678570 P;;US 2013/0053299 W,2012-08-01,USER INTERFACE FOR ANALYTE MONITORING SYSTEMS,"Methods, devices and systems are disclosed for implementing a user interface for analyte monitoring systems. In one aspect, the analyte monitoring systems of the present technology include an interactive graphical and audio user interface that enables a user to identify individual patterns and changes in the level of analytical substances found in a bodily fluid (e.g., blood, saliva, or urine) of a patient, as well as guide the patient as to what actions to take based on the analyte level, e.g., such as the timing and dosage of a medication, meal planning, physical activities, or other interventions.",YOFIMETER LLC,SHAANAN JESSICA;;GOLDMAN MARC;;BARTIG KEVIN;;KIM INHOE;;SHAANAN GAD,,https://lens.org/109-909-236-140-577,Granted Patent,no,0,0,12,12,0,G06Q10/00;;G06Q50/22;;G16H40/67;;G16H40/67;;G06Q10/00;;G06Q10/00;;G06Q50/10;;G06Q50/22;;G16H10/40;;G16H10/40,G06Q50/22,,0,0,,,,INACTIVE
102,WO,A1,WO 2023/149975 A1,148-557-774-656-173,2023-08-10,2023,US 2022/0080469 W,2022-11-25,US 202217591435 A,2022-02-02,SYSTEM FOR DRAWING FLUID FROM A BAG UNDER SUB-AMBIENT CONDITIONS,A portable system and method for infusing liquid medicaments to a patient through an elastomeric fluid channel includes an airtight pressure shell for holding a collapsible bag of the fluid medicament to be infused. A pressure sensor connected to the pressure shell monitors decreases below ambient pressure inside the shell to determine when the sub-ambient pressure becomes insufficient to continue assisting the withdrawal of fluid from the collapsible bag to an external pinch/squeeze unit. An equilibration valve is synchronized with the pinch/squeeze unit to reestablish ambient pressure in the pressure shell for continued operation as the pinch/squeeze unit acts to sequentially push liquid medicament for infusion into the patient.,MODULAR MEDICAL INC,DIPERNA PAUL M;;GOLDMAN MARC D;;NEESE DAVID;;HEARTY PATRICK,,https://lens.org/148-557-774-656-173,Patent Application,yes,4,0,1,4,0,F04B43/082;;A61M5/14228;;A61M5/16854;;A61M2205/3351,A61M5/148;;A61M5/142;;A61M5/168;;F04B43/08,,0,0,,,,PENDING
103,WO,A1,WO 2013/109498 A1,144-170-850-970-534,2013-07-25,2013,US 2013/0021419 W,2013-01-14,US 201261588827 P;;US 201261652224 P;;US 201213686898 A,2012-01-20,EARPIECE,"An earpiece that enables efficient interaction between a user and a users various wireless devices. An earpiece may include a first and second speaker, processor, memory battery, and various antennas. The first and second speakers may be configured and positioned on the earpiece so that when the earpiece is worn by a user the speakers do not block or enter an ear canal of the user.",QUALCOMM INC,SHAANAN GAD;;GOLDMAN MARC D;;BARTIG KEVIN WAYNE;;KIM INHOE,,https://lens.org/144-170-850-970-534,Patent Application,yes,4,0,2,2,0,H04R1/10;;H04R25/554;;H04R2225/49;;H04R2225/51;;H04R2420/07;;H04R2225/49;;H04R25/554;;H04R1/10;;H04R2225/51;;H04R2420/07;;H04R5/033,H04R1/10,,0,0,,,,PENDING
104,WO,A1,WO 2014/022711 A1,154-621-768-977-000,2014-02-06,2014,US 2013/0053299 W,2013-08-01,US 201261678570 P,2012-08-01,USER INTERFACE FOR ANALYTE MONITORING SYSTEMS,"Methods, devices and systems are disclosed for implementing a user interface for analyte monitoring systems. In one aspect, the analyte monitoring systems of the present technology include an interactive graphical and audio user interface that enables a user to identify individual patterns and changes in the level of analytical substances found in a bodily fluid (e.g., blood, saliva, or urine) of a patient, as well as guide the patient as to what actions to take based on the analyte level, e.g., such as the timing and dosage of a medication, meal planning, physical activities, or other interventions.",YOFIMETER LLC,SHAANAN JESSICA;;GOLDMAN MARC;;BARTIG KEVIN;;KIM INHOE;;SHAANAN GAD,,https://lens.org/154-621-768-977-000,Patent Application,yes,7,31,12,12,0,G06Q10/00;;G06Q50/22;;G16H40/67;;G16H40/67;;G06Q10/00;;G06Q10/00;;G06Q50/10;;G06Q50/22;;G16H10/40;;G16H10/40,G06Q50/22,,1,0,,,See also references of EP 2880621A4,PENDING
105,CN,A,CN 104718557 A,169-655-363-180-239,2015-06-17,2015,CN 201380051654 A,2013-08-01,US 2013/0053299 W;;US 201261678570 P,2012-08-01,User interface for analyte monitoring systems,"Methods, devices and systems are disclosed for implementing a user interface for analyte monitoring systems. In one aspect, the analyte monitoring systems of the present technology include an interactive graphical and audio user interface that enables a user to identify individual patterns and changes in the level of analytical substances found in a bodily fluid (e.g., blood, saliva, or urine) of a patient, as well as guide the patient as to what actions to take based on the analyte level, e.g., such as the timing and dosage of a medication, meal planning, physical activities, or other interventions.",YOFIMETER LLC,SHAANAN JESSICA;;GOLDMAN MARC;;BARTIG KEVIN;;KIM INHOE;;SHAANAN GAD,,https://lens.org/169-655-363-180-239,Patent Application,no,6,10,12,12,0,G06Q10/00;;G06Q50/22;;G16H40/67;;G16H40/67;;G06Q10/00;;G06Q10/00;;G06Q50/10;;G06Q50/22;;G16H10/40;;G16H10/40,G06Q50/22,,0,0,,,,DISCONTINUED
106,US,A1,US 2013/0188803 A1,007-084-810-783-744,2013-07-25,2013,US 201213686898 A,2012-11-27,US 201213686898 A;;US 201261588827 P;;US 201261652224 P,2012-01-20,EARPIECE,"An earpiece that enables efficient interaction between a user and a user's various wireless devices. An earpiece may include a first and second speaker, processor, memory battery, and various antennas. The first and second speakers may be configured and positioned on the earpiece so that when the earpiece is worn by a user the speakers do not block or enter an ear canal of the user.",QUALCOMM INC;;QUALCOMM INC,SHAANAN GAD;;GOLDMAN MARC D;;BARTIG KEVIN WAYNE;;KIM INHOE,QUALCOMM INCORPORATED (2012-10-24),https://lens.org/007-084-810-783-744,Patent Application,yes,3,34,2,2,0,H04R1/10;;H04R25/554;;H04R2225/49;;H04R2225/51;;H04R2420/07;;H04R2225/49;;H04R25/554;;H04R1/10;;H04R2225/51;;H04R2420/07;;H04R5/033,H04R5/033,381/74,0,0,,,,DISCONTINUED
107,US,B1,US 10721187 B1,109-332-532-499-468,2020-07-21,2020,US 201715599394 A,2017-05-18,US 201715599394 A,2017-05-18,Emulating output queued behavior in a virtual output queue switch,"A system and method for routing network packets. A switch fabric connects a plurality of forwarding units, including an egress forwarding unit and two or more ingress forwarding units, each ingress forwarding unit forwarding network packets to the egress forwarding unit via the switch fabric. The egress forwarding unit includes a scheduler and an output queue. Each ingress forwarding unit includes a Virtual Output Queue (VOQ) connected to the output queue and a VOQ manager. The scheduler receives time of arrival information for network packets stored in the VOQs, determines, based on the time of arrival information for each network packet, a device resident time for the network packets stored in the VOQs, and requests, from one of the VOQs and based on the device resident times, the network packet with the longest device resident time.",JUNIPER NETWORKS INC,GOLDMAN GARY;;THOMAS SARIN;;FRAILONG JEAN-MARC;;AGASHE HARSHAD B,JUNIPER NETWORKS INC (2017-05-15),https://lens.org/109-332-532-499-468,Granted Patent,yes,14,26,2,2,0,H04L49/3027;;H04L49/3045;;H04L47/566;;H04L49/3027;;H04L49/206;;H04L49/9057,H04L47/52;;H04L49/111,,0,0,,,,ACTIVE
108,CA,A1,CA 2848541 A1,012-504-263-193-751,2014-02-06,2014,CA 2848541 A,2013-08-01,US 201261678570 P;;US 2013/0053299 W,2012-08-01,USER INTERFACE FOR ANALYTE MONITORING SYSTEMS,"Methods, devices and systems are disclosed for implementing a user interface for analyte monitoring systems. In one aspect, the analyte monitoring systems of the present technology include an interactive graphical and audio user interface that enables a user to identify individual patterns and changes in the level of analytical substances found in a bodily fluid (e.g., blood, saliva, or urine) of a patient, as well as guide the patient as to what actions to take based on the analyte level, e.g., such as the timing and dosage of a medication, meal planning, physical activities, or other interventions.",YOFIMETER LLC,SHAANAN JESSICA;;GOLDMAN MARC;;BARTIG KEVIN;;KIM INHOE;;SHAANAN GAD,,https://lens.org/012-504-263-193-751,Patent Application,no,0,0,12,12,0,G06Q10/00;;G06Q50/22;;G16H40/67;;G16H40/67;;G06Q10/00;;G06Q10/00;;G06Q50/10;;G06Q50/22;;G16H10/40;;G16H10/40,G06Q50/22,,0,0,,,,INACTIVE
109,AU,A1,AU 2013/296293 A1,003-823-643-559-024,2015-03-05,2015,AU 2013/296293 A,2013-08-01,US 201261678570 P;;US 2013/0053299 W,2012-08-01,User interface for analyte monitoring systems,"Methods, devices and systems are disclosed for implementing a user interface for analyte monitoring systems. In one aspect, the analyte monitoring systems of the present technology include an interactive graphical and audio user interface that enables a user to identify individual patterns and changes in the level of analytical substances found in a bodily fluid (e.g., blood, saliva, or urine) of a patient, as well as guide the patient as to what actions to take based on the analyte level, e.g., such as the timing and dosage of a medication, meal planning, physical activities, or other interventions.",YOFIMETER LLC,SHAANAN JESSICA;;GOLDMAN MARC;;BARTIG KEVIN;;KIM INHOE;;SHAANAN GAD,,https://lens.org/003-823-643-559-024,Patent Application,no,0,0,12,12,0,G06Q10/00;;G06Q50/22;;G06Q10/00;;G16H40/67;;G16H10/40;;G06Q50/10;;G06Q50/22;;G06Q10/00;;G16H10/40;;G16H40/67,G06Q50/22,,0,0,,,,DISCONTINUED
110,EP,A1,EP 2880621 A1,171-226-723-331-288,2015-06-10,2015,EP 13826427 A,2013-08-01,US 201261678570 P;;US 2013/0053299 W,2012-08-01,USER INTERFACE FOR ANALYTE MONITORING SYSTEMS,,YOFIMETER LLC,SHAANAN JESSICA;;GOLDMAN MARC;;BARTIG KEVIN;;KIM INHOE;;SHAANAN GAD,,https://lens.org/171-226-723-331-288,Patent Application,yes,0,0,12,12,0,G06Q10/00;;G06Q50/22;;G16H40/67;;G16H40/67;;G06Q10/00;;G06Q10/00;;G06Q50/10;;G06Q50/22;;G16H10/40;;G16H10/40,G06Q50/22;;G06F19/00;;G06Q10/00,,0,0,,,,DISCONTINUED
111,US,A1,US 2015/0205930 A1,017-969-395-471-110,2015-07-23,2015,US 201314418918 A,2013-08-01,US 201314418918 A;;US 201261678570 P;;US 2013/0053299 W,2012-08-01,USER INTERFACE FOR ANALYTE MONITORING SYSTEMS,"Methods, devices and systems are disclosed for implementing a user interface for analyte monitoring systems. In one aspect, the analyte monitoring systems of the present technology include an interactive graphical and audio user interface that enables a user to identify individual patterns and changes in the level of analytical substances found in a bodily fluid (e.g., blood, saliva, or urine) of a patient, as well as guide the patient as to what actions to take based on the analyte level, e.g., such as the timing and dosage of a medication, meal planning, physical activities, or other interventions.",YOFIMETER LLC,SHAANAN JESSICA;;GOLDMAN MARC;;BARTIG KEVIN;;KIM INHOE;;SHAANAN GAD,,https://lens.org/017-969-395-471-110,Patent Application,yes,0,134,12,12,0,G06Q10/00;;G06Q50/22;;G16H40/67;;G16H40/67;;G06Q10/00;;G06Q10/00;;G06Q50/10;;G06Q50/22;;G16H10/40;;G16H10/40,G06F19/00;;G06Q50/22,,0,0,,,,DISCONTINUED
112,HK,A1,HK 1211370 A1,036-439-277-344-963,2016-05-20,2016,HK 15112108 A,2015-12-08,US 2013/0053299 W;;US 201261678570 P,2012-08-01,USER INTERFACE FOR ANALYTE MONITORING SYSTEMS,,YOFIMETER LLC,SHAANAN JESSICA;;GOLDMAN MARC;;BARTIG KEVIN;;KIM INHOE;;SHAANAN GAD,,https://lens.org/036-439-277-344-963,Patent Application,no,0,0,12,12,0,G06Q10/00;;G06Q50/22;;G16H40/67;;G16H40/67;;G06Q10/00;;G06Q10/00;;G06Q50/10;;G06Q50/22;;G16H10/40;;G16H10/40,G06Q/,,0,0,,,,PENDING
113,EP,A4,EP 2880621 A4,044-970-934-200-22X,2016-03-23,2016,EP 13826427 A,2013-08-01,US 201261678570 P;;US 2013/0053299 W,2012-08-01,USER INTERFACE FOR ANALYTE MONITORING SYSTEMS,,YOFIMETER LLC,SHAANAN JESSICA;;GOLDMAN MARC;;BARTIG KEVIN;;KIM INHOE;;SHAANAN GAD,,https://lens.org/044-970-934-200-22X,Search Report,no,3,0,12,12,0,G06Q10/00;;G06Q50/22;;G16H40/67;;G16H40/67;;G06Q10/00;;G06Q10/00;;G06Q50/10;;G06Q50/22;;G16H10/40;;G16H10/40,G06Q50/22;;G06F19/00;;G06Q10/00,,1,0,,,See also references of WO 2014022711A1,DISCONTINUED
114,US,B1,US 11290395 B1,058-074-427-756-007,2022-03-29,2022,US 202016933590 A,2020-07-20,US 202016933590 A;;US 201715599394 A,2017-05-18,Emulating output queued behavior in a virtual output queue switch,"A system and method for routing network packets. A switch fabric connects a plurality of forwarding units, including an egress forwarding unit and two or more ingress forwarding units, each ingress forwarding unit forwarding network packets to the egress forwarding unit via the switch fabric. The egress forwarding unit includes a scheduler and an output queue. Each ingress forwarding unit includes a Virtual Output Queue (VOQ) connected to the output queue and a VOQ manager. The scheduler receives time of arrival information for packet groups stored in the VOQs, determines, based on the time of arrival information for each packet group, a device resident time for each packet group, and discards the packet groups when the determined device resident time for the packet group is greater than a maximum resident time.",JUNIPER NETWORKS INC,GOLDMAN GARY;;THOMAS SARIN;;FRAILONG JEAN-MARC;;AGASHE HARSHAD B,,https://lens.org/058-074-427-756-007,Granted Patent,yes,18,0,2,2,0,H04L49/3027;;H04L49/3045;;H04L47/566;;H04L49/3027;;H04L49/206;;H04L49/9057,H04L49/00;;H04L49/20;;H04L49/9057,,1,0,,,"Prosecution history from U.S. Appl. No. 15/599,394 dated Jun. 12, 2019 through Mar. 12, 2020, 92 pp.",ACTIVE
115,US,A1,US 2023/0088574 A1,057-109-774-075-40X,2023-03-23,2023,US 202217591435 A,2022-02-02,US 202217591435 A;;US 202117482848 A,2021-09-23,SYSTEM FOR DRAWING FLUID FROM A BAG UNDER SUB-AMBIENT CONDITIONS,A portable system and method for infusing liquid medicaments to a patient through an elastomeric fluid channel includes an airtight pressure shell for holding a collapsible bag of the fluid medicament to be infused. A pressure sensor connected to the pressure shell monitors decreases below ambient pressure inside the shell to determine when the sub-ambient pressure becomes insufficient to continue assisting the withdrawal of fluid from the collapsible bag to an external pinch/squeeze unit. An equilibration valve is synchronized with the pinch/squeeze unit to reestablish ambient pressure in the pressure shell for continued operation as the pinch/squeeze unit acts to sequentially push liquid medicament for infusion into the patient.,MODULAR MEDICAL INC,DIPERNA PAUL M;;GOLDMAN MARC D;;NEESE DAVID;;HEARTY PATRICK,MODULAR MEDICAL INC (2022-05-10),https://lens.org/057-109-774-075-40X,Patent Application,yes,0,0,1,4,0,A61M5/1483;;A61M5/14228;;A61M5/16854;;A61M5/152;;A61M5/16881;;A61M2005/16872;;A61M2005/16868;;A61M2205/3331,A61M5/152;;A61M5/168,,0,0,,,,PENDING
116,US,A1,US 2023/0093674 A1,097-700-136-799-357,2023-03-23,2023,US 202117482848 A,2021-09-23,US 202117482848 A,2021-09-23,PORTABLE INFUSION PUMP WITH NEGATIVE PRESSURE CONTROL,"A portable system and method for infusing fluid medicaments to a patient through an elastomeric fluid channel includes an airtight pressure shell for holding a collapsible bag of the fluid medicament to be infused. A pressure sensor connected to the pressure shell monitors decreases below ambient pressure inside the shell to determine when the ambient pressure becomes insufficient to continue assisting the withdrawal of fluid from the collapsible bag, to an external pinch/squeeze unit. At this point, an equilibrator operates to reestablish ambient pressure in the pressure shell for continued operation. In operation, the pinch/squeeze unit exerts radial forces on the elastomeric fluid channel. These forces act to sequentially push fluid medicament for infusion to the patient when the elastomeric fluid channel is occluded and stressed, and draw fluid medicament from the collapsible bag as the elastomeric fluid channel is unstressed.",MODULAR MEDICAL INC,DIPERNA PAUL M;;GOLDMAN MARC D;;NEESE DAVID;;HEARTY PATRICK,MODULAR MEDICAL INC (2021-10-12),https://lens.org/097-700-136-799-357,Patent Application,yes,3,0,2,4,0,A61M5/16854;;A61M5/14228;;A61M5/148;;A61M5/14244;;A61M5/16854;;A61M2205/3331;;A61M5/16813;;A61M5/1483;;A61M5/14216,A61M5/142;;A61M5/148;;A61M5/168,,0,0,,,,PENDING
117,WO,A1,WO 2023/048916 A1,199-013-578-655-530,2023-03-30,2023,US 2022/0042132 W,2022-08-31,US 202117482848 A,2021-09-23,PORTABLE INFUSION PUMP WITH NEGATIVE PRESSURE CONTROL,"A portable system and method for infusing fluid medicaments to a patient through an elastomeric fluid channel includes an airtight pressure shell for holding a collapsible bag of the fluid medicament to be infused. A pressure sensor connected to the pressure shell monitors decreases below ambient pressure inside the shell to determine when the ambient pressure becomes insufficient to continue assisting the withdrawal of fluid from the collapsible bag, to an external pinch/squeeze unit. At this point, an equilibrator operates to reestablish ambient pressure in the pressure shell for continued operation. In operation, the pinch/squeeze unit exerts radial forces on the elastomeric fluid channel. These forces act to sequentially push fluid medicament for infusion to the patient when the elastomeric fluid channel is occluded and stressed, and draw fluid medicament from the collapsible bag as the elastomeric fluid channel is unstressed.",MODULAR MEDICAL INC,DIPERNA PAUL M;;GOLDMAN MARC D;;NEESE DAVID;;HEARTY PATRICK,,https://lens.org/199-013-578-655-530,Patent Application,yes,4,0,2,4,0,A61M5/16854;;A61M5/14228;;A61M5/148;;A61M5/14244;;A61M5/16854;;A61M2205/3331;;A61M5/16813;;A61M5/1483;;A61M5/14216,A61M5/155;;A61M5/14;;A61M5/142;;A61M5/145;;A61M5/148;;A61M5/168;;A61M5/172,,0,0,,,,PENDING
118,US,A1,US 2021/0249113 A1,052-675-064-479-527,2021-08-12,2021,US 202117166833 A,2021-02-03,US 202117166833 A;;US 202062971789 P;;US 202062971807 P,2020-02-07,MEDICAL PUMP ELECTRONIC PAIRING WITH DEVICE,"Systems and methods for wireless electronic communication between a medical apparatus and a remote electronic computing device comprise generating and outputting by the medical apparatus an output signal, including: encoding data in the output signal according to a predetermined characteristic of the output signal; receiving and decoding by the remote electronic computing device the encoded data in the output signal; and establishing a pairing between the medical apparatus and the remote electronic computing device.",QUASURAS INC,MOLESWORTH HUGH;;HUGHES KEVIN;;GOLDMAN MARC;;PILLAI PRAVIN;;DIPERNA PAUL M,QUASURAS INC (2021-11-22),https://lens.org/052-675-064-479-527,Patent Application,yes,8,2,3,3,0,G16H20/17;;G16H40/63;;G16H40/67;;G06F21/6245;;G06F21/606;;H04W12/50;;A61M5/172;;A61M5/14248;;A61M2205/3523;;A61M2205/3561;;A61M2205/3368;;A61M2205/3344;;A61M2209/01;;G16H20/17;;G16H40/67;;A61M5/172;;A61M2205/3317;;G06F21/6245;;A61M2205/3553;;A61M5/142,G16H20/17;;A61M5/142;;A61M5/172;;G06F21/62;;G16H40/67,,0,0,,,,ACTIVE
119,US,A1,US 2024/0038359 A1,012-678-246-260-22X,2024-02-01,2024,US 202318485156 A,2023-10-11,US 202318485156 A;;US 202117166833 A;;US 202062971789 P;;US 202062971807 P,2020-02-07,MEDICAL PUMP ELECTRONIC PAIRING WITH DEVICE,"Systems and methods for wireless electronic communication between a medical apparatus and a remote electronic computing device comprise generating and outputting by the medical apparatus an output signal, including: encoding data in the output signal according to a predetermined characteristic of the output signal; receiving and decoding by the remote electronic computing device the encoded data in the output signal; and establishing a pairing between the medical apparatus and the remote electronic computing device.",QUASURAS INC,MOLESWORTH HUGH;;HUGHES KEVIN;;GOLDMAN MARC;;PILLAI PRAVIN;;DIPERNA PAUL M,QUASURAS INC (2021-11-22),https://lens.org/012-678-246-260-22X,Patent Application,yes,0,0,3,3,0,G16H20/17;;G16H40/63;;G16H40/67;;G06F21/6245;;G06F21/606;;H04W12/50;;A61M5/172;;A61M5/14248;;A61M2205/3523;;A61M2205/3561;;A61M2205/3368;;A61M2205/3344;;A61M2209/01;;G16H20/17;;G16H40/67;;A61M5/172;;A61M2205/3317;;G06F21/6245;;A61M2205/3553;;A61M5/142,G16H20/17;;A61M5/142;;A61M5/172;;G06F21/62;;G16H40/67,,0,0,,,,PENDING
120,US,A,US 5715425 A,012-716-417-408-642,1998-02-03,1998,US 60390996 A,1996-02-22,US 60390996 A,1996-02-22,Apparatus and method for prefetching data into an external cache,"A central processing unit is connected to an external memory including system memory and an external cache. The central processing unit includes a First-In-First-Out (FIFO) load buffer configured to generate an access to the external memory in response to a data prefetch command. The access to external memory has an associated data load latency period as data is moved from the system memory into the external cache. Instead of requiring the access to external memory to be completed before another FIFO load buffer address is processed, as is typically required in a FIFO load buffer configuration, the FIFO load buffer responds to the data prefetch command by processing additional stored addresses during the data load latency period.",SUN MICROSYSTEMS INC,GOLDMAN GARY S;;PETRICK BRUCE E;;TREMBLAY MARC;;GREENLEY DALE R,SUN MICROSYSTEMS INC (1996-06-20);;ORACLE AMERICA INC (2010-02-12),https://lens.org/012-716-417-408-642,Granted Patent,yes,6,13,1,1,0,G06F12/0862;;G06F12/0862;;G06F9/383;;G06F9/383;;G06F12/0859;;G06F12/0859;;G06F2212/6028;;G06F2212/6028,G06F9/38;;G06F12/08,395/445;;395/421.03;;395/403;;X364DIG  1,3,1,005-476-143-839-31X,10.1109/cmpcon.1994.282903,"Kurpanek, et al, PA7200: A PA RISC Processor With Integrated High Performance MP Bus Interface , Spring COMPCON 94, IEEE Computer Society Press, pp. 375 382.;;PA 8000 Combines Complexity and Speed , Microprocessor Report, vol. 8, No. 15, Nov. 14, 1994.;;MIPS R10000 Microprocessor User s Manual, Section 1.7, MIPS Technologies, Inc., Jan., 1996.",EXPIRED
121,US,B2,US 11817197 B2,188-547-415-163-870,2023-11-14,2023,US 202117166833 A,2021-02-03,US 202117166833 A;;US 202062971789 P;;US 202062971807 P,2020-02-07,Medical pump electronic pairing with device,"Systems and methods for wireless electronic communication between a medical apparatus and a remote electronic computing device comprise generating and outputting by the medical apparatus an output signal, including: encoding data in the output signal according to a predetermined characteristic of the output signal; receiving and decoding by the remote electronic computing device the encoded data in the output signal; and establishing a pairing between the medical apparatus and the remote electronic computing device.",QUASURAS INC,MOLESWORTH HUGH;;HUGHES KEVIN;;GOLDMAN MARC;;PILLAI PRAVIN;;DIPERNA PAUL M,QUASURAS INC (2021-11-22),https://lens.org/188-547-415-163-870,Granted Patent,yes,76,0,3,3,0,G16H20/17;;G16H40/63;;G16H40/67;;G06F21/6245;;G06F21/606;;H04W12/50;;A61M5/172;;A61M5/14248;;A61M2205/3523;;A61M2205/3561;;A61M2205/3368;;A61M2205/3344;;A61M2209/01;;G16H20/17;;G16H40/67;;A61M5/172;;A61M2205/3317;;G06F21/6245;;A61M2205/3553;;A61M5/142,G08B21/04;;A61M5/142;;A61M5/172;;G06F21/62;;G16H20/17;;G16H40/67,,15,0,,,"International Search Report and Written Opinion dated Oct. 18, 2018 in International Application No. PCT/US2018/40944, filed: Jul. 5, 2018 and published as: WO/2019/010324 on Jan. 10, 2019.;;International Search Report and Written Opinion dated Jul. 31, 2015 in International Application No. PCT/US2015/18525 filed: Mar. 3, 2015 and published as: WO/2015/134526 on: Sep. 11, 2015.;;International Search Report and Written Opinion dated Oct. 4, 2019 in International Application No. PCT/US2019/43146 filed: Jul. 24, 2019.;;Office Action dated Jan. 2, 2020 in U.S. Appl. No. 15/122,132, filed Aug. 26, 2016 and published as: 2016/0361489 on Dec. 15, 2016.;;Final Office Action dated Jun. 26, 2020 in U.S. Appl. No. 15/122,132, filed Aug. 26, 2016 and published as: 2016/0361489 on Dec. 15, 2016.;;Office Action dated Nov. 16, 2020 in U.S. Appl. No. 16/028,256, filed Jul. 5, 2018 and published as: 2019/0009023 on Jan. 1, 2019.;;Invitation to Pay Additional Fees dated: Feb. 23, 2021 in International Application No. PCT/US2020/63152 filed: Dec. 3, 2020.;;International Preliminary Report on Patentability dated Jan. 26, 2021 in International Application No. PCT/US2019/43146 filed: Jul. 24, 2019.;;Supplementary European Search Report dated Mar. 12, 2021 in European Patent Application No. EP 18828123.2 filed: Jul. 5, 2018.;;International Search Report and Written Opinion dated Apr. 28, 2021 in International Patent Application No. PCT/US2020/63152 filed: Dec. 3, 3030.;;International Preliminary Report on Patentability dated May 17, 2022 in International Patent Application No. PCT/US2020/63152 filed: Dec. 3, 2020.;;Non-Final Office Action dated Dec. 1, 2022 in U.S. Appl. No. 17/111,396, filed Dec. 3, 2020 and published as: US2021/0170095 on Jun. 10, 2021.;;Non-Final Office Action dated Apr. 26, 2023 in U.S. Appl. No. 17/111,402, filed Dec. 3, 2020 and published as: US/2021/0170094 on Jun. 10, 2021.;;Final Office Action dated Apr. 14, 2023 in U.S. Appl. No. 17/111,396, filed Dec. 3, 2020 and published as: US2021/0170095 on Jun. 10, 2021.;;International Search Report and Written Opinion dated Feb. 23, 2023 in International Patent Application No. PCT/US2022/045065 filed: Sep. 28, 2022 and published as: WO/2023/055819 on: Apr. 6, 2023.",ACTIVE
122,US,S,US D0712881 S,106-442-851-901-221,2014-09-09,2014,US 201329455899 F,2013-05-24,US 201329455899 F,2013-05-24,Earpiece,,QUALCOMM INC,SHAANAN GAD;;KIM INHOE;;JACOBS PAUL E;;GOLDMAN MARC D;;MANULIS ALEKSANDR,QUALCOMM INCORPORATED (2013-12-05),https://lens.org/106-442-851-901-221,Design Right,no,0,8,1,1,0,,,1401;;D14/223,0,0,,,,ACTIVE
123,US,S,US D0765595 S,173-858-035-128-479,2016-09-06,2016,US 201329455900 F,2013-05-24,US 201329455900 F,2013-05-24,Charging apparatus,,QUALCOMM INC,SHAANAN GAD;;KIM INHOE;;JACOBS PAUL E;;GOLDMAN MARC D;;MANULIS ALEKSANDR,QUALCOMM INCORPORATED (2013-12-05),https://lens.org/173-858-035-128-479,Design Right,no,0,9,1,1,0,,,1302;;D13/107,0,0,,,,ACTIVE
124,US,A1,US 2010/0069312 A1,021-215-346-635-995,2010-03-18,2010,US 59534208 A,2008-04-18,EP 07106520 A;;EP 2008054738 W,2007-04-19,AMINOALKYL GLUCOSAMINE PHOSPHATE COMPOUNDS FOR TREATING AUTOIMMUNE DISEASES,The invention provides prophylactic and therapeutic applications of select aminoalkyl glucosamine phosphate (AGP) compounds in autoimmune diseases.,UNIV BRUXELLES,GORIELY STANISLAS;;DE WIT DOMINIQUE;;GOLDMAN MICHEL;;DETIENNE SOPHIE;;BRULET JEAN-MARC,UNIVERSITE LIBRE DE BRUXELLES (2009-10-02),https://lens.org/021-215-346-635-995,Patent Application,yes,2,0,3,3,0,A61P25/00;;A61P37/00;;C07H15/04;;C07H15/04;;C07H13/06;;C07H13/06;;C07H15/12;;C07H15/12,A61K31/7028;;A61P37/00;;C07H15/04,514/25;;536/17.1,0,0,,,,DISCONTINUED
125,US,A1,US 2016/0305948 A1,081-438-136-765-753,2016-10-20,2016,US 201514688010 A,2015-04-16,US 201514688010 A,2015-04-16,Charged Peptide Appendage to Facilitate Oriented Protein Covalent Immobilization,"Genetic fusions of proteins, for example single-domain antibodies (sdAbs), with a positively-charged domain enhanced immobilization of active protein in a desired orientation.",ANDERSON GEORGE P;;LIU JINNY LIN;;RAPHAEL MARC P;;GOLDMAN ELLEN R;;THE GOVEMMENT OF THE US SEC THE NAVY,ANDERSON GEORGE P;;LIU JINNY LIN;;RAPHAEL MARC P;;GOLDMAN ELLEN R,THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (2015-04-08),https://lens.org/081-438-136-765-753,Patent Application,yes,1,1,2,2,5,C07K14/00;;C12N15/62;;G01N33/531;;G01N33/54393;;C07K16/16;;C07K2317/569;;C07K2319/73;;C07K19/00;;G01N33/68;;G01N2333/42;;C07K14/00;;C12N15/62;;G01N33/531;;G01N33/54393;;C07K16/16;;C07K2317/569;;C07K2319/73;;C07K19/00,G01N33/68,,4,2,000-471-938-358-38X;;055-508-269-995-171,10.1016/j.addr.2012.09.039;;pmc3726540;;23026637;;15356144;;10.4049/jimmunol.173.6.3953,"Chen et al. (Adv Drug Deliv Rev. 2013 October 15; 65(10): 1357-1369);;Goldman et al. (Proc. of SPIE 2013; Vol. 8723 872313-9);;Mooney et al (J Immunol September 15, 2004, 173 (6) 3953-3961;;PET22b Vector manual (1998, retrieved from http://www.helmholtz-muenchen.de/fileadmin/PEPF/pET_vectors/pET-22b_map.pdf on 1/22/2017)",ACTIVE
126,US,B2,US 9778265 B2,077-247-713-240-003,2017-10-03,2017,US 201514688010 A,2015-04-16,US 201514688010 A,2015-04-16,Charged peptide appendage to facilitate oriented protein covalent immobilization,"Genetic fusions of proteins, for example single-domain antibodies (sdAbs), with a positively-charged domain enhanced immobilization of active protein in a desired orientation.",ANDERSON GEORGE P;;LIU JINNY LIN;;RAPHAEL MARC P;;GOLDMAN ELLEN R;;US NAVY,ANDERSON GEORGE P;;LIU JINNY LIN;;RAPHAEL MARC P;;GOLDMAN ELLEN R,THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (2015-04-08),https://lens.org/077-247-713-240-003,Granted Patent,yes,13,1,2,2,5,C07K14/00;;C12N15/62;;G01N33/531;;G01N33/54393;;C07K16/16;;C07K2317/569;;C07K2319/73;;C07K19/00;;G01N33/68;;G01N2333/42;;C07K14/00;;C12N15/62;;G01N33/531;;G01N33/54393;;C07K16/16;;C07K2317/569;;C07K2319/73;;C07K19/00,G01N33/68;;C07K14/00;;C07K16/16;;C07K19/00;;C12N15/62;;G01N33/531;;G01N33/543,,5,3,000-471-938-358-38X;;055-508-269-995-171;;065-334-034-096-978,10.1016/j.addr.2012.09.039;;pmc3726540;;23026637;;15356144;;10.4049/jimmunol.173.6.3953;;24793095;;10.1016/j.bios.2014.04.017,"Chen et al. (Adv Drug Deliv Rev. Oct. 15, 2013; 65(10): 1357-1369).;;Goldman et al. (Proc. of SPIE 2013; vol. 8723 872313-9).;;Mooney et al (J Immunol Sep. 15, 2004, 173 (6) 3953-3961.;;PET22b Vector manual (1998, retrieved from http://www.helmholtz-muenchen.de/fileadmin/PEPF/pET—vectors/pET-22b—map.pdf on Jan. 22, 2017).;;Trilling et al. “Orientation of llama antibodies strongly increases sensitivity of biosensors” Biosensors and Bioelectronics 2014, 60: 130-136.",ACTIVE
127,EP,A1,EP 2134349 A1,084-507-205-072-527,2009-12-23,2009,EP 08736383 A,2008-04-18,EP 2008054738 W;;EP 07106520 A;;EP 08736383 A,2007-04-19,AMINOALKYL GLUCOSAMINE PHOSPHATE COMPOUNDS FOR TREATING AUTOIMMUNE DISEASES,,UNIV BRUXELLES,GORIELY STANISLAS;;DE WIT DOMINIQUE;;GOLDMAN MICHEL;;DETIENNE SOPHIE;;BRULET JEAN-MARC,,https://lens.org/084-507-205-072-527,Patent Application,yes,0,0,3,3,0,A61P25/00;;A61P37/00;;C07H15/04;;C07H15/04;;C07H13/06;;C07H13/06;;C07H15/12;;C07H15/12,A61K31/7008;;A61P25/00;;A61P37/00,,1,0,,,See references of WO 2008128997A1,DISCONTINUED
128,WO,A1,WO 2008/128997 A1,014-034-581-165-181,2008-10-30,2008,EP 2008054738 W,2008-04-18,EP 07106520 A,2007-04-19,AMINOALKYL GLUCOSAMINE PHOSPHATE COMPOUNDS FOR TREATING AUTOIMMUNE DISEASES,The invention provides prophylactic and therapeutic applications of select aminoalkyl glucosamine phosphate (AGP) compounds in autoimmune diseases.,UNIV BRUXELLES;;GORIELY STANISLAS;;DE WIT DOMINIQUE;;GOLDMAN MICHEL;;DETIENNE SOPHIE;;BRULET JEAN-MARC,GORIELY STANISLAS;;DE WIT DOMINIQUE;;GOLDMAN MICHEL;;DETIENNE SOPHIE;;BRULET JEAN-MARC,,https://lens.org/014-034-581-165-181,Patent Application,yes,2,3,3,3,0,A61P25/00;;A61P37/00;;C07H15/04;;C07H15/04;;C07H13/06;;C07H13/06;;C07H15/12;;C07H15/12,A61K31/7008;;A61P25/00;;A61P37/00,,2,2,035-050-422-631-650;;122-354-613-635-984,12697089;;10.1179/096805102125001064;;10.1177/09680519020080061501;;10.1146/annurev.med.58.071105.111552;;17217332,"BALDRIDGE J R ET AL: ""IMMUNOSTIMULATORY ACTIVITY OF AMINOALKYL GLUCOSAMINIDE 4-PHOSPHATES (AGPS): INDUCTION OF PROTECTIVE INNATE IMMUNE RESPONSES BY RC-524 AND RC-529"", JOURNAL OF ENDOTOXIN RESEARCH, CHURCHILL LIVINGSTONE, EDINBURGH, GB, vol. 8, no. 6, 2002, pages 453 - 458, XP009026846, ISSN: 0968-0519;;DE JAGER PHILIP L ET AL: ""New therapeutic approaches for multiple sclerosis."", ANNUAL REVIEW OF MEDICINE 2007, vol. 58, February 2007 (2007-02-01), pages 417 - 432, XP002453029, ISSN: 0066-4219",PENDING
129,US,S,US D0751928 S,015-254-980-607-03X,2016-03-22,2016,US 201329455546 F,2013-05-21,US 201329455546 F,2013-05-21,Wrist display,,QUALCOMM INC,SHAANAN GAD;;KIM INHOE;;JACOBS PAUL E;;GOLDMAN MARC D;;MANULIS ALEKSANDR,QUALCOMM INCORPORATED (2013-12-05),https://lens.org/015-254-980-607-03X,Design Right,no,0,8,1,1,0,,,1002;;D10/38;;D14/344,0,0,,,,ACTIVE
130,US,B2,US 9782440 B2,031-250-129-343-319,2017-10-10,2017,US 201313770221 A,2013-02-19,US 201313770221 A;;US 201261599463 P;;US 201261640974 P,2012-02-16,Methods for treating genitourinary disorders,One aspect of the present disclosure can include a therapeutic composition useful for treatment of a genitourinary disorder. The composition can be derived from a culture media having been in contact with a population of bone marrow-derived mesenchymal stem cells for a sufficient time period necessary to endow therapeutic activity in the culture media. The therapeutic property endowed to the culture media is the ability to promote structural and functional recovery of a dysfunctional organ or biological tissue associated with the genitourinary disorder.,CLEVELAND CLINIC FOUND,DAMASER MARGOT S;;DISSARANAN CHARUSPONG;;GOLDMAN HOWARD B;;KIEDROWSKI MATTHEW;;PENN MARC S,THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS (2015-03-03);;THE CLEVELAND CLINIC FOUNDATION (2013-11-13),https://lens.org/031-250-129-343-319,Granted Patent,yes,6,0,2,2,0,A61K35/28;;A61K35/28;;A61K2035/124;;A61K2035/124;;C12N5/0663;;C12N5/0663,A61K35/22;;A61K35/12;;A61K35/28;;C12N5/0775,,15,9,079-840-890-155-088;;014-929-871-591-063;;046-157-741-104-718;;081-652-928-574-880;;022-946-605-648-121;;083-915-107-285-293;;046-157-741-104-718;;020-364-073-424-633;;138-150-177-274-022,10.1111/j.1749-6632.2009.04610.x;;19796241;;pmc3218558;;21842258;;10.1007/s11934-011-0210-4;;10.1016/j.juro.2016.05.106;;27267321;;10.1089/scd.2016.0048;;27226274;;27306402;;10.2174/1574888x11666160614102629;;21219236;;10.1517/14712598.2011.546338;;10.1016/j.juro.2016.05.106;;27267321;;10.1016/j.juro.2016.05.136;;27544623;;10.4161/cam.27293,"Temple University Health Systems. Male & Female Urinary Problems. Retrieved from the TUHS webpage on Jun. 12, 2014: <http://tuh.templehealth.org/content/urinary—problems.htm>.;;RightDiagnosis. Urinary Tract Infections. Retreived from the RightDiagnosis webpage on Jun. 12, 2014: <http://www.rightdiagnosis.com/u/urinary—tract—infections/intro.htm>.;;Krishna. Routes of Drug Administration. PharmacyFundas. Downloaded from the world wide web on May 1, 2013: <http://pharmacyfundas.com/routes-of-drug-administration/>.;;Drost, Adriana et al. In vitro Myogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells as a Potential Treatment for Urethral Sphincter Muscle Repair. Hematopoietic Stem Cells VII. Ann. NY Acad Sci 1176. 2009. pp. 135-143.;;Dissaranan, Charuspong et al. Stem Cell Therapy for Incontinence: Where are we now? What is the realistic potential?. Curr Urolo Rep (2011) 12. Springer Science + Business Media, LLC. pp. 336-344.;;Williams, J. Koudy et al. Cell versus Chemokine Therapy in a Nonhuman Primate Model of Chronic Intrinsic Urinary Sphincter Deficiency. The Journal of Urology. vol. 196, 1809-1815, Dec. 2016.;;Cruz et al., Pelvic Organ . . . Female Rats, Hindawi Publishing Corp., vol. 2012, Art. ID 612946, pp. 1-7.;;Dissaranan, et al., Secreted Factors From Mesenchymal . . . , Glickman Urologic and Kidney Inst., Cleveland Clinic, 1-25.;;Pires et al., “Unveiling the Differences of Secretome of Human Bone Marrow Mesenchymal Stem Cells, Adipose Tissue-Derived Stem Cells, and Human Umbilical Cord Perivascular Cells: A proteomic Analysis,” Stem Cells and Development. 2016; 25(14): 1073-83.;;Luo et al., “Role of Stromal-Derived Factor-1 in Mesenchymal Stem Cell Paracrine-Mediated Tissue Repair,” Curr Stem Cell Res Ther. 2016; 11(7): 585-92.;;Lau TT and Wang DA: “Stromal cell-derived factor-1 (SDF-1): homing factor for engineered regenerative medicine,” Expert Opin Biol Ther. 2011; 11: 189.;;Williams JK et al. “Cell versus Chemokine Therapy in a Nonhuman Primate Model of Intrinsic Urinary Sphincter Deficiency,” Journal of Urology 2016; 196(6): 1809-15.;;Williams JK et al. “Regenerative Medicine Therapies for Stress Urinary Incontinence,” Journal of Urology. 2016; 196: 1619-26.;;Langereis JD et al. Gelsolin expression increases β1-integrin affinity and L1210 cell adhesion. Cytoskeleton (Hoboken) 2013; 70:385-93.;;Langereis, Jeroen D. “Neutrophil integrin affinity regulation in adhesion, migration, and bacterial clearance.” Cell adhesion & migration 7.6 (2013): 486-491.",ACTIVE
131,US,A1,US 2014/0079672 A1,108-419-823-417-667,2014-03-20,2014,US 201313770221 A,2013-02-19,US 201313770221 A;;US 201261599463 P;;US 201261640974 P,2012-02-16,METHODS FOR TREATING GENITOURINARY DISORDER,One aspect of the present disclosure can include a therapeutic composition useful for treatment of a genitourinary disorder. The composition can be derived from a culture media having been in contact with a population of bone marrow-derived mesenchymal stem cells for a sufficient time period necessary to endow therapeutic activity in the culture media. The therapeutic property endowed to the culture media is the ability to promote structural and functional recovery of a dysfunctional organ or biological tissue associated with the genitourinary disorder.,CLEVELAND CLINIC FOUNDATION,DAMASER MARGOT S;;DISSARANAN CHARUSPONG;;GOLDMAN HOWARD B;;KIEDROWSKI MATTHEW;;PENN MARC S,THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS (2015-03-03);;THE CLEVELAND CLINIC FOUNDATION (2013-11-13),https://lens.org/108-419-823-417-667,Patent Application,yes,4,4,2,2,0,A61K35/28;;A61K35/28;;A61K2035/124;;A61K2035/124;;C12N5/0663;;C12N5/0663,A61K35/28;;A61K35/12;;C12N5/0775,424/93.7;;424/577,6,3,079-840-890-155-088;;014-929-871-591-063;;046-157-741-104-718,10.1111/j.1749-6632.2009.04610.x;;19796241;;pmc3218558;;21842258;;10.1007/s11934-011-0210-4;;10.1016/j.juro.2016.05.106;;27267321,"Temple University Health Systems. Male & Female Urinary Problems. Retrieved from the TUHS webpage on 06/12/2014:;;RightDiagnosis. Urinary Tract Infections. Retreived from the RightDiagnosis webpage on 06/12/2014:;;Krishna. Routes of Drug Administration. PharmacyFundas. Downloaded from the world wide web on 05/01/2013:;;Drost, Adriana et al. In vitro Myogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells as a Potential Treatment for Urethral Sphincter Muscle Repair. Hematopoietic Stem Cells VII. Ann. NY Acad Sci 1176. 2009. Pages 135-143.;;Dissaranan, Charuspong et al. Stem Cell Therapy for Incontinence: Where are we now? What is the realistic potential?. Curr Urolo Rep (2011) 12. Springer Science + Business Media, LLC. Pages 336-344.;;Williams, J. Koudy et al. Cell versus Chemokine Therapy in a Nonhuman Primate Model of Chronic Intrinsic Urinary Sphincter Deficiency. The Journal of Urology. Vol. 196, 1809-1815, December 2016.",ACTIVE
132,WO,A3,WO 2003/042851 A3,126-362-703-956-840,2003-10-09,2003,US 0234926 W,2002-10-31,US 99083101 A,2001-11-09,"DISPLAY, INPUT AND FORM FACTOR FOR PORTABLE INSTRUMENTS","A compact appliance providing high resolution display capability in an ergonomically designed package. Subassemblies of the device are mechanically coupled to avoid interference between a user's hands and face while the device is used, while concurrently providing ergonomically located control for substantially all functions of the device.",SYNERDYNE,KNIGHTON MARK S;;GOLDMAN MARC;;AGABRA DAVID S;;DROBNIS DAVID D;;HAYNIE JILL E,,https://lens.org/126-362-703-956-840,Search Report,yes,2,0,4,4,0,H04N23/531;;H04N23/661;;H04N23/632;;H04N23/531;;H04N23/632;;H04N23/661,H04N5/225;;H04N5/232,,1,0,,,"PATENT ABSTRACTS OF JAPAN vol. 1999, no. 04 30 April 1999 (1999-04-30)",PENDING
133,US,B1,US 7359003 B1,144-379-610-656-981,2008-04-15,2008,US 99083101 A,2001-11-09,US 99083101 A,2001-11-09,"Display, input and form factor for portable instruments","A compact appliance providing high resolution display capability in an ergonomically designed package. Subassemblies of the device are mechanically coupled to avoid interference between a user's hands and face while the device is used, while concurrently providing ergonomically located control for substantially all functions of the device.",SYNERDYNE CORP,KNIGHTON MARK S;;GOLDMAN MARC;;AGABRA DAVID S;;DROBNIS DAVID D;;HAYNIE JILL E,SYNERDYNE (2001-11-08),https://lens.org/144-379-610-656-981,Granted Patent,yes,17,28,4,4,0,H04N23/531;;H04N23/661;;H04N23/632;;H04N23/531;;H04N23/632;;H04N23/661,H04N5/225;;H04N5/232,348/376;;348/373;;348/375,1,0,,,"Shimadzu Corp., Patent Abstracts of Japan, vol. 1999, No. 04, Apr. 30, 1999.",EXPIRED
134,AU,A1,AU 2002/350086 A1,075-711-584-087-420,2003-05-26,2003,AU 2002/350086 A,2002-10-31,US 99083101 A;;US 0234926 W,2001-11-09,"Display, input and form factor for portable instruments",,SYNERDYNE,KNIGHTON MARK S;;AGABRA DAVID S;;HAYNIE JILL E;;GOLDMAN MARC;;DROBNIS DAVID D,,https://lens.org/075-711-584-087-420,Patent Application,no,0,0,4,4,0,H04N23/531;;H04N23/661;;H04N23/632;;H04N23/531;;H04N23/632;;H04N23/661,H04N5/225;;H04N5/232,,0,0,,,,DISCONTINUED
135,WO,A2,WO 2003/042851 A2,174-209-970-145-671,2003-05-22,2003,US 0234926 W,2002-10-31,US 99083101 A,2001-11-09,"DISPLAY, INPUT AND FORM FACTOR FOR PORTABLE INSTRUMENTS","A compact appliance providing high resolution display capability in an ergonomically designed package. Subassemblies of the device are mechanically coupled to avoid interference between a user's hands and face while the device is used, while concurrently providing ergonomically located control for substantially all functions of the device.",SYNERDYNE,KNIGHTON MARK S;;GOLDMAN MARC;;AGABRA DAVID S;;DROBNIS DAVID D;;HAYNIE JILL E,,https://lens.org/174-209-970-145-671,Patent Application,yes,0,0,4,4,0,H04N23/531;;H04N23/661;;H04N23/632;;H04N23/531;;H04N23/632;;H04N23/661,H04N5/225;;H04N5/232,,0,0,,,,PENDING
136,US,B1,US 6765501 B1,133-058-736-325-84X,2004-07-20,2004,US 28506302 A,2002-10-31,US 28506302 A,2002-10-31,High performance rotary axis,"
    A high performance rotary axis. An upper and lower unit are coupled together by a pair of bearings to permit relative rotation between the units. The bearings are biased relative to others along a link to reduce play between the bearings. A processor and sensor provide for detection of relative positions between the units. A floating stop may be provided to permit rotation about the axis in greater than 360. 
",NEXTENGINE INC,KNIGHTON MARK S;;TANDON AMIT;;ZHENG JOHN Z;;BAHHOUR BASEL F;;GOLDMAN MARC;;DROBNIS DAVID D;;HAUSER THEODORE J,NEXTENGINE INC (2002-10-30);;NEXTPAT LIMITED (2008-06-24),https://lens.org/133-058-736-325-84X,Granted Patent,yes,9,0,1,1,0,H02K7/116;;H02K29/06;;Y10S384/906;;H02K11/33;;H02K7/116;;H02K29/06;;Y10S384/906;;H02K11/33,H02K7/116;;H02K11/04;;H02K29/06,341/2;;384/906,0,0,,,,EXPIRED
137,US,A1,US 2007/0067145 A1,009-404-263-238-984,2007-03-22,2007,US 71112604 A,2004-08-25,US 71112604 A,2004-08-25,Method and apparatus for function allocation and interface selection,"A method and apparatus for creating, modifying, elaborating and analyzing a task template is disclosed. The task templates created or modified are preferably stored in a repository of templates which are used for further task template specification. The task templates, and processes which operate",SIFT LLC,MILLER CHRISTOPHER A;;GOLDMAN ROBERT P;;FUNK HARRY B;;WU PEGGY;;MEISNER JOHN W;;HAMELL JOSHUA D;;CHAPMAN MARC D;;NORQUIST PEGGY,SIFT LLC (2004-08-23),https://lens.org/009-404-263-238-984,Patent Application,yes,1,21,1,1,0,G06Q10/06;;G06Q10/06,G06G7/48,703/6,0,0,,,,DISCONTINUED
138,US,B1,US 6967244 B1,113-850-551-667-521,2005-11-22,2005,US 58046200 A,2000-05-26,US 58046200 A;;US 34995694 A;;US 89818592 A;;US 32138489 A;;US 17029588 A,1988-03-18,Neuronal nicotinic acetylcholine receptor compositions,"The present invention relates to a family of neuronal nicotinic acetylcholine receptors comprised of neuronal agonist and non-agonist binding subunits, and DNA sequences encoding such subunits. These novel neuronal nicotinic acetylcholine receptor subunits include the agonist binding subunits alpha2, alpha3, alpha4, and alpha5, plus non-agonist binding subunits beta2, beta3 and beta4. Representative cDNA clones that contain the DNA sequences of the invention have been deposited with the American Type Culture Collection for patent purposes.",SALK INST FOR BIOLOGICAL STUDI,HEINEMANN STEPHEN FOX;;PATRICK JAMES WARNER;;BOULTER JAMES RICHARD;;DENERIS EVAN SAMUEL;;WADA KEIJI;;BALLIVET MARC CHARLES;;GOLDMAN DANIEL JAY;;CONNOLLY JOHN GERARD;;DUVOISIN ROBERT MICHAEL;;HEINEMANN EDEN DEER,,https://lens.org/113-850-551-667-521,Granted Patent,yes,1,1,5,19,0,C07K14/70571;;G01N33/944;;G01N2500/04;;C07K14/70571;;G01N33/944;;G01N2500/04,C07K14/705;;C12N15/12;;G01N33/566,536/23.5;;435/69.1;;435/252.3;;435/320.1,97,95,032-154-993-748-243;;038-426-107-403-502;;034-202-041-467-969;;001-910-735-875-801;;088-944-431-004-208;;002-941-512-853-937;;108-665-931-448-827;;014-445-493-084-951;;031-894-285-200-487;;040-995-442-192-126;;084-678-642-354-860;;006-600-008-545-863;;034-854-638-120-494;;080-389-547-198-365;;125-822-815-620-653;;013-437-955-677-617;;119-062-254-409-623;;010-359-077-037-383;;107-112-792-448-248;;080-684-683-067-679;;061-813-575-625-919;;002-471-216-132-744;;147-130-419-609-971;;019-109-310-909-826;;122-711-463-589-62X;;033-531-880-234-18X;;007-488-923-333-88X;;074-626-344-956-161;;020-328-503-259-335;;086-664-235-217-143;;063-740-685-113-437;;014-197-138-389-187;;013-907-848-182-655;;005-102-278-457-275;;154-616-911-445-28X;;047-067-609-947-248;;015-291-617-665-924;;027-323-818-442-275;;070-880-599-513-627;;009-105-479-184-17X;;001-122-805-546-388;;087-834-586-280-481;;054-827-597-793-765;;059-824-183-827-88X;;071-237-454-382-615;;065-785-617-279-55X;;043-548-538-728-049;;045-997-271-617-193;;046-379-499-766-548;;076-528-054-990-947;;039-849-604-670-303;;058-529-957-672-271;;061-039-447-776-026;;086-728-559-738-201;;051-371-151-120-361;;029-127-218-822-412;;052-007-492-168-174;;046-894-764-577-526;;035-667-841-445-027;;051-057-892-199-85X;;126-648-825-745-885;;099-508-175-195-962;;029-167-460-549-342;;039-700-450-238-220;;080-281-384-957-608;;014-495-669-186-034;;116-570-727-130-158;;072-973-092-186-351;;018-549-498-430-042;;013-529-430-516-421;;001-800-549-328-639;;050-392-839-319-076;;007-571-476-901-546;;009-823-812-896-004;;082-333-559-426-820;;117-450-833-942-811;;100-084-428-309-76X;;052-306-680-652-764;;021-479-574-647-612;;072-330-625-331-840;;021-721-900-216-133;;028-678-277-111-340;;047-302-961-865-636;;015-834-812-425-174;;031-852-916-835-740;;023-315-408-617-938;;022-474-872-506-870;;105-182-127-994-450;;005-423-992-450-588;;054-227-081-244-432;;019-531-252-128-872;;020-846-211-688-541;;030-461-226-783-811;;044-253-405-101-224;;084-996-304-110-55X,10.1002/cne.902160106;;6345598;;10.1073/pnas.82.23.8080;;3865218;;pmc391446;;10.1098/rspb.1982.0040;;6127706;;pmc6565314;;10.1523/jneurosci.05-09-02545.1985;;2993547;;10.1038/319368a0;;3753746;;10.1073/pnas.84.21.7763;;pmc299381;;2444984;;10.1016/0092-8674(87)90617-9;;3581171;;pmc432535;;1055412;;10.1073/pnas.72.4.1368;;194659;;10.1016/0006-8993(77)90981-7;;6481621;;10.1113/jphysiol.1984.sp015325;;pmc1193296;;3745150;;10.1016/s0021-9258(18)67264-3;;10.1073/pnas.75.2.1016;;pmc411391;;416436;;6093012;;10.1016/0304-3940(84)90492-0;;10.1523/jneurosci.05-05-01307.1985;;pmc6565049;;3998824;;10.1073/pnas.80.4.1111;;pmc393538;;6573658;;3860855;;10.1073/pnas.82.15.5208;;pmc390529;;6692991;;10.1016/0012-1606(84)90162-3;;3272154;;10.1016/0896-6273(88)90208-5;;10.1073/pnas.80.7.2067;;6572962;;pmc393754;;10.1016/s0021-9258(18)61283-9;;pmc5586536;;2435720;;pmc344629;;6320162;;10.1073/pnas.81.1.155;;10.1113/jphysiol.1980.sp013275;;6253617;;pmc1282881;;10.1021/bi00383a003;;3607023;;10.1523/jneurosci.05-09-02553.1985;;4032011;;pmc6565325;;pmc323669;;3012549;;10.1073/pnas.83.11.4076;;3829125;;10.1016/0092-8674(87)90705-7;;pmc369897;;6960240;;10.1128/mcb.2.9.1044-1051.1982;;10.1128/mcb.2.9.1044;;1065897;;10.1073/pnas.73.7.2424;;pmc430592;;3037383;;10.1038/328215a0;;pmc1435233;;6324907;;10.1016/s0006-3495(84)84152-1;;10.1016/0166-2236(87)90087-7;;10.1038/321171a0;;2422562;;5055788;;pmc2226074;;10.1085/jgp.60.3.248;;10.1126/science.3022377;;3022377;;10.1002/j.1460-2075.1986.tb04389.x;;pmc1166972;;16453690;;3298562;;pmc6568889;;10.1523/jneurosci.07-06-01792.1987;;6850348;;10.1016/0006-8993(83)91312-4;;10.1016/0014-5793(86)80881-x;;2427361;;2423885;;10.1038/321774a0;;3944622;;10.1523/jneurosci.06-01-00281.1986;;pmc6568606;;2432430;;10.1038/324670a0;;10.1128/mcb.6.8.2855;;10.1128/mcb.6.8.2855-2864.1986;;3785216;;pmc367853;;3722144;;10.1016/s0021-9258(19)83877-2;;10.1085/jgp.54.1.245;;pmc2225893;;19873644;;10.1016/0006-8993(85)90187-8;;4063809;;3821734;;10.1128/mcb.7.2.951;;10.1128/mcb.7.2.951-955.1987;;pmc365157;;2436944;;10.1016/0014-5793(87)80065-0;;7150959;;10.1016/0006-8993(82)90406-1;;10.1016/0028-3908(82)90107-1;;7145035;;10.1016/b978-0-12-185203-0.50018-5;;2423008;;10.1146/annurev.ne.09.030186.002123;;pmc6569057;;10.1523/jneurosci.07-03-00742.1987;;3549993;;10.1016/0012-1606(80)90494-7;;6254823;;10.1038/307604a0;;6320016;;10.1038/321406a0;;2423878;;3956748;;10.1016/0014-5793(86)81225-x;;pmc392276;;10.1073/pnas.81.24.7975;;6096871;;10.1007/978-3-642-71649-2_31;;3267226;;10.1002/j.1460-2075.1988.tb02852.x;;pmc454362;;10.1073/pnas.83.9.3008;;3458258;;pmc323436;;6182472;;10.1038/299793a0;;6188060;;10.1038/302528a0;;10.1038/308084d0;;7012663;;10.1016/0306-4522(81)90239-6;;pmc432013;;10.1073/pnas.74.10.4689;;270708;;925016;;10.1016/s0021-9258(19)75267-3;;10.1101/sqb.1983.048.01.009;;6202451;;6339004;;10.1016/0006-8993(83)90638-8;;10.1152/physrev.1984.64.4.1162;;6208568;;10.1113/jphysiol.1981.sp013571;;pmc1275396;;6267251;;287045;;10.1073/pnas.76.4.2072;;pmc383536;;10.1016/s0361-9230(81)80027-5;;7248816;;3816758;;10.1002/j.1460-2075.1986.tb04626.x;;pmc1167309;;10.1016/0896-6273(88)90145-6;;3272170;;10.1038/328221a0;;3037384;;10.1083/jcb.61.2.398;;pmc2109296;;4363958;;10.1016/s0021-9258(18)32860-6;;6826561;;10.1111/j.1432-1033.1985.tb08614.x;;3967651;;pmc6565130;;10.1523/jneurosci.05-10-02726.1985;;2413185;;10.1146/annurev.cb.01.110185.001533;;2435309;;10.1016/0006-8993(86)90311-2;;2424552;;10.1073/pnas.80.14.4532;;pmc384073;;6192437;;pmc6569159;;2822866;;10.1523/jneurosci.07-10-03334.1987;;3839289;;10.1038/315761a0;;10.1523/jneurosci.05-08-02212.1985;;4020435;;pmc6565290;;2832952;;10.1126/science.2832952;;10.1016/0006-291x(74)90254-x;;4451573;;3531428;;pmc6568798;;10.1523/jneurosci.06-10-03061.1986;;3707934;;10.1021/bi00356a037;;2435576;;10.1016/0014-5793(87)81464-3;;10.1038/327515a0;;2438558;;3609304;;10.1016/0014-5793(87)80272-7;;10.1073/pnas.84.2.595;;3467376;;pmc304257;;10.1073/pnas.82.24.8790;;3866252;;pmc391523;;10.1111/j.1471-4159.1986.tb13078.x;;3772372,"Armstrong et al., ""Distribution of Cholinergic Neurons in Rat Brain: Demonstrated by the Immunocytochemical Localization of Choline Acetyltransferase"" J. Comp. Neurol. 216:53-68 (1983).;;Baldwin et al., ""Structure, evolution and regulation of a fast skeletal muscle troponin I gene"" Proc. Natl. Acad. Sci., USA 82:8080-8084 (1985).;;Barnard et al., ""Translation of exogenous messenger RNA coding for nicotinic acetylcholine receptors produces functional receptors in Xenopus oocytes"" Proc. R. Soc. Lond. B. 215:241-246 (1982).;;Boulter et al., ""Isolation of a Clone Coding for the alpha-Subunit of a Mouse Acetylcholine Receptor"" J. Neurosci. 5 (9) :2545-2552 (1985).;;Boulter et al., ""Isolation of a cDNA clone coding for a possible neural nicotinic acetylcholine receptor alpha-subunit"" Nature 319:368-374 (1986).;;Boulter et al., ""Functional expression of two neuronal nicotinic acetylcholine receptors from cDNA clones identifies a gene family"" Proc. Natl. Acad. Sci., USA 84:7763-7767 (1987).;;Breitbart and Nadal-Ginard, ""Developmentally Induced, Muscle-Specific Trans Factors Control the Differential Splicing of Alternative and Constitutive Troponin T Exons"" Cell 49:793-803 (1987).;;Brockes and Hall ""Synthesis of Acetylcholine Receptor by Denervated Rat Diaphragm Muscle"" Proc. Natl. Acad. Sci., USA 72 (4) :1368-1372 (1975).;;Brown and Fumagalli, ""Dissociation of alpha-bungarotoxin binding and receptor block in the rat superior cervical ganglion"" Brain Res. 129:165-168 (1977).;;Brown et al., ""The action of cholinomimetic substances on impulse conduction in the habenulointerpeduncular pathway of the rat in vitro"" J. Physiol. 353:101-109 (1984).;;Buonanno and Merlie, ""Transcriptional Regulation of Nicotinic Acetylcholine Receptor Genes during Muscle Development"" J. Biol. Chem. 261 (25):11452-11455 (1986).;;Carbonetto et al., ""Nonequivalence of alpha-bungarotoxin receptors and acetylcholine receptors in chick sympathetic neurons"" Proc. Natl. Acad. Sci., USA 75(2):1016-1020 (1978).;;Chiappinelli and Dryer, ""Nicotinic transmission in sympathetic ganglia: blockade by the snake venom neurotoxin kappa-bungarotoxin"" Neurosci. Lett. 50:239-244 (1984).;;Clarke et al., ""Nicotinic Binding in the Rat Brain: Autoradiographic Comparison of [<SUP>3</SUP>H]Acetylcholine, [<SUP>3</SUP>H]Nicotine, and [<SUP>125</SUP>H]-alpha-Bungarotoxin"" J. Neurosci. 5(5):1307-1315 (1985).;;Claudio et al., ""Nucleotide and deduced amino acid sequences of Torpedo californica acetylcholine receptor gamma subunit"" Proc. Natl. Acad. Sci., USA 80:1111-1115 (1983).;;Conti-Tronconi et al., ""Brain and muscle nicotinic acetylcholine receptors are different but homologous proteins"" Proc. Natl. Acad. Sci., USA 82:5208-5212 (1985).;;Cox et al., ""Detection of mRNAs in Sea Urchin Embryos by in Situ Hybridization Using Aasymmetric RNA Probes"" Dev. Biol. 101:485-502 (1984).;;Deneris et al., ""Primary Structure and Expression of beta2: A novel Subunit of Neuronal Nicotinic Acetylcholine Receptors"" Neuron 1:45-54 (1988).;;Devillers-Thiery et al., ""Complete mRNA coding sequence of the acetylcholine binding alpha-subunit of Torpedo marmorata acetylcholine receptor: A model for the transmembrane organization of the polypeptide chain"" Proc. Natl. Acad. Sci., USA 80:2067-2071 (1983).;;Evans et al., ""Muscle Acetylcholine Receptor Biosynthesis: Regulation by Transcript Availability"" J. Biol. Chem. 262(10):4911-4916 (1987).;;Finer-Moore and Stroud, ""Amphipathic analysis and possible formation of the ion channel in an acetylcholine receptor"" Proc. Natl. Acad. Sci., USA 81:155-159 (1984).;;Fischbach and Schuetze, ""A post-natal decrease in acetylcholine channel open time at rat end-plates"" J. Physiol. 303:125-137 (1980).;;Giraudat et al., ""Structure of the High-Affinity Binding Site for Noncompetitive Blockers of the Acetylcholine Receptor: [<SUP>3</SUP>H]-Chlorpromazine Labels Homologous Residues in the beta and delta Chains"" Biochem. 26:2410-2418 (1987).;;Goldman et al., ""Muscle Denervation Increases the Levels of Two mRNAs Coding for the Acetylcholine Receptor alpha-Subunit"" J. Neurosci. 5:2553-2558 (1985).;;Goldman et al., ""Mapping of brain areas expressing RNA homologous to two different acetylcholine receptor alpha-subunit cDNAs"" Proc. Natl. Acad. Sci., USA 83:4076-4080 (1986).;;Goldman et al., ""Members of a Nicotinic Acetylcholine Receptor Gene Family Are Expressed in Different Regions of the Mammalian Central Nervous System"" Cell 48:965-973 (1987).;;Gorman et al., ""Recombinant Genomes Which Express Chloramphenicol Acetyltransferase in Mammalian Cells"" Mol. Cell Biol. 2(9):1044-1051 (1982).;;Greene and Tischler, ""Establishment of noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor"" Proc. Natl. Acad. Sci., USA 73:(7)2424-2428 (1976).;;Grenningloh et al., ""The strychnine-binding subunit of the glycine receptor shows homology with nicotinic acetylcholine receptors"" Nature 328:215-220 (1987).;;Guy, H.R., ""A structural model of the acetylcholine receptor channel based on partition energy and helix packing calculations"" Biophys. J. 45:249-261 (1984).;;Guy and Hucho, ""The ion channel of the nicotinic acetylcholine receptor"" Trends Neurosci 10(8):318-321 (1987).;;Hanke and Breer, ""Channel properties of an insect neuronal acetylcholine receptor protein reconstituted in planar lipid bilayers"" Nature 321:171-174 (1986).;;Hartzell and Fambrough, ""Acetylcholine Receptors: Distribution and extrajunctional density in rat diaphragm after denervation correlated with acetylcholine sensitivity"" J. Gen. Physiol. 60:248-262 (1972).;;Heidmann et al., ""Chromosomal Localization of Muscle Nicotinic Acetylcholine Receptor Genes in the Mouse"" Science 234:866-868 (1986).;;Heinemann et al., ""Molecular Biology of the Muscle Land Neural Acetylocholine Receptors"" In: Nicotinic Acetylcholine Receptor: Structure and Function, NATO ASI Series H, A. Maelicke, ed. (Berlin: Springer-Verlag), H3:359-387 (1986).;;Hermans-Borgmeyer et al., ""Primary structure of a developmentally regulated nicotinic acetylcholine receptor protein from Drosophila"" EMBO J. 5:(7)1503-1508 (1986).;;Higgins and Berg, ""Immunological Identification of a Nicotinic Acetylcholine Receptor on Bovine Chromaffin Cells"" J. Neurosci. 7(6):1792-1798 (1987).;;Houser et al., ""Organization and Morphological Characteristics of Cholinergic Neurons: an Immunocytochemical Study with a Monoclonal Antibody to Choline Acetyltransferase"" Brain Res. 266:97-119 (1983).;;Hucho et al., ""The ion channel of the nicotinic acetylcholine receptor in formed by the homologous helices M II of the receptor subunits"" FEBS Lett. 205(1)137-142 (1986).;;Huganir et al., ""Phosphorylation of the nicotinic acetylcholine receptor regulates its rate of desensitization"" Nature 321:774-776 (1986).;;Ichikawa and Hirata, ""Organization of Choline Acetyltransferase-Containing Structures in the Forebrain of the Rat"" J. Neurosci. 6(1):281-292 (1986).;;Imoto et al., ""Location of a delta-subunit region determining ion transport through the acetylcholine receptor channel"" Nature 324:670-674 (1986).;;Jaynes et al., ""Transcriptional Regulation of the Mucsle Creatine Kinase Gene and Regulated Expression in Transfected Mouse Myoblasts"" Mol. Cell. Biol. 6(8):2855-2864 (1986).;;Kao and Karlin, ""Acetylcholine Receptor Binding Site Contains a Disulfide Cross-link between Adjacent Half-Cystinyl Residues"" J. Biol. Chem. 261(18):8085-8088 (1986).;;Karlin, A., ""Chemical Modification of the Active Site of Acetylcholine Receptor"" J. Gen. Phys. 54:245s-264s (1969).;;Kemp et al., ""Purification and Characterization of the alpha-Bungarotoxin Binding Protein from Rat Brain"" Brain Res. 347:274-283 (1985).;;Klarsfeld et al., ""A 5-Flanking Region of the Chicken Acetylcholine Receptor alpha-Subunit Gene Confers Tissue Specificity and Developmental Control of Expression in Transfected Cells"" Mol. Cell. Biol. 7(2):951-955 (1987).;;Kurosaki et al., ""Functional properties of nicotinic acetylcholine receptor subunits expressed in various combinations"" FEBS Lett. 214 (2):253-258 (1987).;;Lamour et al., ""Spread of acetylcholine sensitivity in the necocortex following lesion of the nucleus basalis"" Brain Res. 252:377-381 (1982).;;Lichtensteiger et al., ""Stimulation of Nigrostriatal Dopamine Neurones by Nicotine"" Neuropharmacol. 21:963-968 (1982).;;Martin, B.R., ""Nicotine Receptors in the Central Nervous System"" In: The Receptors, P.M. Conn, ed. (Orlando, FL: Academic Press) 3:393-415 (1986).;;Mauron et al., ""Structure of Chicken Genes Encoding the Nicotinic Acetylcholine Receptor Subunits and Their Variants"" Soc. for Neuroscience, 15th Annual Meeting, Abstract 55.10, p. 171 (1985).;;McCarthy et al., ""The molecular Neurobiology of the Acetylcholine Receptor"" Ann. Rev. Neurosci. 9:383-413 (1986).;;McCormick and Prince, ""Acetylcholine Causes Rapid Nicotinic Excitation in the Medial Habenular Nucleus of Guinea Pig, in vitro"" J. Neurosci. 7(3):742-752 (1987).;;Michler and Sakmann, ""Receptor Stability and Channel Conversion in the Subsynaptic Membrane of the Developing Mammalian Neuromuscular Junction"" Dev. Biol. 80:1-17 (1980).;;Mishina et al., ""Expression of functional acetylcholine receptor from cloned cDNAs"" Nature 307:604-608 (1984).;;Mishina et al., ""Molecular distinction between fetal and adult forms of muscle acetylcholine receptor"" Nature 321:406-411 (1986).;;Mulac-Jericevic and Atassi, ""Segment alpha182-198 of Torpedo californica acetylcholine receptor contains a second toxin-binding region and binds anti-receptor antibodies"" FEBS Lett. 199(1):68-74 (1986).;;Nef et al., ""Structure linkage, and sequence of the two genes encoding the delta and gamma subunits of the nicotinic acetylcholine receptor"" Proc. Natl. Acad. Sci., USA 81:7975-7979 (1984).;;Nef et al., ""Acetylcholine Receptor Related Genes Expressed in the Nervous System"" In: Nicotinic Acetylcholine Receptor: Structure and Function, NATO ASI Series, vol. H3, A. Maelicke, ed., (Springer-Verlag) pp. 417-422 (1986).;;Nef et al., ""Genes expressed in the brain define three distinct neuronal nicotinic acetylcholine receptors"" EMBO J. 7(3):595-601 (1988).;;Neumann et al., ""Mapping of the alpha-bungarotoxin binding site within the alpha subunit of the acetylcholine receptor"" Proc. Natl. Acad. Sci., USA 83:3008-3011 (1986).;;Noda et al., ""Primary structure of alpha-subunit precursor of Torpedo californica acetylcholine receptor deduced from cDNA sequence"" Nature 299:793-797 (1982).;;Noda et al., ""Structural homology of Torpedo californica acetylcholine receptor subunits"" Nature 302:528-532 (1983).;;Noda et al., ""Cloning and sequence analysis of calf cDNA and human genomic DNA encoding alpha-subunit precursor of muscle acetylcholine receptor"" Nature 305:818-823 (1983).;;Oswald and Freeman, ""Alpha-Bungarotoxin Binding and Central Nervous System Nicotinic Acetylcholin Receptors"" Neuroscience 6:1-14 (1981).;;Patrick and Stallcup, ""Immunological distinction between acetylcholine receptor and the alpha-bungarotoxin-binding component on sympathetic neurons"" Proc. Natl. Acad. Sci., USA 74(10):4689-4692 (1977).;;Patrick and Stallcup, ""alpha-Bungarotoxin Binding and Cholinergic Receptor Function on a Rat Sympathetic Nerve Line"" J. Biol. Chem. 252:8629-8633 (1977).;;Patrick et al., ""Molecular Cloning of the Acetylcholine Receptor"" Cold Spring Harbor Symposia on Quantitative Biology XLVIII:71-79 (1983).;;Pearson et al., ""The cortical relationships of certain basal ganglia and the cholinergic basal forebrain nuclei"" Brain Res. 261:327-330 (1983).;;Popot and Changeux, ""Nicotinic Receptor of Acetylcholine: Structure of an Oligomeric Integral Membrane Protein"" Physiological Revs. 64(4):1162-1239 (1984).;;Rang, H.P., ""The Characteristics of Synaptic Currents and Responses to Acetylcholine of Rat Submandibular Ganglion Cells"" J. Physiol. 311:23-55 (1981).;;Ravdin and Berg, ""Inhibition of neuronal acetylcholine sensitivity by alpha-toxins from Bungarus multicinctus venom"" Proc. Natl. Acad. Sci., USA 76(4):2072-2076 (1979).;;Rotter and Jacobowitz, ""Neurochemical Identification of Cholinergic Forebrain Projection Sites of the Nucleus Tegmentalis Dorsalis Lateralis"" Brain Res. Bull. 6:525-529 (1981).;;Safran et al., ""Analysis of acetylcholine receptor phosphorylation sites using antibodies to synthetic peptides and monoclonal antibodies"" EMBO J. 5:3175-3178 (1986).;;Schoepfer et al., ""cDNA Clone Coding for the Structural Subunit of a Chicken Brain Nicotinic Acetylcholine Receptor"" Neuron 1:241-248 (1988).;;Schofield et al., ""Sequence and functional expression of the GABA<SUB>A </SUB>receptor shows a ligand-gated receptor super-family"" Nature 328:221-227 (1987).;;Schubert et al., ""Characterization of a Unique Muscle Cell Line"" J. Cell. Bio. 61:398-413 (1974).;;Sebbane et al., ""Characterization of the mRNA for Mouse Muscle Acetylcholine Receptor alpha Subunit by Quantitative Translation in Vitro"" J. Biol. Chem. 258:3294-3303 (1983).;;Shibahara et al,. ""Cloning and sequencing analysis of human genomic DNA encoding gamma subunit precursor of muscle acetylcholine receptor"" Eur. J. Biochem. 146:349-359 (1985).;;Smith et al., ""Characterization of a Component in Chick Ciliary Ganglia that Cross-reacts with Monoclonal Antibodies to Muscle and Electric Organ Acetylcholine Receptor"" J. Neurosci. 5(10):2726-2731 (1985).;;Stroud and Finer-Moore, ""Acetylcholine Receptor Structure, Function, and Evolution"" Ann. Rev. Cell. Biol. 1:317-351 (1985).;;Sugiyama and Yamashita, ""Characterization of Putative Nicotinic Acetylcholine Receptors Solubilized from Rat Brains"" Brain Res. 373:22-26 (1986).;;Swanson et al., ""Immunohistochemical localization of monoclonal antibodies to the nicotinic acetylcholine receptor in chick midbrain"" Proc. Natl. Acad. Sci., USA 80:4532-4536 (1983).;;Swanson et al., ""Immunohistochemical Localization of Neuronal Nicotinic Receptors in the Rodent Central Nervous System"" J. Neurosci. 7(10):3334-3342 (1987).;;Takai et al., ""Cloning, sequencing and expression of cDNA for a novel subunit of acetylcholine receptor from calf muscle"" Nature 315:761-764 (1985).;;Vicini and Schuetze, ""Gating Properties of Acetylcholine Receptors at Developing Rat Endplates"" J. Neurosci. 5(8):2212-2224 (1985).;;Wada et al,. ""Functional Expression of a New Pharmacological Subtype of Brain Nicotinic Acetylcholine Receptor"" Science 240:330-334 (1988).;;Weill et al., ""Affinity-Labeling of Purified Acetylcholine Receptor From Torpedo Californica"" Biochem. Biophys. Res. Commun. 61(3):997-1003 (1974).;;Whiting and Lindstrom, ""Pharmacological Properties of Immuno-Isolated Neuronal Nicotinic Receptors"" J. Neurosci. 6(10):3061-3069 (1986).;;Whiting and Lindstrom, ""Purification and Characterization of a Nicotinic Acetylcholine Receptor from Chick Brain"" Biochem. 25:2082-2093 (1986).;;Whiting and Lindstrom, ""Affinity labelling of neuronal acetylcholine receptors localizes acetylcholine-binding sites to their beta-subunits"" FEBS Lett. 213(1):55-60 (1987).;;Whiting et al., ""Functional acetylcholine receptor in PC12 cells reacts with a monoclonal antibody to brain nicotinic receptors"" Nature 327:515-518 (1987).;;Whiting et al., ""Neuronal nicotinic acetylcholine receptor beta-subunit is coded for by the cDNA clone alpha<SUB>4</SUB>"" FEBS Lett. 219(2):459-463 (1987).;;Whiting and Lindstrom, ""Purification and characterization of a nicotinic acetylcholine receptor from rat brain"" Proc. Natl. Acad. Sci., USA 84:595-599 (1987).;;Wilson et al., ""Determination of the primary amino acid sequence specifying the alpha-bungarotoxin binding site on the alpha subunit of the acetylcholine receptor for Torpedo californica"" Proc. Natl. Acad. Sci., USA 82:8790-8794 (1985).;;Wonnacott, S., ""alpha-Bungarotoxin Binds to Low-Affinity Nicotine Binding Sites in Rat Brain"" J. Neurochem. 47:1706-1712 (1986).",EXPIRED
139,CA,C,CA 1341554 C,132-069-644-153-806,2007-10-09,2007,CA 1341554 A,1989-03-20,US 32138489 A;;US 17029588 A,1988-03-18,NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR COMPOSITIONS AND ASSAY,,SALK INST FOR BIOLOGICAL STUDI,HEINEMANN EDEN DEER;;DUVOISIN ROBERT MICHAEL;;PATRICK JAMES WARNER;;HEINEMANN STEPHEN FOX;;DENERIS EVAN SAMUEL;;WADA KEIJI;;CONNOLLY JOHN GERARD;;BALLIVET MARC CHARLES;;GOLDMAN DANIEL JAY;;BOULTER JAMES RICHARD,,https://lens.org/132-069-644-153-806,Granted Patent,no,0,0,5,19,0,C07K14/70571;;G01N33/944;;G01N2500/04;;C07K14/70571;;G01N33/944;;G01N2500/04,C12N15/12;;C07K14/705;;C12N5/10;;G01N33/566;;G01N33/567,,0,0,,,,INACTIVE
140,US,A,US 5591590 A,194-631-895-736-656,1997-01-07,1997,US 47298995 A,1995-06-06,US 47298995 A;;US 34995694 A;;US 89818592 A;;US 32138489 A;;US 17029588 A,1988-03-18,Neuronal nicotinic acetylcholine receptor assay,"The present invention relates to a family of neuronal nicotinic acetylcholine receptors comprised of neuronal agonist and non-agonist binding subunits, and DNA sequences encoding such subunits. These novel neuronal nicotinic acetylcholine receptor subunits include the agonist binding subunits alpha2, alpha3, alpha4, and alpha5, plus non-agonist binding subunits beta2, beta3 and beta4. Representative cDNA clones that contain the DNA sequences of the invention have been deposited with the American Type Culture Collection for patent purposes.",SALK INST FOR BIOLOGICAL STUDI,HEINEMANN STEPHEN F;;PATRICK JAMES W;;BOULTER JAMES R;;DENERIS EVAN S;;CONNOLLY JOHN G;;DUVOISIN ROBERT M;;HEINEMANN EDEN D;;WADA KEIJI;;BALLIVET MARC C;;GOLDMAN DANIEL J,,https://lens.org/194-631-895-736-656,Granted Patent,yes,1,12,5,19,0,C07K14/70571;;G01N33/944;;G01N2500/04;;C07K14/70571;;G01N33/944;;G01N2500/04,C07K14/705;;C12N15/12;;G01N33/566,435/7.1;;435/6;;435/7.2;;436/501,99,98,032-154-993-748-243;;038-426-107-403-502;;034-202-041-467-969;;001-910-735-875-801;;088-944-431-004-208;;002-941-512-853-937;;108-665-931-448-827;;014-445-493-084-951;;031-894-285-200-487;;040-995-442-192-126;;084-678-642-354-860;;006-600-008-545-863;;034-854-638-120-494;;080-389-547-198-365;;125-822-815-620-653;;013-437-955-677-617;;119-062-254-409-623;;010-359-077-037-383;;107-112-792-448-248;;080-684-683-067-679;;061-813-575-625-919;;002-471-216-132-744;;147-130-419-609-971;;019-109-310-909-826;;122-711-463-589-62X;;033-531-880-234-18X;;007-488-923-333-88X;;074-626-344-956-161;;020-328-503-259-335;;086-664-235-217-143;;063-740-685-113-437;;014-197-138-389-187;;013-907-848-182-655;;005-102-278-457-275;;034-401-501-920-130;;047-067-609-947-248;;015-291-617-665-924;;027-323-818-442-275;;070-880-599-513-627;;009-105-479-184-17X;;001-122-805-546-388;;087-834-586-280-481;;054-827-597-793-765;;059-824-183-827-88X;;071-237-454-382-615;;065-785-617-279-55X;;043-548-538-728-049;;045-997-271-617-193;;046-379-499-766-548;;076-528-054-990-947;;039-849-604-670-303;;058-529-957-672-271;;061-039-447-776-026;;086-728-559-738-201;;051-371-151-120-361;;029-127-218-822-412;;052-007-492-168-174;;046-894-764-577-526;;035-667-841-445-027;;051-057-892-199-85X;;126-648-825-745-885;;099-508-175-195-962;;029-167-460-549-342;;039-700-450-238-220;;080-281-384-957-608;;014-495-669-186-034;;116-570-727-130-158;;072-973-092-186-351;;018-549-498-430-042;;013-529-430-516-421;;001-800-549-328-639;;050-392-839-319-076;;007-571-476-901-546;;009-823-812-896-004;;082-333-559-426-820;;117-450-833-942-811;;100-084-428-309-76X;;052-306-680-652-764;;021-479-574-647-612;;072-330-625-331-840;;021-721-900-216-133;;028-678-277-111-340;;047-302-961-865-636;;015-834-812-425-174;;031-852-916-835-740;;023-315-408-617-938;;022-474-872-506-870;;105-182-127-994-450;;005-423-992-450-588;;054-227-081-244-432;;019-531-252-128-872;;020-846-211-688-541;;030-461-226-783-811;;044-253-405-101-224;;084-996-304-110-55X;;080-281-384-957-608;;031-617-041-391-20X;;030-461-226-783-811,10.1002/cne.902160106;;6345598;;10.1073/pnas.82.23.8080;;3865218;;pmc391446;;10.1098/rspb.1982.0040;;6127706;;pmc6565314;;10.1523/jneurosci.05-09-02545.1985;;2993547;;10.1038/319368a0;;3753746;;10.1073/pnas.84.21.7763;;pmc299381;;2444984;;10.1016/0092-8674(87)90617-9;;3581171;;pmc432535;;1055412;;10.1073/pnas.72.4.1368;;194659;;10.1016/0006-8993(77)90981-7;;6481621;;10.1113/jphysiol.1984.sp015325;;pmc1193296;;3745150;;10.1016/s0021-9258(18)67264-3;;10.1073/pnas.75.2.1016;;pmc411391;;416436;;6093012;;10.1016/0304-3940(84)90492-0;;10.1523/jneurosci.05-05-01307.1985;;pmc6565049;;3998824;;10.1073/pnas.80.4.1111;;pmc393538;;6573658;;3860855;;10.1073/pnas.82.15.5208;;pmc390529;;6692991;;10.1016/0012-1606(84)90162-3;;3272154;;10.1016/0896-6273(88)90208-5;;10.1073/pnas.80.7.2067;;6572962;;pmc393754;;10.1016/s0021-9258(18)61283-9;;pmc5586536;;2435720;;pmc344629;;6320162;;10.1073/pnas.81.1.155;;10.1113/jphysiol.1980.sp013275;;6253617;;pmc1282881;;10.1021/bi00383a003;;3607023;;10.1523/jneurosci.05-09-02553.1985;;4032011;;pmc6565325;;pmc323669;;3012549;;10.1073/pnas.83.11.4076;;3829125;;10.1016/0092-8674(87)90705-7;;pmc369897;;6960240;;10.1128/mcb.2.9.1044-1051.1982;;10.1128/mcb.2.9.1044;;1065897;;10.1073/pnas.73.7.2424;;pmc430592;;3037383;;10.1038/328215a0;;pmc1435233;;6324907;;10.1016/s0006-3495(84)84152-1;;10.1016/0166-2236(87)90087-7;;10.1038/321171a0;;2422562;;5055788;;pmc2226074;;10.1085/jgp.60.3.248;;10.1126/science.3022377;;3022377;;10.1007/978-3-642-71649-2_29;;3298562;;pmc6568889;;10.1523/jneurosci.07-06-01792.1987;;6850348;;10.1016/0006-8993(83)91312-4;;10.1016/0014-5793(86)80881-x;;2427361;;2423885;;10.1038/321774a0;;3944622;;10.1523/jneurosci.06-01-00281.1986;;pmc6568606;;2432430;;10.1038/324670a0;;10.1128/mcb.6.8.2855;;10.1128/mcb.6.8.2855-2864.1986;;3785216;;pmc367853;;3722144;;10.1016/s0021-9258(19)83877-2;;10.1085/jgp.54.1.245;;pmc2225893;;19873644;;10.1016/0006-8993(85)90187-8;;4063809;;3821734;;10.1128/mcb.7.2.951;;10.1128/mcb.7.2.951-955.1987;;pmc365157;;2436944;;10.1016/0014-5793(87)80065-0;;7150959;;10.1016/0006-8993(82)90406-1;;10.1016/0028-3908(82)90107-1;;7145035;;10.1016/b978-0-12-185203-0.50018-5;;2423008;;10.1146/annurev.ne.09.030186.002123;;pmc6569057;;10.1523/jneurosci.07-03-00742.1987;;3549993;;10.1016/0012-1606(80)90494-7;;6254823;;10.1038/307604a0;;6320016;;10.1038/321406a0;;2423878;;3956748;;10.1016/0014-5793(86)81225-x;;pmc392276;;10.1073/pnas.81.24.7975;;6096871;;10.1007/978-3-642-71649-2_31;;3267226;;10.1002/j.1460-2075.1988.tb02852.x;;pmc454362;;10.1073/pnas.83.9.3008;;3458258;;pmc323436;;6182472;;10.1038/299793a0;;6188060;;10.1038/302528a0;;10.1038/308084d0;;7012663;;10.1016/0306-4522(81)90239-6;;pmc432013;;10.1073/pnas.74.10.4689;;270708;;925016;;10.1016/s0021-9258(19)75267-3;;10.1101/sqb.1983.048.01.009;;6202451;;6339004;;10.1016/0006-8993(83)90638-8;;10.1152/physrev.1984.64.4.1162;;6208568;;10.1113/jphysiol.1981.sp013571;;pmc1275396;;6267251;;287045;;10.1073/pnas.76.4.2072;;pmc383536;;10.1016/s0361-9230(81)80027-5;;7248816;;3816758;;10.1002/j.1460-2075.1986.tb04626.x;;pmc1167309;;10.1016/0896-6273(88)90145-6;;3272170;;10.1038/328221a0;;3037384;;10.1083/jcb.61.2.398;;pmc2109296;;4363958;;10.1016/s0021-9258(18)32860-6;;6826561;;10.1111/j.1432-1033.1985.tb08614.x;;3967651;;pmc6565130;;10.1523/jneurosci.05-10-02726.1985;;2413185;;10.1146/annurev.cb.01.110185.001533;;2435309;;10.1016/0006-8993(86)90311-2;;2424552;;10.1073/pnas.80.14.4532;;pmc384073;;6192437;;pmc6569159;;2822866;;10.1523/jneurosci.07-10-03334.1987;;3839289;;10.1038/315761a0;;10.1523/jneurosci.05-08-02212.1985;;4020435;;pmc6565290;;2832952;;10.1126/science.2832952;;10.1016/0006-291x(74)90254-x;;4451573;;3531428;;pmc6568798;;10.1523/jneurosci.06-10-03061.1986;;3707934;;10.1021/bi00356a037;;2435576;;10.1016/0014-5793(87)81464-3;;10.1038/327515a0;;2438558;;3609304;;10.1016/0014-5793(87)80272-7;;10.1073/pnas.84.2.595;;3467376;;pmc304257;;10.1073/pnas.82.24.8790;;3866252;;pmc391523;;10.1111/j.1471-4159.1986.tb13078.x;;3772372;;pmc432013;;10.1073/pnas.74.10.4689;;270708;;10.1007/bf00582635;;2432468;;10.1073/pnas.84.2.595;;3467376;;pmc304257,"Armstrong et al., Distribution of Cholinergic Neurons in Rat Brain: Demonstrated by the Immunocytochemical Localizaton of Choline Acetyltransferase J. Comp. Neurol. 216:53 68 (1983).;;Baldwin et al., Structure, evolution and regulation of a fast skeletal muscle troponin I gene Proc. Natl. Acad. Sci., USA 82:8080 8084 (1985).;;Barnard et al., Translation of exogenous messenger RNA coding for nicotinic acetylcholine receptors produces functional receptors in Xenopus oocytes Proc. R. Soc. Lond. B. 215:241 246 (1982).;;Boulter et al., Isolation of a Clone Coding for the Subunit of a Mouse Acetylcholine Receptor J. Neurosci. 5(9):2545 2552 (1985).;;Boulter et al., Isolation of a cDNA clone coding for a possible neural nicotinic acetylcholine receptor subunit Nature 319:368 374 (1986).;;Boulter et al., Functional expression of two neuronal nicotinic acetylcholine receptors from cDNA clones identifies a gene family Proc. Natl. Acad. Sci., USA 84:7763 7767 (1987).;;Breitbart and Nadal Ginard, Developmentally Induced, Muscle Specific Trans Factors Control the Differential Splicing of Alternative and Constitutive Troponin T Exons Cell 49:793 803 (1987).;;Brockes and Hall Synthesis of Acetylcholine Receptor by Denervated Rat Diaphragm Muscle Proc. Natl. Acad. Sci., USA 72(4):1368 1372 (1975).;;Brown and Fumagalli, Dissociation of bungarotoxin binding and receptor block in the rat superior cervical ganglion Brain Res. 129:165 168 (1977).;;Brown et al., The action of cholinomimetic substances on impulse conduction in the habenulointerpeduncular pathway of the rat in vitro J. Physiol. 353:101 109 (1984).;;Buonanno and Merlie, Transcriptional Regulation of Nicotinic Acetylcholine Receptor Genes during Muscle Develoment J. Biol. Chem. 261(25):11452 11455 (1986).;;Carbonetto et al., Nonequivalence of bungarotoxin receptors and acetylcholine receptors in chick sympathetic neurons Proc. Natl Acad. Sci., USA 75(2):1016 1020 (1978).;;Chiappinelli and Dryer, Nicotinic transmission in sympathetic ganglia: blockade by the snake venom neurotoxin kappa bungarotoxin Neurosci. Lett. 50:239 244 (1984).;;Clarke et al., Nicotinic Binding in the Rat Brain: Autoradiographic Comparison of 3 H Acetylcholine, 3 H Nicotine, and 125 H Bungarotoxin J. Neurosci. 5(5):1307 1315 (1985).;;Claudio et al., Nucleotide and deduced amino acid sequences of Torpedo californica acetylcholine receptor subunit Proc. Natl. Acad. Sci., USA 80:1111 1115 (1983).;;Conti Tronconi et al., Brain and muscle nicotinic acetylcholine receptors are different but homologous proteins Proc. Natl. Acad. Sci., USA 82:5208 5212 (1985).;;Cox et al., Detection of mRNAs in Sea Urchin Embryos by in Situ Hybridizaton Using Aasymmetric RNA Probes Dev. Biol. 101:485 502 (1984).;;Deneris et al., Primary Structure and Expression of 2: A novel Subunit of Neuronal Nicotinic Acetylcholine Receptors Neuron 1:45 54 (1988).;;Devillers Thiery et al., Complete mRNA coding sequence of the acetylcholine binding subunit of Torpedo marmorata acetylcholine receptor: A model for the transmembrane organization of the polypeptide chain Proc. Natl Acad. Sci., USA 80:2067 2071 (1983).;;Evans et al., Muscle Acetylcholine Receptor Biosynthesis: Regulation by Transcript Availability J. Biol. Chem. 262(10):4911 4916 (1987).;;Finer Moore and Stroud, Amphipathic analysis and possible formation of the ion channel in an acetylcholine receptor Proc. Natl. Acad. Sci., USA 81:155 159 (1984).;;Fischbach and Schuetze, A post natal decrease in acetylcholine channel open time at rat end plates J. Physiol. 303:125 137 (1980).;;Giraudat et al., Structure of the High Affinity Binding Site for Noncompetitive Blockers of the Acetylcholine Receptor: 3 H Chlorpromazine Labels Homologous Residues in the and Chains Biochem. 26:2410 2418 (1987).;;Goldman et al., Muscle Denervation Increases the Levels of Two mRNAs Coding for the Acetylcholine Receptor Subunit J. Neurosci. 5:2553 2558 (1985).;;Goldman et al., Mapping of brain areas expressing RNA homologous to two different acetylcholine receptor subunit cDNAs Proc. Natl. Acad. Sci., USA 83:4076 4080 (1986).;;Goldman et al., Members of a Nicotinic Acetylcholine Receptor Gene Family Are Expressed in Different Regions of the Mammalian Central Nervous System Cell 48:965 973 (1987).;;Gorman et al., Recombinant Genomes Which Express Chloramphenicol Acetyltransferase in Mammalian Cells Mol. Cell. Biol. 2(9):1044 1051 (1982).;;Greene and Tischler, Establishment of noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor Proc. Natl. Acad. Sci., USA 73:(7)2424 2428 (1976).;;Grenningloh et al., The strychnine binding subunit of the glycine receptor shows homology with nicotinic acetylcholine receptors Nature 328:215 220 (1987).;;Guy, H. R., A structural model of the acetylcholine receptor channel based on partition energy and helix packing calculations Biophys. J. 45:249 261 (1984).;;Guy and Hucho, The ion channel of the nicotinic acetylcholine receptor Trends Neurosci 10(8):318 321 (1987).;;Hanke and Breer, Channel properties of an insect neuronal acetylcholine receptor protein reconstituted in planar lipid bilayers Nature 321:171 174 (1986).;;Hartzell and Fambrough, Acetylcholine Receptors: Distribution and extrajunctional density in rat diaphragm after denervation correlated with acetylcholine sensitivity J. Gen. Physiol. 60:248 262 (1972).;;Heidmann et al., Chromosomal Localizaton of Muscle Nicotinic Acetylcholine Receptor Genes in the Mouse Science 234:866 868 (1986).;;Heinemann et al., Molecular Biology of the Muscle Land Neural Acetylcholine Receptors In: Nicotinic Acetylcholine Receptor: Structure and Function, NATO ASI Series H, A. Maelicke, ed. (Berlin: Springer Verlag), H3:359 387 (1986).;;Higgins and Berg, Immunological Identification of a Nicotinic Acetylcholine Receptor on Bovine Chromaffin Cells J. Neurosci. 7(6):1792 1798 (1987).;;Houser et al., Organization and Morphological Characteristics of Cholinergic Neurons: an Immunocytochemical Study with a Monoclonal Antibody to Choline Acetyltransferase Brain Res. 266:97 119 (1983).;;Hucho et al., The ion channel of the nicotinic acetylcholine receptor in formed by the homologous helices M II of the receptor subunits FEBS Lett. 205(1)137 142 (1986).;;Huganir et al., Phosphorylation of the nicotinic acetylcholine receptor regulates its rate of desensitization Nature 321:774 776 (1986).;;Ichikawa and Hirata, Organization of Choline Acetyltransferase Containing Structures in the Forebrain of the Rat J. Neurosci. 6(1):281 292 (1986).;;Imoto et al., Location of a subunit region determining ion transport through the acetylcholine receptor channel Nature 324:670 674 (1986).;;Jaynes et al., Transcriptional Regulation of the Muscle Creatine Kinase Gene and Regulated Expression in Transfected Mouse Myoblasts Mol. Cell. Biol. 6(8):2855 2864 (1986).;;Kao and Karlin, Acetylcholine Receptor Binding Site Contains a Disulfide Cross link between Adjacent Half Cystinyl Residues J. Biol. Chem. 261(18):8085 8088 (1986).;;Karlin, A., Chemical Modification of the Active Site of Acetylcholine Receptor J. Gen. Phys. 54:245s 264s (1969).;;Kemp et al., Purification and Characterization of the Bungarotoxin Binding Protein from Rat Brain Brain Res. 347:274 283 (1985).;;Klarsfeld et al., A 5 Flanking Region of the Chicken Acetylcholine Receptor Subunit Gene Confers Tissue Specificity and Develomental Control of Expression in Transfected Cells Mol. Cell. Biol. 7(2):951 955 (1987).;;Kurosaki et al., Functional properties of nicotinic acetylcholine receptor subunits expressed in various combinations FEBS Lett. 214(2):253 258 (1987).;;Lamour et al., Spread of acetylcholine sensitivity in the necocortex following lesion of the nucleus basalis Brain Res. 252:377 381 (1982).;;Lichtensteiger et al., Stimulation of Nigrostriatal Dopamine Neurones by Nicotine Neuropharmacol. 21:963 968 (1982).;;Martin, B. R., Nicotine Receptors n the Central Nervous System In: The Receptors, P. M. Conn, ed. (Orlando, FL: Academic Press) 3:393 415 (1986).;;Mauron et al., Structure of Chicken Genes Encoding the Nicotinic Acetylcholine Receptor Subunits and Their Variants Soc. for Neuroscience, 15th Annual Meeting, Abstract 55.10, p. 171 (1985).;;McCarthy et al., The molecular Neurobiology of the Acetylcholine Receptor Ann. Rev. Neurosci. 9:383 413 (1986).;;McCormick and Prince, Acetylcholine Causes Rapid Nicotinic Excitation in the Medial Habenular Nucleus of Guinea Pig, in vitro J. Neurosci. 7(3):742 752 (1987).;;Michler and Sakmann, Receptor Stability and Channel Conversion in the Subsynaptic Membrane of the Developing Mammalian Neuromuscular Junction Dev. Biol. 80:1 17 (1980).;;Mishina et al., Expression of functional acetylcholine receptor from cloned cDNAs Nature 307:604 608 (1984).;;Mishina et al., Molecular distinction between fetal and adult forms of muscle acetylcholine receptor Nature 321:406 411 (1986).;;Mulac Jercevic and Atassi, Segment 182 198 of Torpedo californica acetylcholine receptor contains a second toxin binding region and binds anti receptor antibodies FEBS Lett. 199(1):68 74 (1986).;;Nef et al., Structure linkage, and sequence of the two genes encoding the and subunits of the nicotinic acetylcholine receptor Proc. Natl. Acad. Sci., USA 81:7975 7979 (1984).;;Nef et al., Acetylcholine Receptor Related Genes Expressed in the Nervous System In: Nicotinic Acetylcholine Receptor: Structure and Function, NATO ASI Series, vol. H3, A. Maelicke, ed., (Springer Verlag) pp. 417 422 (1986).;;Nef et al., Genes expressed in the brain define three distinct neuronal nicotinic acetylcholine receptors EMBO J. 7(3):595 601 (1988).;;Neumann et al., Mapping of the bungarotoxin binding site within the subunit of the acetylcholine receptor Proc. Natl. Acad. Sci., USA 83:3008 3011 (1986).;;Noda et al., Primary structure of subunit precursor of Torpedo californica acetylcholine receptor deduced from cDNA sequence Nature 299:793 797 (1982).;;Noda et al,. Structural homology of Torpedo californica acetylcholine receptor subunits Nature 302:528 532 (1983).;;Noda et al., Cloning and sequence analysis of calf cDNA and human genomic DNA encoding subunit precursor of muscle acetylcholine receptor Nature 305:818 823 (1983).;;Oswald and Freeman, Alpha Bungarotoxin Binding and Central Nervous System Nicotinic Acetylcholine Receptors Neuroscience 6:1 14 (1981).;;Patrick and Stallcup, Immunological distinction between acetylcholine receptor and the bungarotoxin binding component on sympathetic neurons Proc. Natl. Acad. Sci., USA 74(10):4689 4692 (1977).;;Patrick and Stallcup, Bungarotoxin Binding and Cholinergic Receptor Function on a Rat Sympathetic Nerve Line J. Biol. Chem. 252:8629 8633 (1977).;;Patrick et al., Molecular Cloning of the Acetylcholine Receptor Cold Spring Harbor Symposia on Quantitative Biology XLVIII:71 79 (1983).;;Pearson et al., The cortical relationships of certain basal ganglia and the cholinergic basal forebrain nuclei Brain Res. 261:327 330 (1983).;;Popot and Changeux, Nicotinic Receptor of Acetylcholine: Structure of an Oligomeric Integral Membrane Protein Physiological Revs. 64(4):1162 1239 (1984).;;Rang, H. P., The Characteristics of Synaptic Currents and Responses to Acetylcholine of Rat Submandibular Ganglion Cells J. Physiol. 311:23 55 (1981).;;Ravdin and Berg, Inhibition of neuronal acetylcholine sensitivity by toxins from Bungarus multicinctus venom Proc. Natl. Acad. Sci., USA 76(4):2072 2076 (1979).;;Rotter and Jacobowitz, Neurochemical Identification of Cholinergic Forebrain Projection Sites of the Nucleus Tegmentalis Dorsalis Lateralis Brain Res. Bull. 6:525 529 (1981).;;Safran et al,. Analysis of acetylcholine receptor phosphorylation sites using antibodies to synthetic peptides and monoclonal antibodies EMBO J. 5:3175 3178 (1986).;;Schoepfer et al., cDNA Clone Coding for the Structural Subunit of a Chicken Brain Nicotinic Acetylcholine Receptor Neuron 1:241 248 (1988).;;Schofield et al., Sequence and functional expression of the GABA A receptor shows a ligand gated receptor super family Nature 328:221 227 (1987).;;Schubert et al., Characterization of a Unique Muscle Cell Line J. Cell. Bio. 61:398 413 (1974).;;Sebbane et al., Characterization of the mRNA for Mouse Muscle Acetylcholine Receptor Subunit by Quantitative Translation in Vitro J. Biol. Chem. 258:3294 3303 (1983).;;Shibahara et al,. Cloning and sequencing analysis of human genomic DNA encoding subunit precursor of muscle acetylcholine receptor Eur. J. Biochem. 146:349 359 (1985).;;Smith et al., Characterization of a Component in Chick Ciliary Ganglia that Cross reacts with Monoclonal Antibodies to Muscle and Electric Organ Acetylcholine Receptor J. Neurosci. 5(10):2726 2731 (1985).;;Stroud and Finer Moore, Acetylcholine Receptor Structure, Function, and Evolution Ann. Rev. Cell. Biol. 1:317 351 (1985).;;Sugiyama and Yamashita, Characterization of Putative Nicotinic Acetylcholine Receptors Solubilized from Rat Brains Brain Res. 373:22 26 (1986).;;Swanson et al., Immunohistochemical localization of monoclonal antibodies to the nicotinic acetylcholine receptor in chick midbrain Proc. Natl. Acad. Sci., USA 80:4532 4536 (1983).;;Swanson et al., Immunohistochemical Localization of Neuronal Nicotinic Receptors in the Rodent Central Nervous System J. Neurosci. 7(10):3334 3342 (1987).;;Takai et al., Cloning, sequencing and expression of cDNA for a novel subunit of acetylcholine receptor from calf muscle Nature 315:761 764 (1985).;;Vicini and Schuetze, Gating Properties of Acetylcholine Receptors at Developing Rat Endplates J. Neurosci. 5(8):2212 2224 (1985).;;Wada et al,. Functional Expression of a New Pharmacological Subtype of Brain Nicotinic Acetylcholine Receptor Science 240:330 334 (1988).;;Weill et al., Affinity Labeling of Purified Acetylcholine Receptor from Torpedo Californica Biochem. Biophys. Res. Commun. 61(3):997 1003 (1974).;;Whiting and Lindstrom, Pharmacological Properties of Immuno Isolated Neuronal Nicotinic Receptors J. Neurosci. 6(10):3061 3069 (1986).;;Whiting and Lindstrom, Purification and Characterization of a Nicotinic Acetylcholine Receptor from Chick Brain Biochem. 25:2082 2093 (1986).;;Whiting and Lindstrom, Affinity labelling of neuronal acetylcholine receptors localizes acetylcholine binding sites to their subunits FEBS Lett. 213(1):55 60 (1987).;;Whiting et al., Functional acetylcholine receptor in PC12 cells reacts with a monoclonal antibody to brain nicotinic receptors Nature 327:515 518 (1987).;;Whiting et al., Neuronal nicotinic acetylcholine receptor subunit is coded for by the cDNA clone 4 FEBS Lett. 219(2):459 463 (1987).;;Whiting and Lindstrom, Purification and characterization of a nicotinic acetylcholine receptor from rat brain Proc. Natl. Acad. Sci., USA 84:595 599 (1987).;;Wilson et al., Determination of the primary amino acid sequence specifying the bungarotoxin binding site on the subunit of the acetylcholine receptor for Torpedo californica Proc. Natl. Acad. Sci., USA 82:8790 8794 (1985).;;Wonnacott, S., Bungarotoxin Binds to Low Affinity Nicotine Binding Sites in Rat Brain J. Neurochem. 47:1706 1712 (1986).;;Patrick et al, P.N.A.S. 74:4689 4692, Oct. 1977.;;Mothfessel et al., Pflugers Arch. 407(6):577 588, Dec. 1986, Abstract.;;Whiting et al., P.N.A.S. 84:595 599, Jan. 1987.",EXPIRED
141,US,A,US 6136550 A,068-935-055-963-228,2000-10-24,2000,US 34995694 A,1994-12-06,US 34995694 A;;US 89818592 A;;US 32138489 A;;US 17029588 A,1988-03-18,Neuronal nicotinic acetylcholihne receptor compositions,"The present invention relates to a family of neuronal nicotinic acetylcholine receptors comprised of neuronal agonist and non-agonist binding subunits, and DNA sequences encoding such subunits. These novel neuronal nicotinic acetylcholine receptor subunits include the agonist binding subunits alpha2, alpha3, alpha4, and alpha5, plus non-agonist binding subunits beta2, beta3 and beta4. Representative cDNA clones that contain the DNA sequences of the invention have been deposited with the American Type Culture Collection for patent purposes.",SALK INST FOR BIOLOGICAL STUDI,HEINEMANN STEPHEN FOX;;PATRICK JAMES WARNER;;BOULTER JAMES RICHARD;;DENERIS EVAN SAMUEL;;WADA KEIJI;;BALLIVET MARC CHARLES;;GOLDMAN DANIEL JAY;;CONNOLLY JOHN GERARD;;DUVOISIN ROBERT MICHAEL;;HEINEMANN EDEN DEER,MERCK SHARP & DOHME CORP (2009-11-02),https://lens.org/068-935-055-963-228,Granted Patent,yes,1,3,5,19,0,C07K14/70571;;G01N33/944;;G01N2500/04;;C07K14/70571;;G01N33/944;;G01N2500/04,C07K14/705;;C12N15/12;;G01N33/566,435/7.21;;435/69.1;;435/252.3;;435/320.1;;436/501;;536/23.5,6,4,086-728-559-738-201;;030-461-226-783-811;;088-944-431-004-208;;019-531-252-128-872,10.1038/307604a0;;6320016;;10.1073/pnas.84.2.595;;3467376;;pmc304257;;10.1038/319368a0;;3753746;;10.1038/327515a0;;2438558,"Mishina et al. Expression of Functional Acetylcholine receptor . . . . Nature 307:604 608, Feb. 1984.;;Whiting et al. Proc. Natl. Acad. Sci. USA 84:595 599, Jan. 1987.;;Boulter et al. Isolation of a cDNA clone coding fpr a possible neural nicotinic acetylcholine receptor alpha subunit , Nature 319:368 374, Jan. 1986.;;Goldman et al. Members of a Nicotine Acetylcholine receptor gene family . . . . Cell 48:204 213, Mar. 1987.;;Whiting et al. Functional acetylcholine receptor in PC12 cells . . . . Nature 327:515 518, Jun. 1987.;;Whiting et al. Affinity Labeling of Neuronal acetylcholine receptors . . . . FEBS Letters 23(1):55 60, Feb. 1984.",EXPIRED
142,US,A,US 5371188 A,042-214-497-438-03X,1994-12-06,1994,US 89818592 A,1992-06-12,US 89818592 A;;US 66447391 A;;US 32138489 A;;US 17029588 A,1988-03-18,Neuronal nicotinic acetylcholine receptor compositions,"The present invention relates to a family of neuronal nicotinic acetylcholine receptors comprised of neuronal agonist and non-agonist binding subunits, and DNA sequences encoding such subunits. These novel neuronal nicotinic acetylcholine receptor subunits include the agonist binding subunits alpha2, alpha3, alpha4, and alpha5, plus non-agonist binding subunits beta2, beta3 and beta4. Representative cDNA clones that contain the DNA sequences of the invention have been deposited with the American Type Culture Collection for patent purposes.",SALK INST FOR BIOLOGICAL STUDI,HEINEMANN STEPHEN F;;PATRICK JAMES W;;BOULTER JAMES R;;DENERIS EVAN S;;WADA KEIJI;;BALLIVET MARC C;;GOLDMAN DANIEL J;;CONNOLLY JOHN G;;DUVOISIN ROBERT M;;HEINEMANN EDEN D,,https://lens.org/042-214-497-438-03X,Granted Patent,yes,1,24,5,19,0,C07K14/70571;;G01N33/944;;G01N2500/04;;C07K14/70571;;G01N33/944;;G01N2500/04,C07K14/705;;C12N15/12;;G01N33/566,530/350;;435/6;;435/62.1;;435/252.3;;435/320.1,6,6,086-728-559-738-201;;030-461-226-783-811;;088-944-431-004-208;;033-531-880-234-18X;;019-531-252-128-872;;054-227-081-244-432,10.1038/307604a0;;6320016;;10.1073/pnas.84.2.595;;3467376;;pmc304257;;10.1038/319368a0;;3753746;;3829125;;10.1016/0092-8674(87)90705-7;;10.1038/327515a0;;2438558;;2435576;;10.1016/0014-5793(87)81464-3,"Mishina, M. et al. Expression of Functional Acetylcholine receptor . . . Nature vol. 307, pp. 604 608 Feb. 16, 1984.;;Whiting & Lindstrom, Proc. Natl. Acad. Sci. USA vol. 84, pp. 595 599, Jan. 1987.;;Boulter, J. et al. Isolation of a cDNA clone coding for a possible neural nicotinic acetylcholine receptor subunit Nature vol. 319 pp. 368 374 Jan. 30, 1986.;;Goldman, D. et al. Members of a Nicotine Acetylcholine receptor gene family . . . Cell vol. 48, pp. Mar. 27, 1987.;;Whiting, P. J. et al. Functional acetylcholine receptor in PC12 cells . . . Nature vol. 327 pp. 515 518 Jun. 11, 1987.;;Whiting, Paul & Lindstrom, Jon Affinity Labelling of Neuronal acetylcholine receptors . . . FEBS Letters vol. 23(1) pp. 55 60 Mar. 1987.",EXPIRED
